Form 8-K
8-K — Evolution Metals & Technologies Corp.
Accession: 0001213900-26-054183
Filed: 2026-05-11
Period: 2026-05-07
CIK: 0001866226
SIC: 3690 (MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES)
Item: Entry into a Material Definitive Agreement
Item: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item: Unregistered Sales of Equity Securities
Item: Regulation FD Disclosure
Item: Financial Statements and Exhibits
Documents
8-K — ea0290073-8k_evolution.htm (Primary)
EX-4.1 — FIRST CLOSING DEBENTURE (ea029007301ex4-1.htm)
EX-4.2 — FORM OF CONVERTIBLE DEBENTURE (ea029007301ex4-2.htm)
EX-10.1 — SECURITIES PURCHASE AGREEMENT (ea029007301ex10-1.htm)
EX-10.2 — REGISTRATION RIGHTS AGREEMENT (ea029007301ex10-2.htm)
EX-10.3 — GUARANTY AND SECURITY AGREEMENT (ea029007301ex10-3.htm)
EX-99.1 — PRESS RELEASE DATED MAY 11, 2026 (ea029007301ex99-1.htm)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K — CURRENT REPORT
8-K (Primary)
Filename: ea0290073-8k_evolution.htm · Sequence: 1
false
0001866226
0001866226
2026-05-07
2026-05-07
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities
Exchange Act of 1934
Date of report (Date of earliest event reported):
May 7, 2026
Evolution Metals & Technologies Corp.
(Exact name of registrant as specified in its charter)
Delaware
001-41183
87-1006702
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)
(IRS Employer
Identification No.)
4040
NE 2nd Ave, Suite 349
Miami, Florida 33137
(Address and zip code of principal executive offices)
561-225-3205
(Registrant’s telephone number, including
area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.0001 par value per share
EMAT
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement
Securities Purchase Agreement and Convertible
Debentures
On May 7, 2026, Evolution Metals & Technologies
Corp. (“EMAT” or the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”)
with YA II PN, LTD. (“Yorkville”), a fund managed by Yorkville Advisors Global, LP, pursuant to which the Company agreed to
issue and sell to Yorkville convertible debentures in the aggregate principal amount of up to $100,000,000 (the “Convertible Debentures”
and each a “Convertible Debenture”), which will be convertible into shares of the Company’s common stock, par value
$0.0001 per share (the “Common Stock,” and as converted, the “Conversion Shares”).
The first Convertible Debenture (the “First
Debenture”) in the principal amount of $20,000,000 was issued on May 7, 2026. The second Convertible Debenture in the principal
amount of $5,775,000 is expected to be issued upon effectiveness of the Registration Statement on Form S-1, which the Company has agreed
to file pursuant to the Registration Rights Agreement, as such term is defined below. Additionally, pursuant to the Securities Purchase
Agreement, up to $74,225,000 in Convertible Debentures shall be purchased in subsequent tranches from time to time upon the mutual agreement
of the Company and Yorkville.
Each Convertible Debentures will have a purchase
price equal to 97% of principal amount thereunder. Each Convertible Debenture is convertible into Conversion Shares at a conversion price
equal to the lower of $12.09 or 95% of the lowest daily volume-weighted average price (“VWAP”) during the 5 consecutive trading
days immediately preceding the conversion date. The Company shall not issue any Conversion Shares upon conversion of the Convertible Debentures
held by Yorkville if the issuance of such Conversion Shares would exceed the aggregate number of Common Stock that the Company may issue
in compliance with the Company’s obligations under the rules or regulations of the Nasdaq Stock Market (the “Exchange Cap”).
The Exchange Cap will not apply if the Company obtains the approval of its stockholders as required by the applicable rules of the Nasdaq
Stock Market for issuances of Common Stock in excess of such amount. In addition, no conversion will be permitted to the extent that,
after giving effect to such conversion, the holder together with the certain related parties would beneficially own in excess of 4.99%
of the Common Stock outstanding immediately after giving effect to such conversion, subject to certain adjustments.
The First Debenture bears interest at an annual
rate of 5.0%, unless an event of default occurs and remains uncured, upon which the Convertible Debentures will bear interest at an annual
rate of 18.0%. The Convertible Debentures will mature on November 7, 2027.
The Company will not be required to make monthly
cash payments pursuant to the Convertible Debentures unless an Amortization Event, as such term is defined below, has occurred and then
the Company will make monthly cash payments each month until the entire outstanding amount under the Convertible Debentures have been
repaid. An “Amortization Event” means (i) the VWAP of the Company’s Common Stock is lower than the floor price for any
five of seven consecutive trading days, (ii) the Company has issued in excess of 99% of the Common Stock available under the Exchange
Cap or (iii) Yorkville is unable to use the Registration Statement, as such term is defined below, for a period of 10 consecutive trading
days.
The monthly cash payments will be in an amount
equal to 1/5 of the original principal amount (or the outstanding principal amount of the Convertible Debentures if lower than such amount),
plus a payment premium of 5% and all accrued and unpaid interest as of the date of such payment. Such Amortization Event payments will
commence 7 days following the Amortization Event.
The Securities Purchase Agreement includes customary
registration rights, investor protections, and provisions governing trading activity, including limitations on short selling. The Company
intends to use the proceeds from the facility for general corporate purposes, including supporting the expansion of its operations and
development initiatives.
The foregoing description of the Securities Purchase
Agreement, the First Debenture and the Convertible Debentures does not purport to be complete and is qualified in its entirety by reference
to the full text of each such agreement, which are filed as Exhibits 10.1, 4.1 and 4.2, to this Current Report on Form 8-K and are incorporated
herein by reference.
Registration Rights Agreement
On May 7, 2026, pursuant to the Securities Purchase
Agreement, the Company and Yorkville entered into a Registration Rights Agreement (the “Registration Rights Agreement”) pursuant
to which Yorkville is entitled to certain registration rights under the Securities Act of 1933, as amended (the “Securities Act”).
Pursuant to the Registration Rights Agreement, the Company is required to, on the 30th calendar day following the date of the Securities
Purchase Agreement, file with the Securities and Exchange Commission a registration statement (the “Registration Statement”)
registering the resale by Yorkville of 5.4 million Conversion Shares. Under the Registration Rights Agreement, Yorkville was also granted
piggyback registration rights under certain conditions as described in the Registration Rights Agreement.
1
The foregoing description of the Registration
Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of such document, which
is filed herewith as Exhibit 10.2 and is incorporated herein by reference.
Guaranty and Security Agreement
On May 7, 2026, pursuant to the Securities Purchase
Agreement, the Company and Yorkville entered into a Global Guarantee Agreement (the “Global Guarantee Agreement”), pursuant
to which, the Company and its subsidiaries agreed to guarantee all of the Company’s obligations under the Convertible Debentures.
The foregoing description of the Global Guarantee
Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of each such agreement, which
is filed as Exhibits 10.3, to this Current Report on Form 8-K and is incorporated herein by reference.
Item 2.03 Creation of a Direct Financial
Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The information contained in Item 1.01 is
incorporated herein by reference.
Item 3.02 Unregistered Sales of
Equity Securities.
The information contained
in Item 1.01 is incorporated herein by reference. The issuance of the Convertible Debentures and the Conversion Shares will be exempt
from registration pursuant to Section 4(a)(2) of the Securities Act. Yorkville represented to the Company that it is an “accredited
investor” as defined in Rule 501 of the Securities Act and that each of the Convertible Debentures and the Conversion Shares will
be acquired for investment purposes and not with a view to, or for sale in connection with, any distribution thereof.
Item 7.01 Regulation FD Disclosure
On May 11, 2026, the Company issued a press release
announcing the Company’s securing an investment from Yorkville. A copy of the press release is furnished herewith as Exhibit 99.1
and incorporated herein by reference.
The information in this Item 7.01 of this Current
Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section,
nor shall it be deemed incorporated by reference into any filing by the Company under the Securities Act of 1933, as amended, or the Exchange
Act, except as expressly set forth by specific reference in such filing.
2
Cautionary Statement Regarding Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking
statements within the meaning of the federal securities laws, including within the meaning of the “safe harbor” provisions
of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or
the future financial or operating performance of EMAT and may include, without limitation, statements regarding EMAT’s strategy,
business plans, growth opportunities, projected financial information, expected production capacities, anticipated market demand, regulatory
developments, and other future events or conditions. In some cases, you can identify forward-looking statements by terminology such as
“may,” “should,” “expect,” “intend,” “will,” “estimate,” “anticipate,”
“believe,” “predict,” “potential,” “plan,” “project,” “target,”
“forecast,” or the negatives of these terms or variations of them or similar terminology. These forward-looking statements
are based on management’s current expectations and assumptions and are subject to risks, uncertainties, and other factors that could
cause actual results to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties
include, but are not limited to, EMAT’s ability to execute its business plan, obtain financing, construct and scale facilities,
secure feedstock and offtake agreements, obtain necessary permits and regulatory approvals, manage supply chain disruptions, respond to
competitive pressures, address geopolitical and macroeconomic risks, and other risks described in EMAT’s filings with the U.S. Securities
and Exchange Commission (the “SEC”). Forward-looking statements speak only as of the date they are made. EMAT undertakes no
obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except
as required by law.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
The following exhibits are being filed herewith:
Exhibit No.
Description
4.1
First Closing Debenture
4.2
Form of Convertible Debenture
10.1
Securities Purchase Agreement
10.2
Registration Rights Agreement
10.3
Guaranty and Security Agreement
99.1
Press Release dated May 11, 2026
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
3
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: May 11, 2026
Evolution Metals & Technologies Corp.
By:
/s/ Christopher Clower
Name:
Christopher Clower
Title:
Chief Financial Officer and Chief Operating Officer
4
EX-4.1 — FIRST CLOSING DEBENTURE
EX-4.1
Filename: ea029007301ex4-1.htm · Sequence: 2
Exhibit 4.1
NEITHER THIS DEBENTURE NOR THE SECURITIES
INTO WHICH THIS DEBENTURE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
OF ANY STATE. THESE SECURITIES HAVE BEEN SOLD IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED
IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.
EVOLUTION METALS & TECHNOLOGIES CORP.
Convertible
Debenture
Original Principal Amount:
$20,000,000
Issuance Date: May 7, 2026
Number: EMAT-1
FOR VALUE RECEIVED, EVOLUTION METALS &
TECHNOLOGIES CORP., an entity organized under the laws of Delaware (the “Company”), hereby promises to pay to the
order of YA II PN, LTD., or its registered assigns (the “Holder”) the amount set out above as the Original Principal
Amount (or such lesser amount as reduced pursuant to the terms hereof pursuant to repayment, redemption, conversion or otherwise, the
“Principal”) and the Payment Premium, as applicable, in each case when due, and to pay interest (“Interest”)
on any outstanding Principal at the applicable Interest Rate (as defined below) from the date set out above as the Issuance Date (the
“Issuance Date”) until the same becomes due and payable, whether upon the Maturity Date or acceleration, conversion,
redemption or otherwise (in each case in accordance with the terms hereof). The Issuance Date is the date of the first issuance of this
Convertible Debenture (as amended, amended and restated, extended, supplemented or otherwise modified in writing from time to time, this
“Debenture”) regardless of the number of transfers and regardless of the number of instruments, which may be issued
to evidence such Debenture. This Debenture was originally issued pursuant to the Securities Purchase Agreement dated as of May 7, 2026,
between the Company and the Buyers listed on the Schedule of Buyers attached thereto (as it may be amended from time to time, the “Securities
Purchase Agreement”). Certain capitalized terms used herein are defined in Section (12).
(1) GENERAL TERMS
(a) Maturity
Date. On the Maturity Date, the Company shall pay to the Holder an amount in cash representing all outstanding Principal, accrued
and unpaid Interest, and any other amounts outstanding pursuant to the terms of this Debenture. The “Maturity Date” shall
be November 7, 2027, as may be extended at the option of the Holder.
(b) Interest Rate and Payment
of Interest. Interest shall accrue on the outstanding Principal balance hereof at an annual rate equal to 5.00% (“Interest
Rate”), which Interest Rate shall increase to an annual rate of 18.00% upon the occurrence of an Event of Default (for so long
as such event remains uncured). Interest shall be calculated based on a 365-day year and the actual number of days elapsed, to the extent
permitted by applicable law.
(c) Amortization
Payments. If, any time after the Issuance Date set forth above, and from time to time thereafter, an Amortization Event has occurred,
then the Company shall make monthly cash payments beginning on the 7th Trading Day after the Amortization Event Date and continuing on
the same day of each successive Calendar Month until the entire outstanding amounts shall have been repaid. Each monthly cash payment
shall be in an amount equal to the sum of (i) $4,000,000 of Principal on this Debenture (or the outstanding Principal, if less than such
amount (the “Amortization Principal Amount”), plus (ii) the Payment Premium in respect of such Amortization
Principal Amount, plus (iii) all accrued and unpaid interest hereunder as of each payment date. The obligation of the Company to
make monthly cash payments related to an Amortization Event shall cease (with respect to any payment that has not yet come due) if at
any time after the Amortization Event Date (A) in the event of a Floor Price Event, on the date that is the 10th consecutive Trading Day
that the daily VWAP is greater than the Floor Price then in effect, (B) in the event of an Exchange Cap Event, the date the Company has
obtained stockholder approval to increase the number of Common Shares under the Exchange Cap and/or the Exchange Cap no longer applies,
or (C) in the event of a Registration Event, the condition or event causing the Registration Event has been cured or the Holder is able
to resell the Common Shares issuable upon conversion of this Debenture in accordance with Rule 144 under the Securities Act, unless a
subsequent Amortization Event occurs.
(d) Optional
Redemption. The Company at its option shall have the right, but not the obligation, to redeem (“Optional
Redemption”) early a portion or all amounts outstanding under this Debenture as described in this Section; provided, that
the Company provides the Holder with written notice (each, a “Redemption Notice”) of its desire to exercise an
Optional Redemption, which Redemption Notice (i) shall be delivered to the Holder after the close of regular trading hours on a
Trading Day, and (ii) may only be given if the VWAP of the Common Shares was less than the Fixed Price on the date such Redemption
Notice is delivered, unless otherwise agreed by the Holder. Each Redemption Notice shall be irrevocable and shall specify the
outstanding balance of the Debenture to be redeemed and the Redemption Amount. The “Redemption Amount” shall be
an amount equal to (a) the outstanding Principal balance being redeemed by the Company plus (b) the Payment Premium in
respect of such Principal amount plus (c) all accrued and unpaid interest hereunder as of the date of such redemption.
After receipt of a Redemption Notice, the Holder shall have ten (10) Trading Days (beginning with the Trading Day immediately
following the date such Redemption Notice is delivered to the Holder in accordance with this term of this Section 1(d)) to elect to
convert all or any portion of this Debenture. On the eleventh (11th) Trading Day following the delivery of the applicable
Redemption Notice, the Company shall deliver to the Holder the Redemption Amount with respect to the Principal amount redeemed to
the extent not converted and otherwise after giving effect to conversions or other payments made during such ten (10) Trading Day
period.
(e) Other
than as specifically set forth in this Debenture, the Company shall not have the ability to make any early repayments without the consent
of or at the request of the Holder.
2
(f) Payment
Dates. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall be made
on the next succeeding Business Day.
(2) EVENTS OF DEFAULT.
(a) An
“Event of Default”, wherever used herein, means any one of the following events (whatever the reason and whether it
shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court, or any order,
rule or regulation of any administrative or governmental body) shall have occurred:
(i) The
Company’s failure to pay to the Holder any amount of Principal, Redemption Amount, Payment Premium, Interest, or other amounts when and
as due under this Debenture or any other Transaction Document and within five (5) Trading Days after such payment is due;
(ii) (A)
The Company or any Subsidiary of the Company shall commence, or there shall be commenced against the Company or any Subsidiary of the
Company, any proceeding under any applicable bankruptcy or insolvency laws as now or hereafter in effect or any successor thereto, or
the Company or any Subsidiary of the Company commences any other proceeding under any reorganization, arrangement, adjustment of debt,
relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction whether now or hereafter in effect relating
to the Company or any Subsidiary of the Company, in any such bankruptcy, insolvency or other proceeding which remains undismissed for
a period of sixty one (61) days; (B) the Company or any Subsidiary of the Company is adjudicated insolvent or bankrupt; (C) any order
of relief or other order approving any such case or proceeding is entered; (D) the Company or any Subsidiary of the Company suffers any
appointment of any custodian, private or court appointed receiver or the like for it or all or substantially all of its property which
continues undischarged or unstayed for a period of sixty one (61) days; (E) the Company or any Subsidiary of the Company makes a general
assignment of all or substantially all of its assets for the benefit of creditors; (F) the Company or any Subsidiary of the Company shall
fail to pay, shall state that it is unable to pay, or shall be unable to pay, its debts generally as they become due; (G) the Company
or any Subsidiary of the Company shall call a meeting of its creditors with a view to arranging a composition, adjustment or restructuring
of its debts; (H) the Company or any Subsidiary of the Company shall by any act or failure to act expressly indicate its consent to, approval
of or acquiescence in any of the foregoing; or (I) any corporate or other action is taken by the Company or any Subsidiary of the Company
for the purpose of effecting any of the foregoing;
(iii) The
Company or any Subsidiary of the Company shall default in any of its obligations under any note, debenture, mortgage, credit agreement
or other facility, indenture agreement, factoring agreement or other instrument under which there may be issued, or by which there may
be secured or evidenced any indebtedness for borrowed money or money due under any long term leasing or factoring arrangement of the Company
or any Subsidiary of the Company in an amount exceeding $2,500,000, whether such indebtedness now exists or shall hereafter be created
and such default is not cured within the time prescribed by the documents governing such indebtedness or if no time is prescribed, within
thirty (30) Trading Days, and as a result, such indebtedness becomes or is declared due and payable;
3
(iv) A
final judgment or judgments for the payment of money in excess of $2,500,000 in the aggregate are rendered against the Company and/or
any of its Subsidiaries and which judgments are not, within thirty (30) days after the entry thereof, bonded, discharged, settled or stayed
pending appeal, or are not discharged within thirty (30) days after the expiration of such stay; provided, however, any judgment which
is covered by insurance or an indemnity from a creditworthy party shall not be included in calculating the $250,000 amount set forth above
so long as the Company provides the Holder a written statement from such insurer or indemnity provider (which written statement shall
be reasonably satisfactory to the Holder) to the effect that such judgment is covered by insurance or an indemnity and the Company or
such Subsidiary (as the case may be) will receive the proceeds of such insurance or indemnity within sixty (60) days of the issuance of
such judgment;
(v) The
Common Shares shall cease to be quoted or listed for trading, as applicable, on any Principal Market for a period of ten (10) consecutive
Trading Days;
(vi) The
Company or any Subsidiary of the Company shall be a party to any Change of Control Transaction unless in connection with such Change of
Control Transaction this Debenture is retired;
(vii) The
Company’s (A) failure to deliver the required number of Common Shares to the Holder within two (2) Trading Days after the applicable
Share Delivery Date or (B) notice, written or oral, to any holder of the Debenture, including by way of public announcement, at any time,
of its intention not to comply with a request for conversion of all or a portion of this Debenture into Common Shares that is tendered
in accordance with the provisions of this Debenture;
(viii) The
Company shall fail for any reason to deliver the payment in cash pursuant to a Buy-In (as defined below) within five (5) Business Days
after such payment is due;
(ix) The
Company’s failure to timely file with the Commission any Periodic Report on or before the due date of such filing as established
by the Commission, it being understood, for the avoidance of doubt, that due date includes any permitted filing deadline extension under
Rule 12b-25 under the Exchange Act;
(x) Any
representation or warranty made or deemed to be made by or on behalf of the Company in or in connection with any Transaction
Document, or any waiver hereunder or thereunder, shall prove to have been incorrect in any material respect (or, in the case of any
such representation or warranty already qualified by materiality, such representation or warranty shall prove to have been
incorrect) when made or deemed made;
(xi) (A) Any
material provision of any Transaction Document, at any time after its execution and delivery and for any reason other than as
expressly permitted hereunder or thereunder, ceases to be in full force and effect; (B) the Company or any other Person contests in
writing the validity or enforceability of any provision of any Transaction Document; or (C) the Company denies in writing that it
has any or further liability or obligation under any Transaction Document, or purports in writing to revoke, terminate (other than
in accordance with the relevant termination provisions) or rescind any Transaction Document;
4
(xii) The
Company uses the proceeds of the issuance of this Debenture, whether directly or indirectly, and whether immediately, incidentally or
ultimately, to purchase or carry margin stock (within the meaning of Regulations T, U and X of the Federal Reserve Board, as in effect
from time to time and all official rulings and interpretations thereunder or thereof), or to extend credit to others for the purpose of
purchasing or carrying margin stock or to refund indebtedness originally incurred for such purpose;
(xiii) Any Event
of Default (as defined in the Other Debentures or in any Transaction Document other than this Debenture) occurs with respect to any Other
Debentures, or any breach of any material term of any other debenture, note, or instrument held by the Holder in the Company or any agreement
between or among the Company and the Holder; or
(xiv) The
Company shall fail to observe or perform any material covenant, agreement or warranty contained in, or otherwise commit any material breach
or default of any provision of this Debenture (except as may be otherwise covered by Sections (2)(a)(i) through
(2)(a)(xiii) hereof) or any other Transaction Document, which is not cured or remedied within the time prescribed
or if no time is prescribed within thirty (30) Business Days.
(b)
During the time that any portion of this Debenture is outstanding, if any Event of Default has occurred (other than an event with
respect to the Company described in Section (2)(a)(ii)),
the full unpaid Principal amount of this Debenture and all interest and other amounts owing in respect of this Debenture to the date
of acceleration, shall become, at the Holder’s election given by notice pursuant
to Section (5), immediately
due and payable in cash; provided that, in the case of any event with respect to the Company described in Section (2)(a)(ii),
the full unpaid Principal amount of this Debenture and all accrued and unpaid interest and other amounts owing in respect of this
Debenture to the date of acceleration, shall automatically become due and payable, in each case without presentment, demand, protest
or other notice of any kind, all of which are hereby waived by the Company. Furthermore, in addition to any other remedies, the
Holder shall have the right (but not the obligation) to convert, on one or more occasions all or part of the Debenture in accordance
with Section (3) (and subject
to the limitations set out in Section (3)(c)(i) and
Section (3)(c)(ii)) at any
time after an Event of Default has occurred and is continuing until all amounts outstanding under this Debenture have been repaid in
full. The Holder need not provide, and the Company hereby waives, any presentment demand, protest or other notice of any kind (other
than any required notice of conversion), and the Holder may immediately enforce any and all of its rights and remedies
hereunder and all other remedies available to it under applicable law. Such declaration may be rescinded and annulled by the Holder
in writing at any time prior to payment hereunder. No such rescission or annulment shall affect any subsequent Event of Default or
impair any right consequent thereon.
5
(3) CONVERSION
OF DEBENTURE. This Debenture shall be convertible into Common Shares, on the terms and conditions set forth in this Section (3).
(a) Conversion
Right. Subject to the limitations of Section (3)(c),
at any time or times on or after the Issuance Date, the Holder shall be entitled to convert any portion of the outstanding and unpaid
Conversion Amount into fully paid and nonassessable Common Shares in accordance with Section (3)(b),
at the Conversion Price. The number of Common Shares issuable upon conversion of any Conversion Amount pursuant to this Section (3)(a)
shall be determined by dividing (x) such Conversion Amount by (y) the Conversion Price. The Company shall
not issue any fraction of a Common Shares upon any conversion. All calculations under this Section (3)
shall be rounded to the nearest $0.0001. If the issuance would result in the issuance of a fraction of a
Common Share, the Company shall round such fraction of a Common Share up to the nearest whole share. The Company shall pay any and all
transfer, stamp and similar taxes that may be payable with respect to the issuance and delivery of Common Shares upon conversion of any
Conversion Amount.
(b) Mechanics of Conversion.
(i) Optional
Conversion. To convert any Conversion Amount into Common Shares on any date (a “Conversion Date”), the Holder
shall (A) transmit by email (or otherwise deliver), for receipt on or prior to 11:59 p.m., New York time, on such date, a copy of an
executed notice of conversion in the form attached hereto as Exhibit I (the “Conversion Notice”) to the
Company and (B) if required by Section (3)(b)(iii), surrender this Debenture to a nationally recognized
overnight delivery service for delivery to the Company (or an indemnification undertaking reasonably satisfactory to the Company
with respect to this Debenture in the case of its loss, theft or destruction). On or before the first (1st) Trading Day
following the date of receipt of a Conversion Notice (the “Share Delivery Date”), the Company shall (X) if legends
are not required to be placed on certificates or the book-entry position of the Common Shares and provided that the Transfer Agent
is participating in the Depository Trust Company’s (“DTC”) Fast Automated Securities Transfer Program, instruct
such transfer agent to credit such aggregate number of Common Shares to which the Holder shall be entitled to the Holder’s or its
designee’s balance account with DTC through its Deposit Withdrawal Agent Commission system or (Y) if the Transfer Agent is not
participating in the DTC Fast Automated Securities Transfer Program, issue and deliver to the address as specified in the Conversion
Notice, a certificate or book-entry position, registered in the name of the Holder or its designee, for the number of Common Shares
to which the Holder shall be entitled which certificates shall not bear any restrictive legends unless required pursuant to rules
and regulations of the Commission. If this Debenture is physically surrendered for conversion and the outstanding Principal of this
Debenture is greater than the Principal portion of the Conversion Amount being converted, then the Company shall as soon as
practicable and in no event later than three (3) Business Days after receipt of this Debenture and at its own expense, issue and
deliver to the holder a new Debenture representing the outstanding Principal not converted. The Person or Persons entitled to
receive the Common Shares issuable upon a conversion of this Debenture shall be treated for all purposes as the record holder or
holders of such Common Shares upon the transmission of a Conversion Notice.
6
(ii) Company’s Failure
to Timely Convert. If the Company shall fail, for any reason or for no reason, on or prior to the applicable Share Delivery Date
to issue and deliver a certificate to the Holder or credit the Holder’s balance account with DTC for the number of Common Shares to which
the Holder is entitled upon such Holder’s conversion of any Conversion Amount (a “Conversion Failure”), and if on or
after such Trading Day the Holder purchases (in an open market transaction or otherwise) Common Shares to deliver in satisfaction of
a sale by the Holder of Common Shares issuable upon such conversion that the Holder anticipated receiving from the Company (a “Buy-In”),
then the Company shall, within three (3) Business Days after the Holder’s request and in the Holder’s discretion, either (i) pay cash
to the Holder in an amount equal to the Holder’s total purchase price (including brokerage commissions and other out of pocket expenses,
if any) for the Common Shares so purchased (the “Buy-In Price”), at which point the Company’s obligation to deliver
such certificate (and to issue such Common Shares) shall terminate, or (ii) promptly honor its obligation to deliver to the Holder a
certificate or certificates representing such Common Shares to which the Holder is entitled with respect to such Conversion Notice and
pay cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over the product of (A) such number of Common Shares,
multiplied by (B) the Closing Price on the Conversion Date.
(iii) Book-Entry.
Notwithstanding anything to the contrary set forth herein, upon conversion of any portion of this Debenture in accordance with the terms
hereof, the Holder shall not be required to physically surrender this Debenture to the Company unless (A) the full Conversion Amount represented
by this Debenture is being converted or (B) the Holder has provided the Company with prior written notice (which notice may be included
in a Conversion Notice) requesting reissuance of this Debenture upon physical surrender of this Debenture. The Holder and the Company
shall maintain records showing the Principal and Interest converted and the dates of such conversions or shall use such other method,
reasonably satisfactory to the Holder and the Company, so as not to require physical surrender of this Debenture upon any conversion.
(c) Limitations on Conversions.
(i) Beneficial
Ownership. The Holder shall not have the right to convert any portion of this Debenture to the extent that after giving effect
to such conversion, the Holder, together with any affiliate thereof, would beneficially own (as determined in accordance with
Section 13(d) of the Exchange Act and the rules promulgated thereunder) in excess of 4.99% of the number of Common Shares
outstanding immediately after giving effect to such conversion. Since the Holder will not be obligated to report to the Company the
number of Common Shares it may hold at the time of a conversion hereunder, unless the conversion at issue would result in the
issuance of Common Shares in excess of 4.99% of the then outstanding Common Shares without regard to any other shares which may be
beneficially owned by the Holder or an affiliate thereof, the Holder shall have the authority and obligation to determine whether
the restriction contained in this Section will limit any particular conversion hereunder and to the extent that the Holder
determines that the limitation contained in this Section applies, the determination of which portion of the Principal amount of this
Debenture is convertible shall be the responsibility and obligation of the Holder. If the Holder has delivered a Conversion Notice
for a Principal amount of this Debenture that, without regard to any other shares that the Holder or its affiliates may beneficially
own, would result in the issuance in excess of the permitted amount hereunder, the Company shall notify the Holder of this fact and
shall honor the conversion for the maximum Principal amount permitted to be converted on such Conversion Date in accordance with
Section (3)(a) and, any Principal amount tendered for conversion in excess of the permitted amount
hereunder shall remain outstanding under this Debenture. The provisions of this Section may be waived by a Holder (but only as to
itself and not to any other Holder) upon not less than 65 days prior notice to the Company. Other Holders shall be unaffected by any
such waiver.
7
(ii) Principal
Market Limitation. Notwithstanding anything in this Debenture to the contrary, the Company shall not issue any Common Shares upon
conversion of this Debenture, or otherwise, if the issuance of such Common Shares, together with any Common Shares issued in connection
with any other related transactions that may be considered part of the same series of transactions, would exceed the aggregate number
Common Shares that the Company may issue in a transaction in compliance with the Company’s obligations under the rules or regulations
of the Nasdaq Stock Market LLC (“Nasdaq”) and shall be referred to as the “Exchange Cap,” except
that such limitation shall not apply if the Company’s stockholders have approved such issuances on such terms in excess of the Exchange
Cap in accordance with the rules and regulations of Nasdaq.
(d) Other Provisions.
(i) All
calculations under this Section (3) shall be rounded to the nearest $0.0001 or whole share.
(ii) So
long as this Debenture remains outstanding, the Company shall have reserved from its duly authorized share capital, and shall have instructed
the Transfer Agent to irrevocably reserve, the maximum number of Common Shares issuable upon conversion of this Debenture (assuming for
purposes hereof that (x) this Debenture is convertible at the Floor Price as of the date of determination, and (y) any such conversion
shall not take into account any limitations on the conversion of the Debenture set forth herein or therein (the “Required Reserve
Amount”)), provided that at no time shall the number of Common Shares reserved pursuant to this Section (3)(d)(ii)
be reduced other than pursuant to the conversion of this Debenture and the Other Debentures in accordance
with their terms, and/or cancellation, or reverse stock split. If at any time while this Debenture or any Other Debentures remain outstanding,
the Company does not have a sufficient number of authorized and unreserved Common Shares to satisfy the obligation to reserve for the
issuance the Required Reserve Amount, the Company will promptly take all corporate action necessary to propose to a meeting of its shareholders
an increase of its authorized share capital necessary to meet the Company’s obligations pursuant to this Debenture, and cause its board
of directors to recommend to the shareholders that they approve such proposal.
(iii) Nothing herein
shall limit a Holder’s right to pursue actual damages or declare an Event of Default pursuant to Section (2)
herein for the Company’s failure to deliver certificates representing Common Shares upon conversion within the period
specified herein and such Holder shall have the right to pursue all remedies available to it at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief, in each case without the need to post a bond or provide other
security. The exercise of any such rights shall not prohibit the Holder from seeking to enforce damages pursuant to any other
Section hereof or under applicable law.
8
(iv) Legal
Opinions. The Company is obligated to cause its legal counsel to deliver legal opinions to the Company’s transfer agent in connection
with any legend removal upon the expiration of any holding period or other requirement for which the Underlying Shares may bear legends
restricting the transfer thereof. To the extent a legal opinion is not provided (either timely or at all), then, in addition to being
an Event of Default hereunder, the Company agrees to reimburse the Holder for all reasonable costs incurred by the Holder in connection
with any legal opinions paid for by the Holder in connection with the sale or transfer of the Underlying Shares. The Holder shall notify
the Company of any such costs and expenses it incurs that are referred to in this section from time to time and all amounts owed hereunder
shall be paid by the Company with reasonable promptness.
(e) Adjustment of
Conversion Price upon Subdivision or Combination of Common Shares. If the Company, at any time while this Debenture is
outstanding, shall (i) pay a stock dividend or otherwise make a distribution or distributions on its shares of Common Shares or any
other equity or equity equivalent securities payable in Common Shares, (ii) subdivide outstanding Common Shares into a larger number
of shares, (iii) combine (including by way of reverse stock split) outstanding Common Shares into a smaller number of shares,
or (iv) issue by reclassification of Common Shares any shares of capital stock of the Company, then each of the Fixed Price and the
Floor Price shall be multiplied by a fraction of which the numerator shall be the number of Common Shares (excluding treasury
shares, if any) outstanding before such event and of which the denominator shall be the number of Common Shares outstanding after
such event. Any adjustment made pursuant to this Section shall become effective, in the case of a dividend distribution, immediately
after the record date for the determination of stockholders entitled to receive such dividend or distribution or, in the case of a
subdivision, combination or re- classification, and shall become effective immediately after the effective date of such subdivision,
combination or re-classification.
(f) Adjustment
of Conversion Price upon Issuance of Common Shares. If the Company, at any time while this Debenture is outstanding, issues or
sells any Common Shares or Convertible Securities (other than shares issued or sold by the Company in connection with any Excluded
Securities), for a consideration per share (the “New Issuance Price”) less than a price equal to the Fixed Price
in effect immediately prior to such issue or sale (such price the “Applicable Price”) (the foregoing a
“Dilutive Issuance”), then immediately after such Dilutive Issuance the Fixed Price then in effect shall be reduced
to an amount equal to the New Issuance Price. For the purposes hereof, if the Company in any manner issues or sells any Convertible
Securities (other than shares issued or sold by the Company in connection with any Excluded Securities) and the lowest price per
share for which one Common Share is issuable upon such conversion or exchange or exercise thereof is less than the Applicable Price,
then such Common Share shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance
or sale of such Convertible Securities for such price per share. No further adjustment of the Conversion Price shall be made upon
the actual issuance of such Common Share upon conversion or exchange or exercise of such Convertible Securities.
9
(g) Other
Corporate Events. In addition to and not in substitution for any other rights hereunder, prior to the consummation of any
Fundamental Transaction pursuant to which holders of Common Shares are entitled to receive securities or other assets with respect
to or in exchange for Common Shares (a “Corporate Event”), the Company shall make appropriate provision to ensure
that the Holder will thereafter have the right to receive upon a conversion of this Debenture, at the Holder’s option, (i) in
addition to the Common Shares receivable upon such conversion, such securities or other assets to which the Holder would have been
entitled with respect to such Common Shares had such Common Shares been held by the Holder upon the consummation of such Corporate
Event (without taking into account any limitations or restrictions on the convertibility of this Debenture) or (ii) in lieu of the
Common Shares otherwise receivable upon such conversion, such securities or other assets received by the holders of Common Shares in
connection with the consummation of such Corporate Event in such amounts as the Holder would have been entitled to receive had this
Debenture initially been issued with conversion rights for the form of such consideration (as opposed to Common Shares) at a
conversion rate for such consideration commensurate with the Conversion Price. Provision made pursuant to the preceding sentence
shall be in a form and substance satisfactory to the Required Holders. The provisions of this Section shall apply similarly and
equally to successive Corporate Events and shall be applied without regard to any limitations on the conversion or redemption of
this Debenture.
(h) Whenever
the Conversion Price is adjusted pursuant to Section 3(e) or 3(f) hereof, the Company shall promptly provide the Holder with a written
notice setting forth the Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.
(i)
In case of any (1) merger or consolidation of the Company or any Subsidiary of the Company with or into another Person, or (2) sale
by the Company or any Subsidiary of the Company of more than one-half of the assets of the Company in one or a series of related
transactions, a Holder shall have the right to (A) exercise any rights under Section (3)(f),
(B) convert the aggregate amount of this Debenture then outstanding into the shares of stock and other securities, cash and property
receivable upon or deemed to be held by holders of Common Shares following such merger, consolidation or sale, and such Holder shall
be entitled upon such event or series of related events to receive such amount of securities, cash and property as the Common Shares
into which such aggregate Principal amount of this Debenture could have been converted immediately prior to such merger,
consolidation or sales would have been entitled, or (C) in the case of a merger or consolidation, require the surviving
entity to issue to the Holder a convertible debenture with a Principal amount equal to the aggregate Principal amount of this
Debenture then held by such Holder, plus all accrued and unpaid Interest and other amounts owing thereon, which such newly issued
convertible debenture shall have terms identical (including with respect to conversion) to the terms of this Debenture, and shall be
entitled to all of the rights and privileges of the Holder of this Debenture set forth herein and the agreements pursuant to which
this Debenture was issued. In the case of clause (C), the conversion price applicable for the newly issued shares of convertible
preferred stock or convertible debentures shall be based upon the amount of securities, cash and property that each Common Shares
would receive in such transaction and the Conversion Price in effect immediately prior to the effectiveness or closing date for such
transaction. The terms of any such merger, sale or consolidation shall include such terms so as to continue to give the Holder the
right to receive the securities, cash and property set forth in this Section upon any conversion or redemption following such event.
This provision shall similarly apply to successive such events.
10
(4) REISSUANCE OF THIS DEBENTURE.
(a) Transfer.
If this Debenture is to be transferred, the Holder shall surrender this Debenture to the Company, whereupon the Company will forthwith
issue and deliver upon the order of the Holder a new Debenture (in accordance with Section (4)(d)), registered
in the name of the registered transferee or assignee, representing the outstanding Principal being transferred by the Holder (along with
any accrued and unpaid Interest thereof) and, if less than the entire outstanding Principal is being transferred, a new Debenture (in
accordance with Section (4)(d)) to the Holder representing the outstanding Principal not being transferred.
The Holder and any assignee, by acceptance of this Debenture, acknowledge and agree that, by reason of the provisions of Section (3)(b)(iii)
following conversion or redemption of any portion of this Debenture, the outstanding Principal represented by this Debenture may be less
than the Principal stated on the face of this Debenture.
(b) Lost,
Stolen or Mutilated Debenture. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Debenture, and, in the case of loss, theft or destruction, of any indemnification undertaking by the
Holder to the Company in customary form and substance and, in the case of mutilation, upon surrender and cancellation of this Debenture,
the Company shall execute and deliver to the Holder a new Debenture (in accordance with Section (4)(d)) representing
the outstanding Principal.
(c) Debenture
Exchangeable for Different Denominations. This Debenture is exchangeable, upon the surrender hereof by the Holder at the principal
office of the Company, for a new Debenture or Debentures (in accordance with Section (4)(d)) representing
in the aggregate the outstanding Principal of this Debenture, and each such new Debenture will represent such portion of such outstanding
Principal as is designated by the Holder at the time of such surrender.
(d) Issuance
of New Debentures. Whenever the Company is required to issue a new Debenture pursuant to the terms of this Debenture, such new Debenture
(i) shall be of like tenor with this Debenture, (ii) shall represent, as indicated on the face of such new Debenture, the Principal remaining
outstanding (or in the case of a new Debenture being issued pursuant to Section (4)(a) or Section (4)(c),
the Principal designated by the Holder which, when added to the Principal represented by the other new Debentures issued in connection
with such issuance, does not exceed the Principal remaining outstanding under this Debenture immediately prior to such issuance of new
Debentures), (iii) shall have an issuance date, as indicated on the face of such new Debenture, which is the same as the Issuance Date
of this Debenture, (iv) shall have the same rights and conditions as this Debenture, and (v) shall represent accrued and unpaid Interest
from the Issuance Date.
11
(5) NOTICES. Any
notices, consents, waivers or other communications required or permitted to be given under the terms hereof must be in writing by
letter or electronic mail (“e-mail”) and will be deemed to have been delivered (i) upon receipt, when delivered
personally, (ii) one (1) Business Day after deposit with an overnight courier service with next day delivery specified, as
applicable or (iii) receipt, when sent by e-mail, and, in each case of the foregoing clauses (i), (ii) and (iii), properly addressed
to the party to receive the same. The addresses and e-mail addresses for such communications shall be:
If to the Company, to:
Evolution Metals & Technologies Corp.
4040 NE 2nd Ave, Ste 349
Miami, Florida 33137
Attn:
David Wilcox
Frank Moon
Andrew Knaggs
Christopher Clower
Telephone: 561-225-3205
Email:
david.wilcox@evolution-metals.com
frank.moon@evolution-metals.com
andrew.knaggs@evolution-metals.com
christopher.clower@evolution-metals.com
with a copy (which shall not constitute notice) to:
John Arrastia
4040 NE 2nd Ave, Ste 349
Miami, Florida 33137
Attention: John Arrastia
Telephone: 561-225-3205
Email: john.arrastia@evolution-metals.com
If to the Holder:
YA II PN, Ltd
c/o Yorkville Advisors Global, LLC
1012 Springfield Avenue
Mountainside, NJ 07092
Attention: Mark Angelo
Telephone: 201-985-8300
Email: Legal@yorkvilleadvisors.com
or at such other address and/or e-mail address
and/or to the attention of such other person as the recipient party has specified by written notice given to each other party in accordance
with this Section at least three (3) Business Days prior to the effectiveness of such change. Written confirmation of receipt (a) given
by the recipient of such notice, consent, waiver or other communication, (b) electronically generated by the sender’s email service provider
containing the time, date, recipient email address or (c) provided by a nationally recognized overnight delivery service, shall be rebuttable
evidence of personal service, receipt from a nationally recognized overnight delivery service or receipt by e-mail in accordance with
clause (i), (ii) or (iii) above, respectively.
12
(6) Except
as expressly provided herein, no provision of this Debenture shall alter or impair the obligations of the Company, which are absolute
and unconditional, to pay the Principal of, and Interest and other charges (if any) on, this Debenture at the time, place, and rate, and
in the currency, herein prescribed. This Debenture is a direct obligation of the Company. As long as this Debenture is outstanding, the
Company shall not and shall cause each of its subsidiaries not to, without the consent of the Holder, (i) amend its certificate of incorporation,
bylaws or other charter documents so as to adversely affect any rights of the Holder; (ii) repay, repurchase or offer to repay, repurchase
or otherwise acquire shares of its Common Shares or other equity securities; or (iii) enter into any agreement with respect to any of
the foregoing; or (iv) enter into any agreement or transaction in or of which the terms thereof would restrict or conflict with the ability
of the Company to perform its obligations under the this Debenture, including, without limitation, the obligation of the Company to make
cash payments hereunder.
(7) This
Debenture shall not entitle the Holder to any of the rights of a stockholder of the Company, including without limitation, the right to
vote, to receive dividends and other distributions, or to receive any notice of, or to attend, meetings of stockholders or any other proceedings
of the Company, unless and to the extent converted into Common Shares in accordance with the terms hereof.
(8) CHOICE OF LAW; VENUE; WAIVER OF JURY TRIAL
(a) Governing
Law. This Debenture and the rights and obligations of the Parties hereunder shall, in all respects, be governed by, and construed
in accordance with, the laws (excluding the principles of conflict of laws) of the State of New York (the “Governing Jurisdiction”)
(including Section 5-1401 and Section 5-1402 of the General Obligations Law of the State of New York), including all matters of construction,
validity and performance.
(b) Jurisdiction; Venue; Service.
(i) The
Company hereby irrevocably consents to the non- exclusive personal jurisdiction of the state courts of the Governing Jurisdiction and,
if a basis for federal jurisdiction exists, the non-exclusive personal jurisdiction of any United States District Court for the Governing
Jurisdiction.
(ii) The
Company agrees that venue shall be proper in any court of the Governing Jurisdiction selected by the Holder or, if a basis for federal
jurisdiction exists, in any United States District Court in the Governing Jurisdiction selected by the Holder. The Company waives any
right to object to the maintenance of any suit, claim, action, litigation or proceeding of any kind or description, whether in law or
equity, whether in contract or in tort or otherwise, in any of the state or federal courts of the Governing Jurisdiction on the basis
of improper venue or inconvenience of forum.
13
(iii) Any suit, claim,
action, litigation or proceeding of any kind or description, whether in law or equity, whether in contract or tort or otherwise,
brought by the Company against the Holder arising out of or based upon this Debenture or any matter relating to this Debenture, or
any other Transaction Document, or any contemplated transaction, shall be brought in a court only in the Governing Jurisdiction. The
Company shall not file any counterclaim against the Holder in any suit, claim, action, litigation or proceeding brought by the
Holder against the Company in a jurisdiction outside of the Governing Jurisdiction unless under the rules of the court in which the
Holder brought such suit, claim, action, litigation or proceeding the counterclaim is mandatory, and not permissive, and would be
considered waived unless filed as a counterclaim in the suit, claim, action, litigation or proceeding instituted by the Holder
against the Company. The Company agrees that any forum outside the Governing Jurisdiction is an inconvenient forum and that any
suit, claim, action, litigation or proceeding brought by the Company against the Holder in any court outside the Governing
Jurisdiction should be dismissed or transferred to a court located in the Governing Jurisdiction. Furthermore, the Company
irrevocably and unconditionally agrees that it will not bring or commence any suit, claim, action, litigation or proceeding of any
kind or description, whether in law or equity, whether in contract or in tort or otherwise, against the Holder arising out of or
based upon this Debenture or any matter relating to this Debenture, or any other Transaction Document, or any contemplated
transaction, in any forum other than the courts of the State of New York sitting in New York County, and the United States District
Court of the Southern District of New York, and any appellate court from any thereof, and each of the parties hereto irrevocably and
unconditionally submits to the jurisdiction of such courts and agrees that all claims in respect of any such suit, claim, action,
litigation or proceeding may be heard and determined in such New York State Court or, to the fullest extent permitted by applicable
law, in such federal court. The Company and the Holder agree that a final judgment in any such suit, claim, action, litigation or
proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by
law.
(iv) The
Company and the Holder irrevocably consent to the service of process out of any of the aforementioned courts in any such suit, claim,
action, litigation or proceeding by e-mail or the mailing of copies thereof by registered or certified mail postage prepaid, to it at
the e-mail address or physical address, as applicable, provided for notices in this Debenture, such service to become effective thirty
(30) days after the date of such e-mail or mailing, as applicable. The Company and the Holder each irrevocably waive any defense it may
have on the grounds of insufficient or improper service with respect to service of process effected in accordance with this Section (8)(b)(iv).
(v) Nothing
herein shall affect the right of the Holder to serve process in any other manner permitted by law or to commence legal proceedings or
to otherwise proceed against the Company or any other Person in the Governing Jurisdiction or in any other jurisdiction.
(c) THE
PARTIES MUTUALLY WAIVE ALL RIGHT TO TRIAL BY JURY OF ALL CLAIMS OF ANY KIND ARISING OUT OF OR BASED UPON THIS DEBENTURE OR ANY MATTER
RELATING TO THIS DEBENTURE, OR ANY OTHER TRANSACTION DOCUMENT, OR ANY CONTEMPLATED TRANSACTION. THE PARTIES ACKNOWLEDGE THAT THIS IS A
WAIVER OF A LEGAL RIGHT AND THAT THE PARTIES EACH MAKE THIS WAIVER VOLUNTARILY AND KNOWINGLY AFTER CONSULTATION WITH COUNSEL OF THEIR
RESPECTIVE CHOICE. THE PARTIES AGREE THAT ALL SUCH CLAIMS SHALL BE TRIED BEFORE A JUDGE OF A COURT HAVING JURISDICTION, WITHOUT A JURY.
14
(d) The
Company expressly acknowledges and agrees that this Debenture constitutes an instrument for the payment of money only within the meaning
of section 3213 of the New York Civil Practice Law and Rules (“CPLR §3213”), and that upon any default under or
breach of the terms of this Debenture, the Holder may immediately commence an action by motion for summary judgment in lieu of complaint
without any further notice or demand. The Company irrevocably waives (i) any right to require the Holder to commence any action by summons
and complaint, (ii) any right to assert defenses, setoffs, counterclaims or delays in any CPLR §3213 proceeding (other than the defense
of full payment of any amount that the Holder seeks to recover), and (iii) any right to object to the sufficiency of this Debenture as
an instrument for the payment of money only within the meaning of CPLR §3213 and agrees not to assert that this Debenture is not
such an instrument. The Company agrees that all amounts due under this Debenture shall be deemed liquidated, unconditional and immediately
due and payable for purposes of CPLR §3213.
(9) If
the Company fails to strictly comply with the terms of this Debenture, then the Company shall reimburse the Holder promptly for all fees,
costs and expenses, including, without limitation, attorneys’ fees and expenses incurred by the Holder in any action in connection
with this Debenture, including, without limitation, those incurred: (i) during any workout, attempted workout, and/or in connection with
the rendering of legal advice as to the Holder’s rights, remedies and obligations, (ii) collecting any sums which become due to
the Holder, (iii) defending or prosecuting any proceeding or any counterclaim to any proceeding or appeal; or (iv) the protection, preservation
or enforcement of any rights or remedies of the Holder.
(10) Any
waiver by the Holder of a breach of any provision of this Debenture shall not operate as or be construed to be a waiver of any other breach
of such provision or of any breach of any other provision of this Debenture. The failure of the Holder to insist upon strict adherence
to any term of this Debenture on one or more occasions shall not be considered a waiver or deprive that party of the right thereafter
to insist upon strict adherence to that term or any other term of this Debenture. No provision of this Debenture may be waived or amended
other than by a written agreement signed by the parties to this Debenture. No custom or practice of the parties at variance with the terms
hereof shall constitute a waiver by any party of its right to exercise any right, power or remedy available to it hereunder or any other
right, power or remedy or to demand strict compliance with the terms of this Debenture.
(11) If any provision of
this Debenture is invalid, illegal or unenforceable, the balance of this Debenture shall remain in effect, and if any provision is
inapplicable to any person or circumstance, it shall nevertheless remain applicable to all other persons and circumstances. If it
shall be found that any Interest or other amount deemed Interest due hereunder shall violate applicable laws governing usury, the
applicable rate of interest due hereunder shall automatically be lowered to equal the maximum permitted rate of Interest. The
Company covenants (to the extent that it may lawfully do so) that it shall not at any time insist upon, plead, or in any manner
whatsoever claim or take the benefit or advantage of, any stay, extension or usury law or other law which would prohibit or forgive
the Company from paying all or any portion of the Principal of or interest on this Debenture as contemplated herein, wherever
enacted, now or at any time hereafter in force, or which may affect the covenants or the performance of this Debenture, and the
Company (to the extent it may lawfully do so) hereby expressly waives all benefits or advantage of any such law, and covenants that
it will not, by resort to any such law, hinder, delay or impede the execution of any power herein granted to the Holder, but will
suffer and permit the execution of every such power as though no such law has been enacted.
15
(12) CERTAIN
DEFINITIONS. For purposes of this Debenture, the following terms shall have the following meanings:
(a) Amortization
Event” shall mean (i) the daily VWAP is less than the Floor Price then in effect for five Trading Days during a period of seven
consecutive Trading Days (a “Floor Price Event”), (ii) the Company has issued in excess of 99% of the Common Shares
available under the Exchange Cap, where applicable (an “Exchange Cap Event”), or (iii) any time after the Effectiveness
Deadline (as defined in the Registration Rights Agreement), the Investor is unable to utilize a Registration Statement to resell Underlying
Shares for a period of ten (10) consecutive Trading Days (a “Registration Event”)] (the first day of each such occurrence,
an “Amortization Event Date”).
(b) “Amortization Principal Amount” shall have the meaning set forth in Section 1(c).
(c) “Applicable Price” shall have the meaning set forth in Section (3)(f).
(d) “Approved Stock Plan” means any employee benefit plan or share incentive plan which has been approved by the Board of Directors of the Company, pursuant to which the Company’s securities may be issued to any employee, officer or director for services provided to the Company.
(e) “Bloomberg”
means Bloomberg Financial Markets (or if not available, a similar service provider of national recognized standing).
(f) “Business
Day” means any day except Saturday, Sunday and any day which shall be a federal legal holiday in the United States or a day
on which banking institutions in the State of New York are authorized or required by law or other government action to close.
(g) “Buy-In” shall have the meaning set forth in Section (3)(b)(ii).
(h) “Buy-In Price” shall have the meaning set forth in Section (3)(b)(ii).
(i) “Calendar
Month” means the period from a particular date in one month to the same date in the next month.
16
(j)
“Change of Control Transaction” means the occurrence of (a) an acquisition after the date hereof by an individual
or legal entity or “group” (as described in Rule 13d-5(b)(1) promulgated under the Exchange Act) of effective control
(whether through legal or beneficial ownership of capital stock of the Company, by contract or otherwise) of in excess of fifty
percent (50%) of the voting power of the Company (except that the acquisition of voting securities by the Holder or any other
current holder of convertible securities of the Company shall not constitute a Change of Control Transaction for purposes hereof),
(b) a replacement at one time or over time of more than one-half of the members of the board of directors of the Company (other than
as due to the death or disability of a member of the board of directors) which is not approved by a majority of those individuals
who are members of the board of directors on the date hereof (or by those individuals who are serving as members of the board of
directors on any date whose nomination to the board of directors was approved by a majority of the members of the board of directors
who are members on the date hereof), (c) the merger, consolidation or sale of fifty percent (50%) or more of the assets of the
Company or any Subsidiary of the Company in one or a series of related transactions with or into another entity, or (d) the
execution by the Company of an agreement to which the Company is a party or by which it is bound, providing for any of the events
set forth above in (a), (b) or (c). No transfer to a wholly-owned Subsidiary shall be deemed a Change of Control Transaction under
this provision.
(k) “Closing
Price” means the price per share in the last reported trade of the Common Shares on a Principal Market or on the exchange which
the Common Shares is then listed as quoted by Bloomberg.
(l) “Commission” means the Securities and Exchange Commission.
(m)
“Common Shares” means the shares of common stock, par value $0.0001, of the Company and stock of any other class
into which such shares may hereafter be changed or reclassified.
(n) “Conversion
Amount” means the portion of the Principal, Interest, or other amounts outstanding under this Debenture to be converted, redeemed
or otherwise with respect to which this determination is being made.
(o)
“Conversion Date” shall have the meaning set forth in Section( 3)(b)(i).
(p) “Conversion Failure”
shall have the meaning set forth in Section (3)(b)(ii).
(q) “Conversion Notice”
shall have the meaning set forth in Section (3)(b)(i).
(r) “Conversion Price”
means, as of any Conversion Date or other date of determination the lower of (i) $12.09 per Common Share (the “Fixed
Price”), or (ii) 95% of the lowest daily VWAP during the 5 consecutive Trading Days immediately preceding the Conversion
Date or other date of determination (the “Variable Price”), but which Variable Price shall not be lower than the
Floor Price then in effect. The Conversion Price shall be adjusted from time to time pursuant to the other terms and conditions of
this Debenture.
(s) “Convertible
Securities” means any stock or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable
for Common Shares.
(t) “Dilutive Issuance”
shall have the meaning set forth in Section (3)(f).
17
(u) “Exchange
Act” means the Securities Exchange Act of 1934, as amended.
(v)
“Excluded Securities” means any Common Shares issued or issuable or deemed to be issued by the Company:
(i) under any Approved Stock Plan, (ii) upon conversion of any of the Debentures issued pursuant to the Securities Purchase
Agreement; (iii) upon conversion, exercise or exchange of any Options or Convertible Securities which are outstanding on the day
immediately preceding the date of the Securities Purchase Agreement; provided, that such issuance of Common Shares upon exercise of
such Options or Convertible Securities is made pursuant to the terms of such Options or Convertible Securities in effect on such
date and such Options or Convertible Securities are not amended, modified or changed on or after such date, or (iv) upon a stock
split, reverse stock split, distribution of bonus shares, combination or other recapitalization events.
(w) “Floor Price” solely
with respect to the Variable Price, shall mean $1.86 per Common Share.
(x) “Fundamental
Transaction” means any of the following: (1) the Company effects any merger or consolidation of the Company with or into
another Person and the Company is the non-surviving company (other than a merger or consolidation with a wholly owned Subsidiary of the
Company for the purpose of redomiciling the Company), (2) the Company effects any sale of all or substantially all of its assets in one
or a series of related transactions, (3) any tender offer or exchange offer (whether by the Company or another Person) is completed pursuant
to which holders of Common Shares are permitted to tender or exchange their shares for other securities, cash or property, or (4) the
Company effects any reclassification of the Common Shares or any compulsory share exchange pursuant to which the Common Shares is effectively
converted into or exchanged for other securities, cash or property.
(y) “Material
Adverse Effect” has the meaning given such term in the Securities Purchase Agreement.
(z) “New Issuance Price” shall
have the meaning set forth in Section (3)(f).
(aa) “Optional
Redemption” shall have the meaning set forth in (1)(d).
(bb) “Options” means
any rights, warrants or options to subscribe for or purchase Common Shares or Convertible Securities.
(cc) “Other Debentures”
means any other debentures issued pursuant to the Securities Purchase Agreement and any other debentures, notes, or other instruments
issued in exchange, replacement, or modification of the foregoing.
(dd)
“Payment Premium” means 5% of the Principal Amount being paid.
18
(ee) “Periodic
Reports” shall mean all of the Company’s reports required to be filed by the Company with the Commission under
applicable laws and regulations (including, without limitation, Regulation S-K), including annual reports (on Form 10-K), quarterly
reports (on Form 10-Q), and current reports (on Form 8-K), for so long as any amounts are outstanding under this Debenture; provided that
all such Periodic Reports shall include, when filed, all information, financial statements, audit reports (when applicable) and
other information required to be included in such Periodic Reports in compliance with all applicable laws and regulations.
(ff) “Person”
means a corporation, an association, a partnership, organization, a business, an individual, a government or political subdivision thereof
or a governmental agency.
(gg) “Principal Market”
means the Nasdaq Global Market; provided however, that in the event the Company’s Common Shares are ever listed or traded on any
of the New York Stock Exchange, the NYSE American, the Nasdaq Capital Market, or the Nasdaq Global Select Market, or such successor thereto,
the “Principal Market” shall mean that market on which the Common Shares are then listed or traded
(hh)
“Redemption Amount” shall have the meaning set forth in (1)(d).
(ii)
“Redemption Notice” shall have the meaning set forth in (1)(d).
(jj)
“Registration Rights Agreement” has the meaning given such term in the Securities Purchase Agreement.
(kk) “Registration
Statement” means a registration statement meeting the requirements set forth in the Registration Rights Agreement, covering
among other things the resale of the Underlying Shares and naming the Holder as a “selling stockholder” thereunder.
(ll) “Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
(mm) “Share
Delivery Date” shall have the meaning set forth in Section (3)(b)(i).
(nn)
“Subsidiary” shall mean any Person in which the Company, directly or indirectly, (x) owns a majority of the
outstanding capital stock or holds a majority of the equity or similar interest of such Person or (y) controls or operates all or
substantially all of the business, operations or administration of such Person, and the foregoing are collectively referred to
herein as “Subsidiaries.”
(oo) “Trading Day”
means a day on which the Common Shares are quoted or traded on a Principal Market on which the Common Shares are then quoted or listed;
provided, that in the event that the Common Shares are not listed or quoted, then Trading Day shall mean a Business Day.
(pp)
“Transaction Document” has the meaning given such term in the Securities Purchase Agreement.
(qq)
“Underlying Shares” means the Common Shares issuable upon conversion of this Debenture in accordance with the
terms hereof.
(rr) “VWAP”
shall mean for any Trading Day, the volume weighted average price of the Common Shares on the Principal Market, for such Trading Day as
reported by Bloomberg L.P. through its “HP” function.
[Signature Page Follows]
19
IN WITNESS WHEREOF, the Company has caused
this Convertible Debenture to be duly executed by a duly authorized officer as of the date set forth above.
COMPANY:
EVOLUTION METALS & TECHNOLOGIES CORP.
By:
/s/ David Wilcox
Name:
David Wilcox
Title:
Executive Chairman
20
EX-4.2 — FORM OF CONVERTIBLE DEBENTURE
EX-4.2
Filename: ea029007301ex4-2.htm · Sequence: 3
Exhibit 4.2
NEITHER THIS DEBENTURE NOR THE SECURITIES
INTO WHICH THIS DEBENTURE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
OF ANY STATE. THESE SECURITIES HAVE BEEN SOLD IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD
EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. NOTWITHSTANDING
THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED
BY THE SECURITIES.
EVOLUTION METALS & TECHNOLOGIES CORP.
Convertible
Debenture
Original Principal Amount: $[____________]
Issuance Date: [____________]
Number: EMAT-[1][2][3]
FOR VALUE RECEIVED, EVOLUTION
METALS & TECHNOLOGIES CORP., an entity organized under the laws of Delaware (the “Company”), hereby promises
to pay to the order of YA II PN, LTD., or its registered assigns (the “Holder”) the amount set out above as the
Original Principal Amount (or such lesser amount as reduced pursuant to the terms hereof pursuant to repayment, redemption,
conversion or otherwise, the “Principal”) and the Payment Premium, as applicable, in each case when due, and to
pay interest (“Interest”) on any outstanding Principal at the applicable Interest Rate (as defi ned below) from
the date set out above as the Issuance Date (the “Issuance Date”) until the same becomes due and payable, whether
upon the Maturity Date or acceleration, conversion, redemption or otherwise (in each case in accordance with the terms hereof). The
Issuance Date is the date of the first issuance of this Convertible Debenture (as amended, amended and restated, extended,
supplemented or otherwise modified in writing from time to time, this “Debenture”) regardless of the number of
transfers and regardless of the number of instruments, which may be issued to evidence such Debenture. This Debenture was originally
issued pursuant to the Securities Purchase Agreement dated as of [ ], 2026, between the Company and the Buyers listed on
the Schedule of Buyers attached thereto (as it may be amended from time to time, the “Securities Purchase
Agreement”). Certain capitalized terms used herein are defined in Section (12).
(1)
GENERAL TERMS
(a) Maturity
Date. On the Maturity Date, the Company shall pay to the Holder an amount in cash representing all outstanding Principal,
accrued and unpaid Interest, and any other amounts outstanding pursuant to the terms of this Debenture. The “Maturity
Date” shall be [ ], 202[ ___]1, as may be extended at the option of the Holder.
(b) Interest
Rate and Payment of Interest. Interest shall accrue on the outstanding Principal balance hereof at an annual rate equal to 5.00% (“Interest
Rate”), which Interest Rate shall increase to an annual rate of 18.00% upon the occurrence of an Event of Default (for so long
as such event remains uncured). Interest shall be calculated based on a 365-day year and the actual number of days elapsed, to the extent
permitted by applicable law.
(c) Amortization Payments.
If, any time after the Issuance Date set forth above, and from time to time thereafter, an Amortization Event has occurred, then the Company
shall make monthly cash payments beginning on the 7th Trading Day after the Amortization Event Date and continuing on the same day of
each successive Calendar Month until the entire outstanding amounts shall have been repaid. Each monthly cash payment shall be in an amount
equal to the sum of (i) $[ __________ ]2 of Principal on this Debenture (or the outstanding Principal, if less than such
amount (the “Amortization Principal Amount”), plus (ii) the Payment Premium in respect of such Amortization
Principal Amount, plus (iii) all accrued and unpaid interest hereunder as of each payment date. The obligation of the Company to
make monthly cash payments related to an Amortization Event shall cease (with respect to any payment that has not yet come due) if at
any time after the Amortization Event Date (A) in the event of a Floor Price Event, on the date that is the 10th consecutive Trading Day
that the daily VWAP is greater than the Floor Price then in effect, (B) in the event of an Exchange Cap Event, the date the Company has
obtained stockholder approval to increase the number of Common Shares under the Exchange Cap and/or the Exchange Cap no longer applies,
or (C) in the event of a Registration Event, the condition or event causing the Registration Event has been cured or the Holder is able
to resell the Common Shares issuable upon conversion of this Debenture in accordance with Rule 144 under the Securities Act, unless a
subsequent Amortization Event occurs.
1 Maturity Date to be set as the date 18 months from the First
Closing Date.
2 Amount to be set as 1/5 of the Original Principal Amount of
the Debenture.
(d) Optional Redemption.
The Company at its option shall have the right, but not the obligation, to redeem (“Optional Redemption”) early a
portion or all amounts outstanding under this Debenture as described in this Section; provided, that the Company provides the
Holder with written notice (each, a “Redemption Notice”) of its desire to exercise an Optional Redemption, which Redemption
Notice (i) shall be delivered to the Holder after the close of regular trading hours on a Trading Day, and (ii) may only be given if
the VWAP of the Common Shares was less than the Fixed Price on the date such Redemption Notice is delivered, unless otherwise agreed
by the Holder. Each Redemption Notice shall be irrevocable and shall specify the outstanding balance of the Debenture to be redeemed
and the Redemption Amount. The “Redemption Amount” shall be an amount equal to (a) the outstanding Principal balance
being redeemed by the Company plus (b) the Payment Premium in respect of such Principal amount plus (c) all accrued and
unpaid interest hereunder as of the date of such redemption. After receipt of a Redemption Notice, the Holder shall have ten (10) Trading
Days (beginning with the Trading Day immediately following the date such Redemption Notice is delivered to the Holder in accordance
with this term of this Section 1(d)) to elect to convert all or any portion of this Debenture. On the eleventh (11th) Trading
Day following the delivery of the applicable Redemption Notice, the Company shall deliver to the Holder the Redemption Amount with respect
to the Principal amount redeemed to the extent not converted and otherwise after giving effect to conversions or other payments made
during such ten (10) Trading Day period.
(e) Other
than as specifically set forth in this Debenture, the Company shall not have the ability to make any early repayments without the consent
of or at the request of the Holder.
(f) Payment
Dates. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall be made
on the next succeeding Business Day.
(2)
EVENTS OF DEFAULT.
(a) An
“Event of Default”, wherever used herein, means any one of the following events (whatever the reason and whether it
shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court, or any order,
rule or regulation of any administrative or governmental body) shall have occurred:
(i) The
Company’s failure to pay to the Holder any amount of Principal, Redemption Amount, Payment Premium, Interest, or other amounts when and
as due under this Debenture or any other Transaction Document and within five (5) Trading Days after such payment is due;
(ii) (A) The Company or
any Subsidiary of the Company shall commence, or there shall be commenced against the Company or any Subsidiary of the Company, any
proceeding under any applicable bankruptcy or insolvency laws as now or hereafter in effect or any successor thereto, or the Company
or any Subsidiary of the Company commences any other proceeding under any reorganization, arrangement, adjustment of debt, relief of
debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction whether now or hereafter in effect relating to
the Company or any Subsidiary of the Company, in any such bankruptcy, insolvency or other proceeding which remains undismissed for a
period of sixty one (61) days; (B) the Company or any Subsidiary of the Company is adjudicated insolvent or bankrupt; (C) any order
of relief or other order approving any such case or proceeding is entered; (D) the Company or any Subsidiary of the Company suffers
any appointment of any custodian, private or court appointed receiver or the like for it or all or substantially all of its property
which continues undischarged or unstayed for a period of sixty one (61) days; (E) the Company or any Subsidiary of the Company makes
a general assignment of all or substantially all of its assets for the benefit of creditors; (F) the Company or any Subsidiary of
the Company shall fail to pay, shall state that it is unable to pay, or shall be unable to pay, its debts generally as they become
due; (G) the Company or any Subsidiary of the Company shall call a meeting of its creditors with a view to arranging a composition,
adjustment or restructuring of its debts; (H) the Company or any Subsidiary of the Company shall by any act or failure to act
expressly indicate its consent to, approval of or acquiescence in any of the foregoing; or (I) any corporate or other action is
taken by the Company or any Subsidiary of the Company for the purpose of effecting any of the foregoing;
(iii) The
Company or any Subsidiary of the Company shall default in any of its obligations under any note, debenture, mortgage, credit agreement
or other facility, indenture agreement, factoring agreement or other instrument under which there may be issued, or by which there may
be secured or evidenced any indebtedness for borrowed money or money due under any long term leasing or factoring arrangement of the Company
or any Subsidiary of the Company in an amount exceeding $2,500,000, whether such indebtedness now exists or shall hereafter be created
and such default is not cured within the time prescribed by the documents governing such indebtedness or if no time is prescribed, within
thirty (30) Trading Days, and as a result, such indebtedness becomes or is declared due and payable;
(iv) A
final judgment or judgments for the payment of money in excess of $2,500,000 in the aggregate are rendered against the Company and/or
any of its Subsidiaries and which judgments are not, within thirty (30) days after the entry thereof, bonded, discharged, settled or stayed
pending appeal, or are not discharged within thirty (30) days after the expiration of such stay; provided, however, any judgment which
is covered by insurance or an indemnity from a creditworthy party shall not be included in calculating the $250,000 amount set forth above
so long as the Company provides the Holder a written statement from such insurer or indemnity provider (which written statement shall
be reasonably satisfactory to the Holder) to the effect that such judgment is covered by insurance or an indemnity and the Company or
such Subsidiary (as the case may be) will receive the proceeds of such insurance or indemnity within sixty (60) days of the issuance of
such judgment;
2
(v) The
Common Shares shall cease to be quoted or listed for trading, as applicable, on any Principal Market for a period of ten (10) consecutive
Trading Days;
(vi) The
Company or any Subsidiary of the Company shall be a party to any Change of Control Transaction unless in connection with such Change of
Control Transaction this Debenture is retired;
(vii) The
Company’s (A) failure to deliver the required number of Common Shares to the Holder within two (2) Trading Days after the applicable
Share Delivery Date or (B) notice, written or oral, to any holder of the Debenture, including by way of public announcement, at any time,
of its intention not to comply with a request for conversion of all or a portion of this Debenture into Common Shares that is tendered
in accordance with the provisions of this Debenture;
(viii) The
Company shall fail for any reason to deliver the payment in cash pursuant to a Buy-In (as defined below) within five (5) Business Days
after such payment is due;
(ix) The
Company’s failure to timely file with the Commission any Periodic Report on or before the due date of such filing as established
by the Commission, it being understood, for the avoidance of doubt, that due date includes any permitted filing deadline extension under
Rule 12b-25 under the Exchange Act;
(x) Any
representation or warranty made or deemed to be made by or on behalf of the Company in or in connection with any Transaction Document,
or any waiver hereunder or thereunder, shall prove to have been incorrect in any material respect (or, in the case of any such representation
or warranty already qualified by materiality, such representation or warranty shall prove to have been incorrect) when made or deemed
made;
(xi) (A)
Any material provision of any Transaction Document, at any time after its execution and delivery and for any reason other than as expressly
permitted hereunder or thereunder, ceases to be in full force and effect; (B) the Company or any other Person contests in writing the
validity or enforceability of any provision of any Transaction Document; or
(C) the Company denies in writing that it has
any or further liability or obligation under any Transaction Document, or purports in writing to revoke, terminate (other than in accordance
with the relevant termination provisions) or rescind any Transaction Document;
(xii) The
Company uses the proceeds of the issuance of this Debenture, whether directly or indirectly, and whether immediately, incidentally or
ultimately, to purchase or carry margin stock (within the meaning of Regulations T, U and X of the Federal Reserve Board, as in effect
from time to time and all official rulings and interpretations thereunder or thereof), or to extend credit to others for the purpose of
purchasing or carrying margin stock or to refund indebtedness originally incurred for such purpose;
(xiii) Any
Event of Default (as defined in the Other Debentures or in any Transaction Document other than this Debenture) occurs with respect to
any Other Debentures, or any breach of any material term of any other debenture, note, or instrument held by the Holder in the Company
or any agreement between or among the Company and the Holder; or
(xiv) The
Company shall fail to observe or perform any material covenant, agreement or warranty contained in, or otherwise commit any material breach
or default of any provision of this Debenture (except as may be otherwise covered by Sections (2)(a)(i) through (2)(a)(xiii) hereof) or
any other Transaction Document, which is not cured or remedied within the time prescribed or if no time is prescribed within thirty (30)
Business Days.
(b) During the time that
any portion of this Debenture is outstanding, if any Event of Default has occurred (other than an event with respect to the Company
described in Section (2)(a)(ii)), the full unpaid Principal amount of this Debenture and all interest and other amounts owing in
respect of this Debenture to the date of acceleration, shall become, at the Holder’s election given by notice pursuant to Section
(5), immediately due and payable in cash; provided that, in the case of any event with respect to the Company described in Section
(2)(a)(ii), the full unpaid Principal amount of this Debenture and all accrued and unpaid interest and other amounts owing in
respect of this Debenture to the date of acceleration, shall automatically become due and payable, in each case without presentment,
demand, protest or other notice of any kind, all of which are hereby waived by the Company. Furthermore, in addition to any other
remedies, the Holder shall have the right (but not the obligation) to convert, on one or more occasions all or part of the Debenture
in accordance with Section (3) (and subject to the limitations set out in Section (3)(c)(i) and Section (3)(c)(ii)) at any time
after an Event of Default has occurred and is continuing until all amounts outstanding under this Debenture have been repaid in
full. The Holder need not provide, and the Company hereby waives, any presentment demand, protest or other notice of any kind (other
than any required notice of conversion), and the Holder may immediately enforce any and all of its rights and remedies hereunder and
all other remedies available to it under applicable law. Such declaration may be rescinded and annulled by the Holder in writing at
any time prior to payment hereunder. No such rescission or annulment shall affect any subsequent Event of Default or impair any
right consequent thereon.
3
(3) CONVERSION
OF DEBENTURE. This Debenture shall be convertible into Common Shares, on the terms and conditions set forth in this Section (3).
(a) Conversion
Right. Subject to the limitations of Section (3)(c), at any time or times on or after the Issuance Date, the Holder shall be entitled
to convert any portion of the outstanding and unpaid Conversion Amount into fully paid and nonassessable Common Shares in accordance with
Section (3)(b), at the Conversion Price. The number of Common Shares issuable upon conversion of any Conversion Amount pursuant to this
Section (3)(a) shall be determined by dividing (x) such Conversion Amount by (y) the Conversion Price. The Company shall not issue any
fraction of a Common Shares upon any conversion. All calculations under this Section (3) shall be rounded to the nearest $0.0001. If the
issuance would result in the issuance of a fraction of a Common Share, the Company shall round such fraction of a Common Share up to the
nearest whole share. The Company shall pay any and all transfer, stamp and similar taxes that may be payable with respect to the issuance
and delivery of Common Shares upon conversion of any Conversion Amount.
(b)
Mechanics of Conversion.
(i) Optional
Conversion. To convert any Conversion Amount into Common Shares on any date (a “Conversion Date”), the Holder
shall (A) transmit by email (or otherwise deliver), for receipt on or prior to 11:59 p.m., New York time, on such date, a copy of an
executed notice of conversion in the form attached hereto as Exhibit I (the “Conversion Notice”) to the
Company and (B) if required by Section (3)(b)(iii), surrender this Debenture to a nationally recognized overnight delivery service
for delivery to the Company (or an indemnification undertaking reasonably satisfactory to the Company with respect to this Debenture
in the case of its loss, theft or destruction). On or before the first (1st) Trading Day following the date of receipt of
a Conversion Notice (the “Share Delivery Date”), the Company shall (X) if legends are not required to be placed on
certificates or the book-entry position of the Common Shares and provided that the Transfer Agent is participating in the Depository
Trust Company’s (“DTC”) Fast Automated Securities Transfer Program, instruct such transfer agent to credit such
aggregate number of Common Shares to which the Holder shall be entitled to the Holder’s or its designee’s balance account with DTC
through its Deposit Withdrawal Agent Commission system or (Y) if the Transfer Agent is not participating in the DTC Fast Automated
Securities Transfer Program, issue and deliver to the address as specified in the Conversion Notice, a certificate or book-entry
position, registered in the name of the Holder or its designee, for the number of Common Shares to which the Holder shall be
entitled which certificates shall not bear any restrictive legends unless required pursuant to rules and regulations of the
Commission. If this Debenture is physically surrendered for conversion and the outstanding Principal of this Debenture is greater
than the Principal portion of the Conversion Amount being converted, then the Company shall as soon as practicable and in no event
later than three (3) Business Days after receipt of this Debenture and at its own expense, issue and deliver to the holder a new
Debenture representing the outstanding Principal not converted. The Person or Persons entitled to receive the Common Shares issuable
upon a conversion of this Debenture shall be treated for all purposes as the record holder or holders of such Common Shares upon the
transmission of a Conversion Notice.
(ii) Company’s Failure
to Timely Convert. If the Company shall fail, for any reason or for no reason, on or prior to the applicable Share Delivery Date
to issue and deliver a certificate to the Holder or credit the Holder’s balance account with DTC for the number of Common Shares
to which the Holder is entitled upon such Holder’s conversion of any Conversion Amount (a “Conversion Failure”),
and if on or after such Trading Day the Holder purchases (in an open market transaction or otherwise) Common Shares to deliver in satisfaction
of a sale by the Holder of Common Shares issuable upon such conversion that the Holder anticipated receiving from the Company (a “Buy-In”),
then the Company shall, within three (3) Business Days after the Holder’s request and in the Holder’s discretion, either
(i) pay cash to the Holder in an amount equal to the Holder’s total purchase price (including brokerage commissions and other out
of pocket expenses, if any) for the Common Shares so purchased (the “Buy-In Price”), at which point the Company’s
obligation to deliver such certificate (and to issue such Common Shares) shall terminate, or (ii) promptly honor its obligation to deliver
to the Holder a certificate or certificates representing such Common Shares to which the Holder is entitled with respect to such Conversion
Notice and pay cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over the product of (A) such number of
Common Shares, multiplied by (B) the Closing Price on the Conversion Date.
(iii) Book-Entry.
Notwithstanding anything to the contrary set forth herein, upon conversion of any portion of this Debenture in accordance with the terms
hereof, the Holder shall not be required to physically surrender this Debenture to the Company unless (A) the full Conversion Amount represented
by this Debenture is being converted or (B) the Holder has provided the Company with prior written notice (which notice may be included
in a Conversion Notice) requesting reissuance of this Debenture upon physical surrender of this Debenture. The Holder and the Company
shall maintain records showing the Principal and Interest converted and the dates of such conversions or shall use such other method,
reasonably satisfactory to the Holder and the Company, so as not to require physical surrender of this Debenture upon any conversion.
4
(c)
Limitations on Conversions.
(i) Beneficial
Ownership. The Holder shall not have the right to convert any portion of this Debenture to the extent that after giving effect
to such conversion, the Holder, together with any affiliate thereof, would beneficially own (as determined in accordance with
Section 13(d) of the Exchange Act and the rules promulgated thereunder) in excess of 4.99% of the number of Common Shares
outstanding immediately after giving effect to such conversion. Since the Holder will not be obligated to report to the Company the
number of Common Shares it may hold at the time of a conversion hereunder, unless the conversion at issue would result in the
issuance of Common Shares in excess of 4.99% of the then outstanding Common Shares without regard to any other shares which may be
beneficially owned by the Holder or an affiliate thereof, the Holder shall have the authority and obligation to determine whether
the restriction contained in this Section will limit any particular conversion hereunder and to the extent that the Holder
determines that the limitation contained in this Section applies, the determination of which portion of the Principal amount of this
Debenture is convertible shall be the responsibility and obligation of the Holder. If the Holder has delivered a Conversion Notice
for a Principal amount of this Debenture that, without regard to any other shares that the Holder or its affiliates may beneficially
own, would result in the issuance in excess of the permitted amount hereunder, the Company shall notify the Holder of this fact and
shall honor the conversion for the maximum Principal amount permitted to be converted on such Conversion Date in accordance with
Section (3)(a) and, any Principal amount tendered for conversion in excess of the permitted amount hereunder shall remain
outstanding under this Debenture. The provisions of this Section may be waived by a Holder (but only as to itself and not to any
other Holder) upon not less than 65 days prior notice to the Company. Other Holders shall be unaffected by any such waiver.
(ii) Principal
Market Limitation. Notwithstanding anything in this Debenture to the contrary, the Company shall not issue any Common Shares upon
conversion of this Debenture, or otherwise, if the issuance of such Common Shares, together with any Common Shares issued in connection
with any other related transactions that may be considered part of the same series of transactions, would exceed the aggregate number
Common Shares that the Company may issue in a transaction in compliance with the Company’s obligations under the rules or regulations
of the Nasdaq Stock Market LLC (“Nasdaq”) and shall be referred to as the “Exchange Cap,” except
that such limitation shall not apply if the Company’s stockholders have approved such issuances on such terms in excess of the Exchange
Cap in accordance with the rules and regulations of Nasdaq.
(d)
Other Provisions.
(i) All
calculations under this Section (3) shall be rounded to the nearest $0.0001 or whole share.
(ii) So
long as this Debenture remains outstanding, the Company shall have reserved from its duly authorized share capital, and shall have instructed
the Transfer Agent to irrevocably reserve, the maximum number of Common Shares issuable upon conversion of this Debenture (assuming for
purposes hereof that (x) this Debenture is convertible at the Floor Price as of the date of determination, and (y) any such conversion
shall not take into account any limitations on the conversion of the Debenture set forth herein or therein (the “Required Reserve
Amount”)), provided that at no time shall the number of Common Shares reserved pursuant to this Section (3)(d)(ii) be reduced
other than pursuant to the conversion of this Debenture and the Other Debentures in accordance with their terms, and/or cancellation,
or reverse stock split. If at any time while this Debenture or any Other Debentures remain outstanding, the Company does not have a sufficient
number of authorized and unreserved Common Shares to satisfy the obligation to reserve for the issuance the Required Reserve Amount, the
Company will promptly take all corporate action necessary to propose to a meeting of its shareholders an increase of its authorized share
capital necessary to meet the Company’s obligations pursuant to this Debenture, and cause its board of directors to recommend to the shareholders
that they approve such proposal.
(iii) Nothing herein shall
limit a Holder’s right to pursue actual damages or declare an Event of Default pursuant to Section (2) herein for the
Company’s failure to deliver certificates representing Common Shares upon conversion within the period specified herein and
such Holder shall have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief, in each case without the need to post a bond or provide other security. The
exercise of any such rights shall not prohibit the Holder from seeking to enforce damages pursuant to any other Section hereof or
under applicable law.
(iv) Legal
Opinions. The Company is obligated to cause its legal counsel to deliver legal opinions to the Company’s transfer agent in connection
with any legend removal upon the expiration of any holding period or other requirement for which the Underlying Shares may bear legends
restricting the transfer thereof. To the extent a legal opinion is not provided (either timely or at all), then, in addition to being
an Event of Default hereunder, the Company agrees to reimburse the Holder for all reasonable costs incurred by the Holder in connection
with any legal opinions paid for by the Holder in connection with the sale or transfer of the Underlying Shares. The Holder shall notify
the Company of any such costs and expenses it incurs that are referred to in this section from time to time and all amounts owed hereunder
shall be paid by the Company with reasonable promptness.
5
(e) Adjustment
of Conversion Price upon Subdivision or Combination of Common Shares. If the Company, at any time while this Debenture is outstanding,
shall (i) pay a stock dividend or otherwise make a distribution or distributions on its shares of Common Shares or any other equity or
equity equivalent securities payable in Common Shares, (ii) subdivide outstanding Common Shares into a larger number of shares, (iii)
combine (including by way of reverse stock split) outstanding Common Shares into a smaller number of shares, or (iv) issue by reclassification
of Common Shares any shares of capital stock of the Company, then each of the Fixed Price and the Floor Price shall be multiplied by a
fraction of which the numerator shall be the number of Common Shares (excluding treasury shares, if any) outstanding before such event
and of which the denominator shall be the number of Common Shares outstanding after such event. Any adjustment made pursuant to this Section
shall become effective, in the case of a dividend distribution, immediately after the record date for the determination of stockholders
entitled to receive such dividend or distribution or, in the case of a subdivision, combination or re- classification, and shall become
effective immediately after the effective date of such subdivision, combination or re-classification.
(f) Adjustment of
Conversion Price upon Issuance of Common Shares. If the Company, at any time while this Debenture is outstanding, issues or
sells any Common Shares or Convertible Securities (other than shares issued or sold by the Company in connection with any Excluded
Securities), for a consideration per share (the “New Issuance Price”) less than a price equal to the Fixed Price
in effect immediately prior to such issue or sale (such price the “Applicable Price”) (the foregoing a
“Dilutive Issuance”), then immediately after such Dilutive Issuance the Fixed Price then in effect shall be reduced
to an amount equal to the New Issuance Price. For the purposes hereof, if the Company in any manner issues or sells any Convertible
Securities (other than shares issued or sold by the Company in connection with any Excluded Securities) and the lowest price per
share for which one Common Share is issuable upon such conversion or exchange or exercise thereof is less than the Applicable Price,
then such Common Share shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance
or sale of such Convertible Securities for such price per share. No further adjustment of the Conversion Price shall be made upon
the actual issuance of such Common Share upon conversion or exchange or exercise of such Convertible Securities.
(g) Other
Corporate Events. In addition to and not in substitution for any other rights hereunder, prior to the consummation of any Fundamental
Transaction pursuant to which holders of Common Shares are entitled to receive securities or other assets with respect to or in exchange
for Common Shares (a “Corporate Event”), the Company shall make appropriate provision to ensure that the Holder will
thereafter have the right to receive upon a conversion of this Debenture, at the Holder’s option, (i) in addition to the Common Shares
receivable upon such conversion, such securities or other assets to which the Holder would have been entitled with respect to such Common
Shares had such Common Shares been held by the Holder upon the consummation of such Corporate Event (without taking into account any limitations
or restrictions on the convertibility of this Debenture) or (ii) in lieu of the Common Shares otherwise receivable upon such conversion,
such securities or other assets received by the holders of Common Shares in connection with the consummation of such Corporate Event in
such amounts as the Holder would have been entitled to receive had this Debenture initially been issued with conversion rights for the
form of such consideration (as opposed to Common Shares) at a conversion rate for such consideration commensurate with the Conversion
Price. Provision made pursuant to the preceding sentence shall be in a form and substance satisfactory to the Required Holders. The provisions
of this Section shall apply similarly and equally to successive Corporate Events and shall be applied without regard to any limitations
on the conversion or redemption of this Debenture.
(h) Whenever
the Conversion Price is adjusted pursuant to Section 3(e) or 3(f) hereof, the Company shall promptly provide the Holder with a written
notice setting forth the Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.
(i) In case of any (1)
merger or consolidation of the Company or any Subsidiary of the Company with or into another Person, or (2) sale by the Company or
any Subsidiary of the Company of more than one-half of the assets of the Company in one or a series of related transactions, a
Holder shall have the right to (A) exercise any rights under Section (3)(f),(B) convert the aggregate amount of this Debenture then
outstanding into the shares of stock and other securities, cash and property receivable upon or deemed to be held by holders of
Common Shares following such merger, consolidation or sale, and such Holder shall be entitled upon such event or series of related
events to receive such amount of securities, cash and property as the Common Shares into which such aggregate Principal amount of
this Debenture could have been converted immediately prior to such merger, consolidation or sales would have been entitled, or (C)
in the case of a merger or consolidation, require the surviving entity to issue to the Holder a convertible debenture with a
Principal amount equal to the aggregate Principal amount of this Debenture then held by such Holder, plus all accrued and unpaid
Interest and other amounts owing thereon, which such newly issued convertible debenture shall have terms identical (including with
respect to conversion) to the terms of this Debenture, and shall be entitled to all of the rights and privileges of the Holder of
this Debenture set forth herein and the agreements pursuant to which this Debenture was issued. In the case of clause (C), the
conversion price applicable for the newly issued shares of convertible preferred stock or convertible debentures shall be based upon
the amount of securities, cash and property that each Common Shares would receive in such transaction and the Conversion Price in
effect immediately prior to the effectiveness or closing date for such transaction. The terms of any such merger, sale or
consolidation shall include such terms so as to continue to give the Holder the right to receive the securities, cash and property
set forth in this Section upon any conversion or redemption following such event. This provision shall similarly apply to successive
such events.
6
(4)
REISSUANCE OF THIS DEBENTURE.
(a) Transfer.
If this Debenture is to be transferred, the Holder shall surrender this Debenture to the Company, whereupon the Company will forthwith
issue and deliver upon the order of the Holder a new Debenture (in accordance with Section (4)(d)), registered in the name of the registered
transferee or assignee, representing the outstanding Principal being transferred by the Holder (along with any accrued and unpaid Interest
thereof) and, if less than the entire outstanding Principal is being transferred, a new Debenture (in accordance with Section (4)(d))
to the Holder representing the outstanding Principal not being transferred. The Holder and any assignee, by acceptance of this Debenture,
acknowledge and agree that, by reason of the provisions of Section (3)(b)(iii) following conversion or redemption of any portion of this
Debenture, the outstanding Principal represented by this Debenture may be less than the Principal stated on the face of this Debenture.
(b) Lost,
Stolen or Mutilated Debenture. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Debenture, and, in the case of loss, theft or destruction, of any indemnification undertaking by the
Holder to the Company in customary form and substance and, in the case of mutilation, upon surrender and cancellation of this Debenture,
the Company shall execute and deliver to the Holder a new Debenture (in accordance with Section (4)(d)) representing the outstanding Principal.
(c) Debenture
Exchangeable for Different Denominations. This Debenture is exchangeable, upon the surrender hereof by the Holder at the principal
office of the Company, for a new Debenture or Debentures (in accordance with Section (4)(d)) representing in the aggregate the outstanding
Principal of this Debenture, and each such new Debenture will represent such portion of such outstanding Principal as is designated by
the Holder at the time of such surrender.
(d) Issuance
of New Debentures. Whenever the Company is required to issue a new Debenture pursuant to the terms of this Debenture, such new Debenture
(i) shall be of like tenor with this Debenture, (ii) shall represent, as indicated on the face of such new Debenture, the Principal remaining
outstanding (or in the case of a new Debenture being issued pursuant to Section (4)(a) or Section (4)(c), the Principal designated by
the Holder which, when added to the Principal represented by the other new Debentures issued in connection with such issuance, does not
exceed the Principal remaining outstanding under this Debenture immediately prior to such issuance of new Debentures), (iii) shall have
an issuance date, as indicated on the face of such new Debenture, which is the same as the Issuance Date of this Debenture, (iv) shall
have the same rights and conditions as this Debenture, and (v) shall represent accrued and unpaid Interest from the Issuance Date.
(5) NOTICES. Any notices, consents,
waivers or other communications required or permitted to be given under the terms hereof must be in writing by letter or electronic
mail (“e-mail”) and will be deemed to have been delivered (i) upon receipt, when delivered personally, (ii) one (1)
Business Day after deposit with an overnight courier service with next day delivery specified, as applicable or (iii) receipt, when
sent by e-mail, and, in each case of the foregoing clauses (i), (ii) and (iii), properly addressed to the party to receive the same.
The addresses and e-mail addresses for such communications shall be:
If to the Company, to:
Evolution Metals & Technologies
Corp.
4040 NE 2nd Ave, Ste 349
Miami, Florida 33137
Attn:
David Wilcox
Frank Moon
Andrew Knaggs
Christopher Clower
Telephone: 561-225-3205
Email:
david.wilcox@evolution-metals.com
frank.moon@evolution-metals.com
andrew.knaggs@evolution-metals.com
christopher.clower@evolution-metals.com
with a copy (which shall not constitute notice) to:
John Arrastia
4040 NE 2nd Ave, Ste 349
Miami, Florida 33137
Attention: John Arrastia
Telephone:
561-225-3205
Email: john.arrastia@evolution-metals.com
7
If to the Holder:
YA II PN, Ltd
c/o Yorkville Advisors Global, LLC
1012 Springfield Avenue
Mountainside, NJ 07092
Attention: Mark Angelo
Telephone:
201-985-8300
Email: Legal@yorkvilleadvisors.com
or at such other address and/or e-mail
address and/or to the attention of such other person as the recipient party has specified by written notice given to each other
party in accordance with this Section at least three (3) Business Days prior to the effectiveness of such change. Written
confirmation of receipt (a) given by the recipient of such notice, consent, waiver or other communication, (b) electronically
generated by the sender’s email service provider containing the time, date, recipient email address or (c) provided by a nationally
recognized overnight delivery service, shall be rebuttable evidence of personal service, receipt from a nationally recognized
overnight delivery service or receipt by e-mail in accordance with clause (i), (ii) or (iii) above, respectively.
(6) Except
as expressly provided herein, no provision of this Debenture shall alter or impair the obligations of the Company, which are absolute
and unconditional, to pay the Principal of, and Interest and other charges (if any) on, this Debenture at the time, place, and rate, and
in the currency, herein prescribed. This Debenture is a direct obligation of the Company. As long as this Debenture is outstanding, the
Company shall not and shall cause each of its subsidiaries not to, without the consent of the Holder, (i) amend its certificate of incorporation,
bylaws or other charter documents so as to adversely affect any rights of the Holder; (ii) repay, repurchase or offer to repay, repurchase
or otherwise acquire shares of its Common Shares or other equity securities; or (iii) enter into any agreement with respect to any of
the foregoing; or (iv) enter into any agreement or transaction in or of which the terms thereof would restrict or conflict with the ability
of the Company to perform its obligations under the this Debenture, including, without limitation, the obligation of the Company to make
cash payments hereunder.
(7) This
Debenture shall not entitle the Holder to any of the rights of a stockholder of the Company, including without limitation, the right to
vote, to receive dividends and other distributions, or to receive any notice of, or to attend, meetings of stockholders or any other proceedings
of the Company, unless and to the extent converted into Common Shares in accordance with the terms hereof.
(8)
CHOICE OF LAW; VENUE; WAIVER OF JURY TRIAL
(a) Governing
Law. This Debenture and the rights and obligations of the Parties hereunder shall, in all respects, be governed by, and construed
in accordance with, the laws (excluding the principles of conflict of laws) of the State of New York (the “Governing Jurisdiction”)
(including Section 5-1401 and Section 5-1402 of the General Obligations Law of the State of New York), including all matters of construction,
validity and performance.
(b)
Jurisdiction; Venue; Service.
(i) The
Company hereby irrevocably consents to the non- exclusive personal jurisdiction of the state courts of the Governing Jurisdiction and,
if a basis for federal jurisdiction exists, the non-exclusive personal jurisdiction of any United States District Court for the Governing
Jurisdiction.
(ii) The
Company agrees that venue shall be proper in any court of the Governing Jurisdiction selected by the Holder or, if a basis for federal
jurisdiction exists, in any United States District Court in the Governing Jurisdiction selected by the Holder. The Company waives any
right to object to the maintenance of any suit, claim, action, litigation or proceeding of any kind or description, whether in law or
equity, whether in contract or in tort or otherwise, in any of the state or federal courts of the Governing Jurisdiction on the basis
of improper venue or inconvenience of forum.
(iii) Any suit, claim,
action, litigation or proceeding of any kind or description, whether in law or equity, whether in contract or tort or otherwise,
brought by the Company against the Holder arising out of or based upon this Debenture or any matter relating to this Debenture, or
any other Transaction Document, or any contemplated transaction, shall be brought in a court only in the Governing Jurisdiction. The
Company shall not file any counterclaim against the Holder in any suit, claim, action, litigation or proceeding brought by the
Holder against the Company in a jurisdiction outside of the Governing Jurisdiction unless under the rules of the court in which the
Holder brought such suit, claim, action, litigation or proceeding the counterclaim is mandatory, and not permissive, and would be
considered waived unless filed as a counterclaim in the suit, claim, action, litigation or proceeding instituted by the Holder
against the Company. The Company agrees that any forum outside the Governing Jurisdiction is an inconvenient forum and that any
suit, claim, action, litigation or proceeding brought by the Company against the Holder in any court outside the Governing
Jurisdiction should be dismissed or transferred to a court located in the Governing Jurisdiction. Furthermore, the Company
irrevocably and unconditionally agrees that it will not bring or commence any suit, claim, action, litigation or proceeding of any
kind or description, whether in law or equity, whether in contract or in tort or otherwise, against the Holder arising out of or
based upon this Debenture or any matter relating to this Debenture, or any other Transaction Document, or any contemplated
transaction, in any forum other than the courts of the State of New York sitting in New York County, and the United States District
Court of the Southern District of New York, and any appellate court from any thereof, and each of the parties hereto irrevocably and
unconditionally submits to the jurisdiction of such courts and agrees that all claims in respect of any such suit, claim, action,
litigation or proceeding may be heard and determined in such New York State Court or, to the fullest extent permitted by applicable
law, in such federal court. The Company and the Holder agree that a final judgment in any such suit, claim, action, litigation or
proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by
law.
8
(iv) The
Company and the Holder irrevocably consent to the service of process out of any of the aforementioned courts in any such suit, claim,
action, litigation or proceeding by e-mail or the mailing of copies thereof by registered or certified mail postage prepaid, to it at
the e-mail address or physical address, as applicable, provided for notices in this Debenture, such service to become effective thirty
(30) days after the date of such e-mail or mailing, as applicable. The Company and the Holder each irrevocably waive any defense it may
have on the grounds of insufficient or improper service with respect to service of process effected in accordance with this Section (8)(b)(iv).
(v) Nothing
herein shall affect the right of the Holder to serve process in any other manner permitted by law or to commence legal proceedings or
to otherwise proceed against the Company or any other Person in the Governing Jurisdiction or in any other jurisdiction.
(c) THE PARTIES MUTUALLY
WAIVE ALL RIGHT TO TRIAL BY JURY OF ALL CLAIMS OF ANY KIND ARISING OUT OF OR BASED UPON THIS DEBENTURE OR ANY MATTER RELATING TO THIS
DEBENTURE, OR ANY OTHER TRANSACTION DOCUMENT, OR ANY CONTEMPLATED TRANSACTION. THE PARTIES ACKNOWLEDGE THAT THIS IS A WAIVER OF A LEGAL
RIGHT AND THAT THE PARTIES EACH MAKE THIS WAIVER VOLUNTARILY AND KNOWINGLY AFTER CONSULTATION WITH COUNSEL OF THEIR RESPECTIVE CHOICE.
THE PARTIES AGREE THAT ALL SUCH CLAIMS SHALL BE TRIED BEFORE A JUDGE OF A COURT HAVING JURISDICTION, WITHOUT A JURY.
(d) The
Company expressly acknowledges and agrees that this Debenture constitutes an instrument for the payment of money only within the meaning
of section 3213 of the New York Civil Practice Law and Rules (“CPLR §3213”), and that upon any default under or
breach of the terms of this Debenture, the Holder may immediately commence an action by motion for summary judgment in lieu of complaint
without any further notice or demand. The Company irrevocably waives (i) any right to require the Holder to commence any action by summons
and complaint, (ii) any right to assert defenses, setoffs, counterclaims or delays in any CPLR §3213 proceeding (other than the defense
of full payment of any amount that the Holder seeks to recover), and (iii) any right to object to the sufficiency of this Debenture as
an instrument for the payment of money only within the meaning of CPLR §3213 and agrees not to assert that this Debenture is not
such an instrument. The Company agrees that all amounts due under this Debenture shall be deemed liquidated, unconditional and immediately
due and payable for purposes of CPLR §3213.
(9) If
the Company fails to strictly comply with the terms of this Debenture, then the Company shall reimburse the Holder promptly for all fees,
costs and expenses, including, without limitation, attorneys’ fees and expenses incurred by the Holder in any action in connection
with this Debenture, including, without limitation, those incurred: (i) during any workout, attempted workout, and/or in connection with
the rendering of legal advice as to the Holder’s rights, remedies and obligations, (ii) collecting any sums which become due to
the Holder, (iii) defending or prosecuting any proceeding or any counterclaim to any proceeding or appeal; or (iv) the protection, preservation
or enforcement of any rights or remedies of the Holder.
(10) Any
waiver by the Holder of a breach of any provision of this Debenture shall not operate as or be construed to be a waiver of any other breach
of such provision or of any breach of any other provision of this Debenture. The failure of the Holder to insist upon strict adherence
to any term of this Debenture on one or more occasions shall not be considered a waiver or deprive that party of the right thereafter
to insist upon strict adherence to that term or any other term of this Debenture. No provision of this Debenture may be waived or amended
other than by a written agreement signed by the parties to this Debenture. No custom or practice of the parties at variance with the terms
hereof shall constitute a waiver by any party of its right to exercise any right, power or remedy available to it hereunder or any other
right, power or remedy or to demand strict compliance with the terms of this Debenture.
(11) If any provision of
this Debenture is invalid, illegal or unenforceable, the balance of this Debenture shall remain in effect, and if any provision is
inapplicable to any person or circumstance, it shall nevertheless remain applicable to all other persons and circumstances. If it
shall be found that any Interest or other amount deemed Interest due hereunder shall violate applicable laws governing usury, the
applicable rate of interest due hereunder shall automatically be lowered to equal the maximum permitted rate of Interest. The
Company covenants (to the extent that it may lawfully do so) that it shall not at any time insist upon, plead, or in any manner
whatsoever claim or take the benefit or advantage of, any stay, extension or usury law or other law which would prohibit or forgive
the Company from paying all or any portion of the Principal of or interest on this Debenture as contemplated herein, wherever
enacted, now or at any time hereafter in force, or which may affect the covenants or the performance of this Debenture, and the
Company (to the extent it may lawfully do so) hereby expressly waives all benefits or advantage of any such law, and covenants that
it will not, by resort to any such law, hinder, delay or impede the execution of any power herein granted to the Holder, but will
suffer and permit the execution of every such power as though no such law has been enacted.
9
(12) CERTAIN
DEFINITIONS. For purposes of this Debenture, the following terms shall have the following meanings:
(a) Amortization
Event” shall mean (i) the daily VWAP is less than the Floor Price then in effect for five Trading Days during a period of seven
consecutive Trading Days (a “Floor Price Event”), (ii) the Company has issued in excess of 99% of the Common Shares
available under the Exchange Cap, where applicable (an “Exchange Cap Event”), or (iii) any time after the Effectiveness
Deadline (as defined in the Registration Rights Agreement), the Investor is unable to utilize a Registration Statement to resell Underlying
Shares for a period of ten (10) consecutive Trading Days (a “Registration Event”)] (the first day of each such occurrence,
an “Amortization Event Date”).
(b) “Amortization
Principal Amount” shall have the meaning set forth in Section 1(c).
(c)
“Applicable Price” shall have the meaning set forth in Section (3)(f).
(d) “Approved
Stock Plan” means any employee benefit plan or share incentive plan which has been approved by the Board of Directors of
the Company, pursuant to which the Company’s securities may be issued to any employee, officer or director for services
provided to the Company.
(e) “Bloomberg”
means Bloomberg Financial Markets (or if not available, a similar service provider of national recognized standing).
(f) “Business
Day” means any day except Saturday, Sunday and any day which shall be a federal legal holiday in the United States or a day
on which banking institutions in the State of New York are authorized or required by law or other government action to close.
(g)
“Buy-In” shall have the meaning set forth in Section (3)(b)(ii).
(h)
“Buy-In Price” shall have the meaning set forth in Section (3)(b)(ii).
(i) “Calendar
Month” means the period from a particular date in one month to the same date in the next month.
(j) “Change of
Control Transaction” means the occurrence of (a) an acquisition after the date hereof by an individual or legal entity or
“group” (as described in Rule 13d-5(b)(1) promulgated under the Exchange Act) of effective control (whether through
legal or beneficial ownership of capital stock of the Company, by contract or otherwise) of in excess of fifty percent (50%) of the
voting power of the Company (except that the acquisition of voting securities by the Holder or any other current holder of
convertible securities of the Company shall not constitute a Change of Control Transaction for purposes hereof), (b) a replacement
at one time or over time of more than one-half of the members of the board of directors of the Company (other than as due to the
death or disability of a member of the board of directors) which is not approved by a majority of those individuals who are members
of the board of directors on the date hereof (or by those individuals who are serving as members of the board of directors on any
date whose nomination to the board of directors was approved by a majority of the members of the board of directors who are members
on the date hereof), (c) the merger, consolidation or sale of fifty percent (50%) or more of the assets of the Company or any
Subsidiary of the Company in one or a series of related transactions with or into another entity, or (d) the execution by the
Company of an agreement to which the Company is a party or by which it is bound, providing for any of the events set forth above in
(a), (b) or (c). No transfer to a wholly-owned Subsidiary shall be deemed a Change of Control Transaction under this provision.
(k) “Closing
Price” means the price per share in the last reported trade of the Common Shares on a Principal Market or on the exchange which
the Common Shares is then listed as quoted by Bloomberg.
(l)
“Commission” means the Securities and Exchange Commission.
(m) “Common
Shares” means the shares of common stock, par value $0.0001, of the Company and stock of any other class into which such
shares may hereafter be changed or reclassified.
10
(n) “Conversion
Amount” means the portion of the Principal, Interest, or other amounts outstanding under this Debenture to be converted, redeemed
or otherwise with respect to which this determination is being made.
(o)
“Conversion Date” shall have the meaning set forth in Section (3)(b)(i).
(p)
“Conversion Failure” shall have the meaning set forth in Section (3)(b)(ii).
(q) “Conversion Notice” shall have the meaning
set forth in Section (3)(b)(i).
(r)
“Conversion Price” means, as of any Conversion Date or other date of determination the lower of (i) [$____
]3 per Common Share (the “Fixed Price”), or (ii) 95% of the lowest daily VWAP during the 5 consecutive
Trading Days immediately preceding the Conversion Date or other date of determination (the “Variable Price”), but
which Variable Price shall not be lower than the Floor Price then in effect. The Conversion Price shall be adjusted from time to
time pursuant to the other terms and conditions of this Debenture.
(s) “Convertible
Securities” means any stock or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable
for Common Shares.
(t) “Dilutive Issuance” shall
have the meaning set forth in Section (3)(f).
(u)
“Exchange Act” means the Securities Exchange Act of 1934, as amended.
(v)
“Excluded Securities” means any Common Shares issued or issuable or deemed to be issued by the Company: (i) under
any Approved Stock Plan, (ii) upon conversion of any of the Debentures issued pursuant to the Securities Purchase Agreement; (iii)
upon conversion, exercise or exchange of any Options or Convertible Securities which are outstanding on the day immediately
preceding the date of the Securities Purchase Agreement; provided, that such issuance of Common Shares upon exercise of such Options
or Convertible Securities is made pursuant to the terms of such Options or Convertible Securities in effect on such date and such
Options or Convertible Securities are not amended, modified or changed on or after such date, or (iv) upon a stock split, reverse
stock split, distribution of bonus shares, combination or other recapitalization events.
(w) “Floor Price”
solely with respect to the Variable Price, shall mean [$ ]4 per Common
Share.
(x) “Fundamental
Transaction” means any of the following: (1) the Company effects any merger or consolidation of the Company with or into
another Person and the Company is the non-surviving company (other than a merger or consolidation with a wholly owned Subsidiary of the
Company for the purpose of redomiciling the Company), (2) the Company effects any sale of all or substantially all of its assets in one
or a series of related transactions, (3) any tender offer or exchange offer (whether by the Company or another Person) is completed pursuant
to which holders of Common Shares are permitted to tender or exchange their shares for other securities, cash or property, or (4) the
Company effects any reclassification of the Common Shares or any compulsory share exchange pursuant to which the Common Shares is effectively
converted into or exchanged for other securities, cash or property.
(y) “Material
Adverse Effect” has the meaning given such term in the Securities Purchase Agreement.
3 For each Debenture, to be the price equal to 130% of the
VWAP on the day prior to the Issuance Date of such Debenture.
4 Insert price equal to 20% of the VWAP of the Common Shares
immediately prior to the date of the Securities Purchase Agreement.
11
(z)
“New Issuance Price” shall have the meaning set forth in Section (3)(f).
(aa)
“Optional Redemption” shall have the meaning set forth in (1)(d).
(bb) “Options” means any rights,
warrants or options to subscribe for or purchase Common Shares or Convertible Securities.
(cc) “Other Debentures”
means any other debentures issued pursuant to the Securities Purchase Agreement and any other debentures, notes, or other instruments
issued in exchange, replacement, or modification of the foregoing.
(dd) “Payment
Premium” means 5% of the Principal Amount being paid.
(ee) “Periodic Reports” shall mean all of the
Company’s reports required to be filed by the Company with the Commission under applicable laws and regulations (including,
without limitation, Regulation S-K), including annual reports (on Form 10-K), quarterly reports (on Form 10-Q), and current reports
(on Form 8-K), for so long as any amounts are outstanding under this Debenture; provided that all such Periodic Reports shall
include, when filed, all information, financial statements, audit reports (when applicable) and other information required to be
included in such Periodic Reports in compliance with all applicable laws and regulations.
(ff) “Person”
means a corporation, an association, a partnership, organization, a business, an individual, a government or political subdivision thereof
or a governmental agency.
(gg) “Principal Market”
means the Nasdaq Global Market; provided however, that in the event the Company’s Common Shares are ever listed or traded on any
of the New York Stock Exchange, the NYSE American, the Nasdaq Capital Market, or the Nasdaq Global Select Market, or such successor thereto,
the “Principal Market” shall mean that market on which the Common Shares are then listed or traded
(hh) “Redemption Amount” shall have
the meaning set forth in (1)(d).
(ii) “Redemption Notice” shall have
the meaning set forth in (1)(d).
(jj) “Registration
Rights Agreement” has the meaning given such term in the Securities Purchase Agreement.
(kk) “Registration
Statement” means a registration statement meeting the requirements set forth in the Registration Rights Agreement, covering
among other things the resale of the Underlying Shares and naming the Holder as a “selling stockholder” thereunder.
(ll) “Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
(mm) “Share Delivery Date” shall have the
meaning set forth in Section (3)(b)(i).
(nn) “Subsidiary” shall mean any
Person in which the Company, directly or indirectly, (x) owns a majority of the outstanding capital stock or holds a majority of the
equity or similar interest of such Person or (y) controls or operates all or substantially all of the business, operations or
administration of such Person, and the foregoing are collectively referred to herein as “Subsidiaries.”
(oo) “Trading Day”
means a day on which the Common Shares are quoted or traded on a Principal Market on which the Common Shares are then quoted or listed;
provided, that in the event that the Common Shares are not listed or quoted, then Trading Day shall mean a Business Day.
(pp) “Transaction
Document” has the meaning given such term in the Securities Purchase Agreement.
(qq) “Underlying
Shares” means the Common Shares issuable upon conversion of this Debenture in accordance with the terms hereof.
(rr) “VWAP”
shall mean for any Trading Day, the volume weighted average price of the Common Shares on the Principal Market, for such Trading Day as
reported by Bloomberg L.P. through its “HP” function.
[Signature Page Follows]
12
IN WITNESS WHEREOF, the Company has caused
this Convertible Debenture to be duly executed by a duly authorized officer as of the date set forth above.
COMPANY:
EVOLUTION METALS & TECHNOLOGIES CORP.
By:
Name:
David Wilcox
Title:
Executive Chairman
13
EX-10.1 — SECURITIES PURCHASE AGREEMENT
EX-10.1
Filename: ea029007301ex10-1.htm · Sequence: 4
Exhibit 10.1
SECURITIES PURCHASE AGREEMENT
THIS SECURITIES
PURCHASE AGREEMENT (this “Agreement”), dated as of May 7, 2026, is between EVOLUTION METALS & TECHNOLOGIES
CORP., a company incorporated under the laws of the State of Delaware, with principal executive offices located at 4040 NE 2nd
Avenue, Ste 349, Miami, Florida 33137 (the “Company”), and each of the investors listed on the Schedule of Buyers attached
as Schedule I hereto (individually, a “Buyer” and collectively the “Buyers”).
WITNESSETH
WHEREAS,
the Company and each Buyer desire to enter into this transaction for the Company to sell and the Buyers to purchase the Convertible Debentures
(as defined below) pursuant to an exemption from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the
“Securities Act”) and/or Rule 506 of Regulation D (“Regulation D”) promulgated by the U.S. Securities
and Exchange Commission (the “SEC”) thereunder;
WHEREAS, the
parties desire that, upon the terms and subject to the conditions contained herein, the Company shall issue and sell to the
Buyer(s), as provided herein, and the Buyer(s) shall purchase convertible debentures in the form attached hereto as
“Exhibit A” (the “Convertible Debentures”) in the aggregate principal amount of up to
$100,000,000 (the “Subscription Amount”), which shall be convertible into shares of the Company’s common
stock, par value $0.0001 per share (the “Common Shares”) (as converted, the “Conversion
Shares”), of which $20,000,000 shall be purchased upon the signing this Agreement (the “First
Closing”), $5,775,000 shall be purchased on or before the first Business Day after the date the initial Registration
Statement (as defined in the Registration Rights Agreement (as defined below)) filed with the SEC registering the resale of the
Conversion Shares has first been declared effective (the “Second Closing”), and up to $74,225,000 shall be
purchased in subsequent tranches from time to time during the term of this Agreement, subject to, and upon the mutual agreement of
the Company and the Buyer(s) (each, a “Subsequent Closing”) (individually referred to as a
“Closing” and collectively referred to as the “Closings”), at a purchase price equal to 97% of
the Subscription Amount (the “Purchase Price”) in the respective amounts set forth opposite each Buyer(s) name on
Schedule I to this Agreement;
WHEREAS,
on or before the First Closing Date (as defined in Section 1(c) below), the parties hereto are executing and delivering a Registration
Rights Agreement (the “Registration Rights Agreement”) pursuant to which the Company has agreed to provide certain
registration rights under the Securities Act and the rules and regulations promulgated thereunder, and applicable state securities laws;
WHEREAS,
contemporaneously with the execution and delivery of this Agreement, the Company is delivering Irrevocable Transfer Agent Instructions
(the “Irrevocable Transfer Agent Instructions”) to its transfer agent in the form agreed upon by the Company and the
Buyer; and
WHEREAS,
on or before the First Closing Date, each subsidiary of the Company shall enter into a global guaranty agreement (the “Global
Guaranty”) in favor of the Buyer;
WHEREAS, the
Convertible Debentures and the Conversion Shares are collectively referred to herein as the “Securities.”
AGREEMENT
NOW, THEREFORE,
in consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Company and each Buyer hereby agree as follows:
1. PURCHASE AND SALE OF CONVERTIBLE DEBENTURES.
(a) Purchase
of Convertible Debentures. Subject to the satisfaction (or waiver in accordance with the terms of Section 9(k)) of the conditions
set forth in Sections 6 and 7 below, the Company shall issue and sell to each Buyer, and each Buyer severally, but not jointly, agrees
to purchase from the Company at each Closing, Convertible Debentures with principal amount corresponding to the Subscription Amount set
forth opposite each Buyer’s name on Schedule I attached hereto.
(b) Closing
Dates. Each Closing shall occur remotely by conference call and electronic delivery of documentation. The date and time of each Closing
shall be as follows: (i) the First Closing shall be 10:00 a.m., New York time, on the first Business Day on which the conditions to the
Closing set forth in Sections 6 and 7 below are satisfied or waived (in accordance with the terms of Section 9(k)) (or such other date
as is mutually agreed to by the Company and each Buyer) (the “First Closing Date”), (ii) the Second Closing shall be
10:00 a.m., New York time, on the first Business Day after the Registration Statement is first declared effective by the SEC, provided
the conditions to the Closing set forth in Sections 6 and 7 below are satisfied or waived (in accordance with the terms of Section 9(k))
(or such other date as is mutually agreed to by the Company and each Buyer) (the “Second Closing Date”), and (iii)
each Subsequent Closing shall take place at such date and time as is mutually agreed to by the Company and each Buyer, provided that the
Company and the Buyer consent to such Subsequent Closing (in the sole discretion of each Party) (each, a “Subsequent Closing
Date” and collectively with the First Closing Date and the Second Closing Date, the “Closing Dates”). As
used herein “Business Day” means any day other than a Saturday, Sunday or other day on which commercial banks in New
York, New York are authorized or required by law to remain closed.
(c)
Form of Payment; Deliveries. Subject to the satisfaction (or waiver in accordance with the terms of Section 9(k))
of the terms and conditions of this Agreement, on each Closing Date, (i) the Buyers shall deliver to the Company, in immediately available
funds to a bank account designated in writing by the Company, the Purchase Price for the Convertible Debentures to be issued and sold
to such Buyer at such Closing, minus any fees or expenses to be paid directly from the proceeds of such Closing as set forth herein,
and (ii) the Company shall deliver to each Buyer, Convertible Debentures which such Buyer is purchasing at such Closing with a principal
amount corresponding with the Subscription Amount set forth opposite each Buyer’s name on Schedule of Buyers attached as Schedule
I hereto, duly executed on behalf of the Company.
2
(d) Maximum
Shares. Notwithstanding anything in this Agreement to the contrary, the Company shall not issue any Common Shares pursuant to the
transactions contemplated hereby or any other Transaction Documents (as defined below) if the issuance of Common Shares would exceed the
aggregate number of Common Shares that the Company may issue in this transaction in compliance with the Company’s obligations under
the rules or regulations of the Nasdaq Stock Market LLC (“Nasdaq”) (the number of shares which may be issued without
violating such rules and regulations shall be referred to as the “Exchange Cap”), except that such limitation shall
not apply in the event that the Company obtains the approval of its stockholders as required by the applicable rules of the Nasdaq for
issuances of Common Shares in excess of such amount.
2. BUYER’S REPRESENTATIONS AND WARRANTIES.
Each Buyer, severally
and not jointly, represents and warrants to the Company with respect to only itself that, as of the date hereof and as of each Closing
Date:
(a) Investment
Purpose. The Buyer is acquiring the Securities for its own account for investment purposes and not with a view towards, or for resale
in connection with, the public sale or distribution thereof, except pursuant to sales registered under or exempt from the registration
requirements of the Securities Act; provided, however, that by making the representations herein, such Buyer does not agree, or make any
representation or warranty, to hold any of the Securities for any minimum or other specific term and reserves the right to dispose of
the Securities at any time in accordance with, or pursuant to, a registration statement covering such Securities or an available exemption
under the Securities Act. Such Buyer does not presently have any agreement or understanding, directly or indirectly, with any Person (as
defined below) to distribute any of the Securities in violation of applicable securities laws. As used herein, “Person”
means a corporation, a limited liability company, an association, a partnership, an organization, a business, an individual, a governmental
or political subdivision thereof or a governmental agency.
(b) Accredited
Investor Status. The Buyer is an “Accredited Investor” as that term is defined in Rule 501(a)(3) of Regulation D.
(c) Reliance
on Exemptions. The Buyer understands that the Securities are being offered and sold to it in reliance on specific exemptions from
the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the truth
and accuracy of, and such Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and understandings
of such Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of such Buyer to acquire
the Securities.
3
(d) Information.
The Buyer and its advisors (and its counsel), if any, have been furnished with all materials relating to the business, finances and
operations of the Company and information the Buyer deemed material to making an informed investment decision regarding its purchase
of the Securities, which have been requested by such Buyer. The Buyer and its advisors, if any, have been afforded the opportunity
to ask questions of the Company and its management. Neither such inquiries nor any other due diligence investigations conducted by
such Buyer or its advisors, if any, or its representatives shall modify, amend or affect such Buyer’s right to rely on the
Company’s representations and warranties contained in Section 3 below. The Buyer understands that its investment in the
Securities involves a high degree of risk. The Buyer has sought such accounting, legal and tax advice, as it has considered
necessary to make an informed investment decision with respect to its acquisition of the Securities.
(e) Transfer
or Resale. The Buyer understands that: (i) the Securities have not been registered under the Securities Act or any state securities
laws, and may not be offered for sale, sold, assigned or transferred unless (A) subsequently registered thereunder, (B) such Buyer shall
have delivered to the Company an opinion of counsel, in a generally acceptable form, to the effect that such Securities to be sold, assigned
or transferred may be sold, assigned or transferred pursuant to an exemption from such registration requirements, or (C) such Buyer provides
the Company with reasonable assurances (in the form of seller and broker representation letters) that such Securities can be sold, assigned
or transferred pursuant to Rule 144 promulgated under the Securities Act, as amended (or a successor rule thereto) (collectively, “Rule
144”), in each case following the applicable holding period set forth therein; and (ii) any sale of the Securities made in reliance
on Rule 144 may be made only in accordance with the terms of Rule 144 and further, if Rule 144 is not applicable, any resale of the Securities
under circumstances in which the seller (or the Person through whom the sale is made) may be deemed to be an underwriter (as that term
is defined in the Securities Act) may require compliance with some other exemption under the Securities Act or the rules and regulations
of the SEC thereunder. Notwithstanding the foregoing, the Securities may be pledged in connection with a bona fide margin account or other
loan or financing arrangement secured by the Securities and such pledge of Securities shall not be deemed to be a transfer, sale or assignment
of the Securities hereunder, provided that the Buyer shall provide prior written notice to the Company of any such pledge, and no Buyer
effecting a pledge of Securities shall be required to provide the Company with any notice thereof or otherwise make any delivery to the
Company pursuant to this Agreement or any other Transaction Document, including, without limitation, this Section 2(e).
(f) Legends.
The Buyer agrees to the imprinting, so long as its required by this Section 2(f),
of a restrictive legend on the Securities in substantially the following form:
THE SECURITIES REPRESENTED BY THIS
CERTIFICATE [AND THOSE SECURITIES INTO WHICH THEY ARE CONVERTIBLE] HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES [AND THOSE SECURITIES INTO WHICH THEY ARE CONVERTIBLE] HAVE BEEN
ACQUIRED SOLELY FOR INVESTMENT PURPOSES AND NOT WITH A VIEW TOWARD RESALE AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR
ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER
SAID ACT OR APPLICABLE STATE SECURITIES LAWS. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA
FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.
4
Certificates evidencing the Conversion Shares
shall not contain any legend (including the legend set forth above), (i) while a registration statement covering the resale of such
security is effective under the Securities Act, (ii) following any sale of such Conversion Shares pursuant to Rule 144, (iii) if
such Conversion Shares are eligible for sale under Rule 144, or (iv) if such legend is not required under applicable requirements of
the Securities Act (including judicial interpretations and pronouncements issued by the staff of the SEC). If a legend is not
required pursuant to the foregoing, the Company shall no later than two (2) Trading Days (or such earlier date as required pursuant
to the Exchange Act (as defined below) or other applicable law, rule or regulation for the settlement of a trade initiated on the
date such Buyer delivers such legended certificate representing such securities to the Company) following the delivery by a Buyer to
the Company or the transfer agent (with notice to the Company) of a legended certificate representing such securities (endorsed or
with stock powers attached, and otherwise in form necessary to affect the reissuance and/or transfer, if applicable), together with
any other deliveries from such Buyer as may be required above in this Section 2(f),
as directed by such Buyer, either: (A) provided that the Company’s transfer agent is participating in the DTC Fast Automated
Securities Transfer Program, credit the aggregate number of shares of Common Shares to which such Buyer shall be entitled to such
Buyer’s or its designee’s balance account with DTC through its Deposit/Withdrawal at Custodian system or (B) if the
Company’s transfer agent is not participating in the DTC Fast Automated Securities Transfer Program, issue and deliver (via
reputable overnight courier) to such Buyer, a certificate representing such securities that is free from all restrictive and other
legends, registered in the name of such Buyer or its designee. The Company shall be responsible for any transfer agent fees or DTC
fees with respect to any issuance of Securities or the removal of any legends with respect to any Securities in accordance herewith.
The Buyer agrees that the removal of a restrictive legend from certificates representing Securities as set forth in this Section 2(f)
is predicated upon the Company’s reliance that the Buyer will sell any Securities pursuant to either the registration
requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that
if Securities are sold pursuant to a registration statement, they will be sold in compliance with the plan of distribution set forth
therein.
(g) Organization;
Authority. Such Buyer is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its
organization with the requisite power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
to which it is a party and otherwise to carry out its obligations hereunder and thereunder.
(h) Authorization,
Enforcement. The Transaction Documents to which each such Buyer is a party have been duly and validly authorized, executed and
delivered on behalf of such Buyer and shall constitute the legal, valid and binding obligations of such Buyer enforceable against
such Buyer in accordance with their terms, except as such enforceability may be limited by general principles of equity or to
applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting
generally, the enforcement of applicable creditors' rights and remedies.
5
(i) No
Conflicts. The execution, delivery and performance by such Buyer of this Agreement and the consummation by such Buyer of the transactions
contemplated hereby will not (i) result in a violation of the organizational documents of such Buyer, (ii) conflict with, or constitute
a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any agreement, indenture or instrument to which such Buyer is a party or (iii) result in a
violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws) applicable to such Buyer,
except, in the case of clauses (ii) and (iii) above, for such conflicts, defaults, rights or violations which could not, individually
or in the aggregate, reasonably be expected to have a material adverse effect on the ability of such Buyer to perform its obligations
hereunder.
(j) Certain
Trading Activities. The Buyer has not directly or indirectly, nor has any Person acting on behalf of or pursuant to any understanding
with the Buyer, engaged in any transactions in the securities of the Company (including, without limitation, any Short Sales (as defined
below) involving the Company's securities) during the period commencing as of the time that the Buyer first contacted the Company or the
Company's agents regarding the specific investment in the Company contemplated by this Agreement and ending immediately prior to the execution
of this Agreement by such Buyer.
(k) No
General Solicitation. The Buyer is not purchasing or acquiring the Securities as a result of any general solicitation or general advertising
(within the meaning of Regulation D) in connection with the offer or sale of the Securities.
(l) Not
an Affiliate. The Buyer is not (i) an officer or director of the Company or any of its Subsidiaries, (ii) an “affiliate”
(as defined in Rule 144) of the Company or any of its Subsidiaries or (iii) a “beneficial owner” of more than 10% of the shares
of Common Shares (as defined for purposes of Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)).
6
3. REPRESENTATIONS AND WARRANTIES OF THE COMPANY.
Except as set forth (i)
under the corresponding section of the disclosure schedule (dated as of the date of this Agreement) delivered to the Buyer by the
Company on the date of this Agreement (the “Disclosure Schedule”) which Disclosure Schedule shall be deemed a
part hereof and to qualify any representation or warranty otherwise made herein to the extent of such disclosure, or (ii) in the SEC
Documents (as defined below) that are available on the SEC’s website through the EDGAR system at least one (1) Business Day
prior to the date of this Agreement (unless the context provides otherwise), the Company hereby makes the representations and
warranties set forth below to each Buyer:
(a) Organization
and Qualification. The Company and each of its Subsidiaries are entities duly formed, validly existing and in good standing under
the laws of the jurisdiction in which they are formed, and have the requisite power and authority to own their properties and to carry
on their business as now being conducted and as presently proposed to be conducted. The Company and each of its Subsidiaries is duly qualified
as a foreign entity to do business and is in good standing in every jurisdiction in which its ownership of property or the nature of the
business conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified or be in good standing
would not reasonably be expected to have a Material Adverse Effect (as defined below). As used in this Agreement, “Material Adverse
Effect” means any material adverse effect on (i) the business, properties, assets, liabilities, operations (including results
thereof), condition (financial or otherwise) of the Company and its Subsidiaries, taken as a whole, (ii) the transactions contemplated
hereby or in any of the other Transaction Documents or any other agreements or instruments to be entered into by the Company in connection
herewith or therewith or (iii) the authority or ability of the Company to perform any of its obligations under any of the Transaction
Documents; provided, however, that no effect arising out of or resulting from any of the following will constitute or be taken into account
in determining whether a Material Adverse Effect has occurred: (A) general economic, financial, or political conditions in the United
States or global markets; (B) conditions generally affecting the critical minerals, rare earth elements, or advanced magnet manufacturing
industries; (C) acts of terrorism, war, sabotage, or natural disasters; or (D) any changes or proposed changes in applicable laws, regulations,
or GAAP. “Subsidiaries” means any Person in which the Company, directly or indirectly, owns a majority of the outstanding
capital stock having voting power or holds a majority of the equity or similar interest of such Person, and each of the foregoing, is
individually referred to herein as a “Subsidiary.”
(b) Authorization;
Enforcement; Validity. The Company has the requisite corporate power and authority to enter into and perform its obligations
under this Agreement and the other Transaction Documents and to issue the Securities in accordance with the terms hereof and
thereof. The execution and delivery of this Agreement and the other Transaction Documents by the Company and the consummation by the
Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Convertible
Debentures, the reservation for issuance and issuance of the Conversion Shares issuable upon conversion of the Convertible
Debentures), have been duly authorized by the Company's board of directors and no further filing, consent or authorization is
required by the Company, its board of directors or its shareholders or other governmental body. This Agreement has been, and the
other Transaction Documents to which the Company is a party will be prior to the Closing, duly executed and delivered by the
Company, and each constitutes the legal, valid and binding obligations of the Company, enforceable against the Company in accordance
with its respective terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of
applicable creditors' rights and remedies and except as rights to indemnification and to contribution may be limited by federal or
state securities law. “Transaction Documents” means, collectively, this Agreement, the Registration Rights
Agreement, the Convertible Debentures, the Global Guaranty, the Irrevocable Transfer Agent Instructions, and each of the other
agreements and instruments entered into by the Company or delivered by the Company in connection with the transactions contemplated
hereby and thereby, as may be amended from time to time.
7
(c) Issuance
of Securities. The issuance of the Securities has been duly authorized and, upon issuance and payment in accordance with the terms
of the Transaction Documents the Securities shall be validly issued, fully paid and non-assessable and free from all preemptive or similar
rights, mortgages, defects, claims, liens, pledges, charges, taxes, rights of first refusal, encumbrances, security interests and other
encumbrances (collectively “Liens”) with respect to the issuance thereof. As of each Closing Date, the Company shall
have reserved from its duly authorized capital stock not less than the Required Reserve Amount (as defined herein). Upon issuance or conversion
in accordance with the Convertible Debentures, the Conversion Shares, when issued, will be validly issued, fully paid and nonassessable
and free from all preemptive or similar rights or Liens with respect to the issue thereof (other than any such Liens imposed pursuant
to the organizational documents of the Company or applicable laws), with the holders being entitled to all rights accorded to a holder
of Common Shares.
(d) No Conflicts.
The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the Company of the
transactions contemplated hereby and thereby (including, without limitation, the issuance of the Convertible Debentures, the
Conversion Shares, and the reservation for issuance of the Conversion Shares) will not (i) result in a violation of the Certificate
of Incorporation (as defined below), Bylaws (as defined below), certificate of formation, memorandum of association, articles of
association, bylaws or other organizational documents of the Company or any of its Subsidiaries, or any capital stock or other
securities of the Company or any of its Subsidiaries, (ii) conflict with, or constitute a default under, or give to others any
rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Company or
any of its Subsidiaries is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree
(including, without limitation, U.S. federal and state securities laws and regulations, the securities laws of the jurisdictions of
the Company's incorporation or in which it or its subsidiaries operate and the rules and regulations of the Nasdaq Capital Market
(the “Principal Market,” provided however, that in the event the Company’s Common Shares is ever listed or
traded on any of the New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market or the Nasdaq Global Market, the
“Principal Market” shall mean that market on which the Common Shares is then listed or traded) and including all
applicable laws, rules and regulations of the jurisdiction of incorporation of the Company) applicable to the Company or any of its
Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected. For the avoidance of
doubt, conflicts, defaults, or violations with respect to the matters described in clauses (ii) and (iii) above shall constitute a
breach of this representation only if they would reasonably be expected to have, individually or in the aggregate, a any material
adverse effect on (i) the transactions contemplated hereby or in any of the other Transaction Documents or any other agreements or
instruments to be entered into by the Company in connection herewith or therewith or (ii) the authority or ability of the Company to
perform any of its obligations under any of the Transaction Documents.
8
(e) Consents.
The Company is not required to obtain any consent from, authorization or order of, or make any filing or registration with (other than
any filings as may be required by any federal or state securities agencies and any filings as may be required by the Principal Market),
any Governmental Entity (as defined below) or any regulatory or self-regulatory agency or any other Person in order for it to execute,
deliver or perform any of its obligations under or contemplated by the Transaction Documents, in each case, in accordance with the terms
hereof or thereof. All consents, authorizations, orders, filings and registrations which the Company or any Subsidiary is required to
obtain pursuant to the preceding sentence have been or will be obtained or effected on or prior to each Closing Date, and neither the
Company nor any of its Subsidiaries are aware of any facts or circumstances which might prevent the Company or any of its Subsidiaries
from obtaining or effecting any of the registration, application or filings contemplated by the Transaction Documents. The Company is
not in violation of the requirements of the Principal Market and has no knowledge of any facts or circumstances which could reasonably
lead to delisting or suspension of the Common Shares in the foreseeable future. “Governmental Entity” means any nation,
state, county, city, town, village, district, or other political jurisdiction of any nature, federal, state, local, municipal, foreign,
or other government, governmental or quasi-governmental authority of any nature (including any governmental agency, branch, department,
official, or entity and any court or other tribunal), multi-national organization or body; or body exercising, or entitled to exercise,
any administrative, executive, judicial, legislative, police, regulatory, or taxing authority or power of any nature or instrumentality
of any of the foregoing, including any entity or enterprise owned or controlled by a government or a public international organization
or any of the foregoing.
(f) Acknowledgment
Regarding Buyer's Purchase of Securities. The Company acknowledges and agrees that each Buyer is acting solely in the capacity of
an arm's length purchaser with respect to the Transaction Documents and the transactions contemplated hereby and thereby and that no Buyer
is (i) an officer or director of the Company or any of its Subsidiaries, (ii) to its knowledge, an "affiliate" (as defined in
Rule 144 promulgated under the Securities Act (or a successor rule thereto) (collectively, “Rule 144”)) of the Company
or any of its Subsidiaries or (iii) to its knowledge, a “beneficial owner” of more than 10% of the Common Shares (as defined
for purposes of Rule 13d-3 of the Exchange Act). The Company further acknowledges that no Buyer (nor any affiliate of any Buyer) is acting
as a financial advisor or fiduciary of the Company or any of its Subsidiaries (or in any similar capacity) with respect to the Transaction
Documents and the transactions contemplated hereby and thereby, and any advice given by a Buyer or any of its representatives or agents
in connection with the Transaction Documents and the transactions contemplated hereby and thereby is merely incidental to such Buyer's
purchase of the Securities. The Company further represents to each Buyer that the Company's decision to enter into the Transaction Documents
to which it is a party has been based solely on the independent evaluation by the Company and its representatives.
9
(g) No Integrated
Offering. None of the Company, its Subsidiaries or any of their affiliates, nor any Person acting on their behalf has, directly
or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would
cause this offering of the Securities to require approval of shareholders of the Company under any applicable shareholders approval
provisions, including, without limitation, under the rules and regulations of any exchange or automated quotation system on which
any of the securities of the Company are listed or designated for quotation. None of the Company, its Subsidiaries, their affiliates
nor any Person acting on their behalf will take any action or steps that would cause the offering of any of the Securities to be
integrated with other offerings of securities of the Company.
(h) Dilutive
Effect. The Company understands and acknowledges that the number of Conversion Shares will increase in certain circumstances. The
Company further acknowledges its obligation to issue the Conversion Shares upon conversion of the Convertible Debentures in accordance
with the terms thereof is, absolute and unconditional regardless of the dilutive effect that such issuance may have on the ownership interests
of other shareholders of the Company.
(i) Application
of Takeover Protections; Rights Agreement. The Company and its board of directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, interested shareholders, business combination, poison pill (including, without limitation,
any distribution under a rights agreement), shareholders rights plan or other similar anti-takeover provision under the Certificate of
Incorporation, Bylaws or other organizational documents or the laws of the jurisdiction of its incorporation or otherwise which is or
could become applicable to any Buyer as a result of the transactions contemplated by this Agreement, including, without limitation, the
Company's issuance of the Securities and any Buyer's ownership of the Securities.
10
(j) SEC Documents;
Financial Statements. During the two (2) years prior to the date hereof, the Company has timely filed all reports, schedules,
forms, proxy statements, statements and other documents required to be filed by it with the SEC pursuant to the reporting
requirements of the Exchange Act (all of the foregoing filed prior to the date hereof and all exhibits and appendices included
therein and financial statements, notes and schedules thereto and documents incorporated by reference therein being hereinafter
referred to as the “SEC Documents”). The Company has delivered or has made available to the Buyers or their
respective representatives true, correct and complete copies of each of the SEC Documents not available on the EDGAR system. As of
their respective dates, the SEC Documents complied in all material respects with the requirements of the Exchange Act or the
Securities Act, as applicable and none of the SEC Documents, at the time they were filed with the SEC, contained any untrue
statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading. As of their respective dates, the
financial statements of the Company included in the SEC Documents complied in all material respects with applicable accounting
requirements and the published rules and regulations of the SEC with respect thereto as in effect as of the time of filing. Such
financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”),
consistently applied, during the periods involved (except (i) as may be otherwise indicated in such financial statements or the
notes thereto, or (ii) in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or
summary statements) and fairly present in all material respects the financial position of the Company as of the dates thereof and
the results of its operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal
year-end audit adjustments which will not be material, either individually or in the aggregate). The reserves, if any, established
by the Company or the lack of reserves, if applicable, are reasonable based upon facts and circumstances known by the Company on the
date hereof and there are no loss contingencies that are required to be accrued by the Statement of Financial Accounting Standard
No. 5 of the Financial Accounting Standards Board which are not provided for by the Company in its financial statements or
otherwise. No other information provided by or on behalf of the Company to any of the Buyers which is not included in the SEC
Documents (including, without limitation, information referred to in Section 2(d) or in the Disclosure Schedule to this Agreement)
contains any untrue statement of a material fact or omits to state any material fact necessary in order to make the statements
therein not misleading, in the light of the circumstance under which they are or were made. The Company is not currently
contemplating to amend or restate any of the financial statements (including, without limitation, any notes or any letter of the
independent accountants of the Company with respect thereto) included in the SEC Documents (the “Financial
Statements”), nor is the Company currently aware of facts or circumstances which would require the Company to amend or
restate any of the Financial Statements, in each case, in order for any of the Financials Statements to be in compliance with GAAP
and the rules and regulations of the SEC. The Company has not been informed by its independent accountants that they recommend that
the Company amend or restate any of the Financial Statements or that there is any need for the Company to amend or restate any of
the Financial Statements.
(k) Absence of Certain
Changes. Since the date of the Company's most recent audited financial statements contained in a Form 10-K, there has been no
Material Adverse Effect, nor any event or occurrence specifically affecting the Company or its Subsidiaries that would be reasonably
expected to result in a Material Adverse Effect. Since the date of the Company's most recent audited financial statements contained
in a Form 10-K, neither the Company nor any of its Subsidiaries has (i) declared or paid any dividends, (ii) sold any material
assets, individually or in the aggregate, outside of the ordinary course of business or (iii) made any material capital
expenditures, individually or in the aggregate, outside of the ordinary course of business. Neither the Company nor any of its
Subsidiaries has taken any steps to seek protection pursuant to any law or statute relating to bankruptcy, insolvency,
reorganization, receivership, liquidation or winding up, nor does the Company or any Subsidiary have any knowledge or reason to
believe that any of their respective creditors intend to initiate involuntary bankruptcy proceedings or any actual knowledge of any
fact which would reasonably lead a creditor to do so. The Company and its Subsidiaries, individually and on a consolidated basis,
are not as of the date hereof, and after giving effect to the transactions contemplated hereby to occur at the Closing, will not be
Insolvent (as defined below). For purposes of this Section 3(k), “Insolvent” means, (i) with respect to the
Company and its Subsidiaries, on a consolidated basis, (A) the present fair saleable value of the Company’s and its
Subsidiaries’ assets is less than the amount required to pay the Company’s and its Subsidiaries’ total
Indebtedness (as defined below), (B) the Company and its Subsidiaries are unable to pay their debts and liabilities, subordinated,
contingent or otherwise, as such debts and liabilities become absolute and matured or (C) the Company and its Subsidiaries intend to
incur or believe that they will incur debts that would be beyond their ability to pay as such debts mature; or (ii) with respect to
the Company and each Subsidiary, individually, (A) the present fair saleable value of the Company’s or such Subsidiary’s
(as the case may be) assets is less than the amount required to pay its respective total Indebtedness, (B) the Company or such
Subsidiary (as the case may be) is unable to pay its respective debts and liabilities, subordinated, contingent or otherwise, as
such debts and liabilities become absolute and matured or (C) the Company or such Subsidiary (as the case may be) intends to incur
or believes that it will incur debts that would be beyond its respective ability to pay as such debts mature. Neither the Company
nor any of its Subsidiaries has engaged in any business or in any transaction, and is not about to engage in any business or in any
transaction, for which the Company’s or such Subsidiary’s remaining assets constitute unreasonably small capital with
which to conduct the business in which it is engaged as such business is now conducted and is proposed to be conducted.
11
(l) No
Undisclosed Events, Liabilities, Developments or Circumstances. No event, liability, development or circumstance has occurred or exists,
or is reasonably expected to exist or occur specific to the Company, any of its Subsidiaries or any of their respective businesses, properties,
liabilities, operations (including results thereof) or condition (financial or otherwise), that (i) would be required to be disclosed
by the Company under applicable securities laws on a registration statement filed with the SEC relating to an issuance and sale by the
Company of its Common Shares and which has not been publicly announced, (ii) would reasonably be expected to have a Material Adverse Effect.
(m) Conduct of
Business; Regulatory Permits. Neither the Company nor any of its Subsidiaries is in violation of any term under its Certificate
of Incorporation, any certificate of designation, preferences or rights of any other outstanding series of preferred stock of the
Company or any of its Subsidiaries or Bylaws or their organizational charter, certificate of formation, memorandum of association,
articles of association, Certificate of Incorporation or certificate of incorporation or bylaws, respectively. Neither the Company
nor any of its Subsidiaries is in violation of any judgment, decree or order or any statute, ordinance, rule or regulation
applicable to the Company or any of its Subsidiaries, and neither the Company nor any of its Subsidiaries will conduct its business
in violation of any of the foregoing, except in all cases for violations which would not reasonably be expected to have a Material
Adverse Effect. Without limiting the generality of the foregoing, the Company is not in violation of any of the rules, regulations
or requirements of the Principal Market and has no knowledge of any facts or circumstances that could reasonably lead to delisting
or suspension of trading of the Common Shares by the Principal Market in the foreseeable future. The Company and each of its
Subsidiaries possess all certificates, authorizations and permits issued by the appropriate regulatory authorities necessary to
conduct their respective businesses, except where the failure to possess such certificates, authorizations or permits would not
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, and neither the Company nor any of its
Subsidiaries has received any notice of proceedings relating to the revocation or modification of any such certificate,
authorization or permit. There is no agreement, commitment, judgment, injunction, order or decree binding upon the Company or any of
its Subsidiaries or to which the Company or any of its Subsidiaries is a party which has or would reasonably be expected to have the
effect of prohibiting or materially impairing any business practice of the Company or any of its Subsidiaries, any acquisition of
property by the Company or any of its Subsidiaries or the conduct of business by the Company or any of its Subsidiaries as currently
conducted other than such effects, individually or in the aggregate, which have not had and would not reasonably be expected to have
a Material Adverse Effect on the Company or any of its Subsidiaries.
12
(n) Foreign
Corrupt Practices. Neither the Company nor any of its Subsidiaries nor any director, officer, agent, employee, nor any other Person
acting for or on behalf of the Company or any of its Subsidiaries (individually and collectively, a “Company Affiliate”)
have violated the U.S. Foreign Corrupt Practices Act (the “FCPA) or any other applicable anti-bribery or anti- corruption
laws, nor has any Company Affiliate offered, paid, promised to pay, or authorized the payment of any money, or offered, given, promised
to give, or authorized the giving of anything of value, to any officer, employee or any other Person acting in an official capacity for
any Governmental Entity to any political party or official thereof or to any candidate for political office (individually and collectively,
a “Government Official”) or to any Person under circumstances where such Company Affiliate knew or was aware of a high
probability that all or a portion of such money or thing of value would be offered, given or promised, directly or indirectly, to any
Government Official, for the purpose, in violation of applicable law, of: (i) (A) influencing any act or decision of such Government Official
in his/her official capacity, (B) inducing such Government Official to do or omit to do any act in violation of his/her lawful duty, (C)
securing any improper advantage, or (D) inducing such Government Official to influence or affect any act or decision of any Governmental
Entity, or
(ii) assisting the Company or its
Subsidiaries in obtaining or retaining business for or with, or directing business to, the Company or its Subsidiaries.
(o) Equity Capitalization.
(i) Authorized
and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 1,501,000,000 shares
of common stock, of which, 593,349,852 are issued and outstanding and (B) 1,000,000 shares of preferred stock, none of which are issued
and outstanding. As of the date hereof, the Company has reserved 27,800,606 Common Shares for issuance to parties or Persons other than
the Buyers.
(ii) Valid
Issuance; Available Shares. All of such outstanding shares are duly authorized and have been validly issued and are fully paid
and nonassessable. Set forth in a Disclosure Schedule to this Agreement is the number of Common Shares that are (A) reserved for
issuance pursuant to Convertible Securities (as defined below) (other than the Convertible Debentures and the Warrants) and (B) that
are, as of the date hereof, owned by Persons who are “affiliates” (as defined in Rule 405 of the Securities Act and
calculated based on the assumption that only officers, directors and holders of at least 10% of the Company’s issued and
outstanding Common Shares are “affiliates” without conceding that any such Persons are “affiliates” for
purposes of federal securities laws) of the Company or any of its Subsidiaries. To the Company’s knowledge, except as
disclosed in the Disclosure Schedule, no Person owns 10% or more of the Company’s issued and outstanding Common Shares
(calculated based on the assumption that all Convertible Securities (as defined below), whether or not presently exercisable or
convertible, have been fully exercised or converted (as the case may be) taking account of any limitations on exercise or conversion
(including “blockers”) contained therein without conceding that such identified Person is a 10% shareholder for purposes
of federal securities laws). “Convertible Securities” means any capital stock or other security of the Company or
any of its Subsidiaries that is at any time and under any circumstances directly or indirectly convertible into, exercisable or
exchangeable for, or which otherwise entitles the holder thereof to acquire, any capital stock or other security of the Company
(including, without limitation, Common Shares) or any of its Subsidiaries.
13
(iii) Existing
Securities; Obligations. Except as disclosed in the SEC Documents and as disclosed in the Disclosure Schedule: (A) none of the
Company's or any Subsidiary's shares, interests or capital stock is subject to preemptive rights or any other similar rights or
Liens suffered or permitted by the Company or any Subsidiary; (B) there are no outstanding options, warrants, scrip, rights to
subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable
or exchangeable for, any shares, interests or capital stock of the Company or any of its Subsidiaries, or contracts, commitments,
understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound to issue additional shares,
interests or capital stock of the Company or any of its Subsidiaries or options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for,
any shares, interests or capital stock of the Company or any of its Subsidiaries; (C) there are no agreements or arrangements under
which the Company or any of its Subsidiaries is obligated to register the sale of any of their securities under the Securities Act
(except pursuant to this Agreement); (D) there are no outstanding securities or instruments of the Company or any of its
Subsidiaries which contain any redemption or similar provisions, and there are no contracts, commitments, understandings or
arrangements by which the Company or any of its Subsidiaries is or may become bound to redeem a security of the Company or any of
its Subsidiaries; (E) there are no securities or instruments containing antidilution or similar provisions that will be triggered by
the issuance of the Securities; and (F) neither the Company nor any Subsidiary has entered into any Variable Rate Transaction.
(iv) Organizational
Documents. The Company has furnished to the Buyers or filed on EDGAR true, correct and complete copies of the Company's Certificate
of Incorporation, as amended and as in effect on the date hereof (the “Certificate of Incorporation”), and the Company's
bylaws, as amended and as in effect on the date hereof (the “Bylaws”), and the terms of all convertible securities
and the material rights of the holders thereof in respect thereto.
14
(p) Indebtedness and Other
Contracts. Other than as set forth in a Disclosure Schedule to this Agreement, neither the Company nor any of its Subsidiaries, (i)
has any outstanding debt securities, notes, credit agreements, credit facilities or other agreements, documents or instruments evidencing
Indebtedness of the Company or any of its Subsidiaries or by which the Company or any of its Subsidiaries is or may become bound, (ii)
is a party to any contract, agreement or instrument, the violation of which, or default under which, by the other party(ies) to such
contract, agreement or instrument could reasonably be expected to result in a Material Adverse Effect, (iii) has any financing statements
securing obligations in material amounts filed in connection with the Company or any of its Subsidiaries; (iv) is in violation of any
term of, or in default under, any contract, agreement or instrument relating to any Indebtedness, except where such violations and defaults
would not result, individually or in the aggregate, in a Material Adverse Effect, or (v) is a party to any contract, agreement or instrument
relating to any Indebtedness, the performance of which, in the judgment of the Company’s officers, has or is expected to have a
Material Adverse Effect. Neither the Company nor any of its Subsidiaries have any liabilities or obligations required to be disclosed
in the SEC Documents which are not so disclosed in the SEC Documents, other than those incurred in the ordinary course of the Company’s
or its Subsidiaries’ respective businesses and which, individually or in the aggregate, do not or could not have a Material Adverse
Effect. For purposes of this Agreement: (x) “Indebtedness” of any Person means, without duplication (A) all indebtedness
for borrowed money, (B) all obligations issued, undertaken or assumed as the deferred purchase price of property or services (including,
without limitation, “capital leases” in accordance with GAAP) (other than trade payables entered into in the ordinary course
of business consistent with past practice), (C) all reimbursement or payment obligations with respect to letters of credit, surety bonds
and other similar instruments, (D) all obligations evidenced by notes, bonds, debentures or similar instruments, including obligations
so evidenced incurred in connection with the acquisition of property, assets or businesses, (E) all indebtedness created or arising under
any conditional sale or other title retention agreement, or incurred as financing, in either case with respect to any property or assets
acquired with the proceeds of such indebtedness (even though the rights and remedies of the seller or bank under such agreement in the
event of default are limited to repossession or sale of such property), (F) all monetary obligations under any leasing or similar arrangement
which, in connection with GAAP, consistently applied for the periods covered thereby, is classified as a capital lease, (G) all indebtedness
referred to in clauses (A) through (F) above secured by (or for which the holder of such Indebtedness has an existing right, contingent
or otherwise, to be secured by) any Lien upon or in any property or assets (including accounts and contract rights) owned by any Person,
even though the Person which owns such assets or property has not assumed or become liable for the payment of such indebtedness, and
(H) all Contingent Obligations in respect of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G)
above; and (y) “Contingent Obligation” means, as to any Person, any direct or indirect liability, contingent or otherwise,
of that Person with respect to any Indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent
of the Person incurring such liability, or the primary effect thereof, is to provide assurance to the obligee of such liability that
such liability will be paid or discharged, or that any agreements relating thereto will be complied with, or that the holders of such
liability will be protected (in whole or in part) against loss with respect thereto.
15
(q) Litigation.
Other than as set forth in a Disclosure Schedule to this Agreement, there is no action, suit, arbitration, proceeding, inquiry or investigation
before or by the Principal Market, any court, public board, other Governmental Entity, self-regulatory organization or body pending or,
to the knowledge of the Company, threatened against or affecting the Company or any of its Subsidiaries, the Common Shares or any of the
Company's or its Subsidiaries' officers or directors, whether of a civil or criminal nature or otherwise, in their capacities as such,
which would reasonably be expected to result in a Material Adverse Effect. After reasonable inquiry of its employees, the Company is not
aware of any event which might result in or form the basis for any such action, suit, arbitration, investigation, inquiry or other proceeding.
Without limitation of the foregoing, there has not been, and to the knowledge of the Company, there is not pending or contemplated, any
investigation by the SEC involving the Company, any of its Subsidiaries or any current or former director or officer of the Company or
any of its Subsidiaries. Neither the Company nor any of its Subsidiaries is the subject of any order, writ, judgment, injunction, decree,
determination or award of any Governmental Entity that would reasonably be expected to result in a Material Adverse Effect.
(r) Intellectual
Property Rights. The Company and its Subsidiaries own or possess adequate rights or licenses to use all trademarks, trade names, service
marks, service mark registrations, service names, original works of authorship, patents, patent rights, copyrights, inventions, licenses,
approvals, governmental authorizations, trade secrets and other intellectual property rights and all applications and registrations therefor
(“Intellectual Property Rights”) necessary to conduct their respective businesses as now conducted and presently proposed
to be conducted. Each of the patents owned by the Company or any of its Subsidiaries is set forth in a Disclosure Schedule to this Agreement.
Except as set forth in such Disclosure Schedule, none of the Company’s Intellectual Property Rights have expired or terminated or
have been abandoned or are expected to expire or terminate or are expected to be abandoned, within three years from the date of this Agreement.
The Company does not have any knowledge of any infringement by the Company or its Subsidiaries of Intellectual Property Rights of others.
There is no claim, action or proceeding being made or brought, or to the knowledge of the Company or any of its Subsidiaries, being threatened,
against the Company or any of its Subsidiaries regarding its Intellectual Property Rights. Neither the Company nor any of its Subsidiaries
is aware of any facts or circumstances which might give rise to any of the foregoing infringements or claims, actions or proceedings.
The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their
Intellectual Property Rights.
(s) Environmental
Laws. Except, in each case, as would not be reasonably anticipated to have a Material Adverse Effect, the Company and the Subsidiaries
(a) are in compliance with any and all applicable laws relating to the protection of human health and safety, the environment or hazardous
or toxic substances or wastes, pollutants or contaminants, (b) have received and hold all material permits, licenses or other approvals
required of them under all such laws to conduct their respective businesses and (c) are in compliance with all material terms and conditions
of any such permit, license or approval.
16
(t) Tax
Status. The Company and each of its Subsidiaries (i) has timely made or filed all foreign, federal and state income and all other
tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has timely paid all taxes and other governmental
assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations, except those
being contested in good faith and (iii) has set aside on its books provision reasonably adequate for the payment of all taxes for periods
subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed
to be due by the taxing authority of any jurisdiction, and the officers of the Company and its Subsidiaries know of no basis for any such
claim. The Company is not operated in such a manner as to qualify as a passive foreign investment company, as defined in Section 1297
of the Code. The net operating loss carryforwards (“NOLs”) for United States federal income tax purposes of the consolidated
group of which the Company is the common parent, if any, shall not be adversely effected by the transactions contemplated hereby. The
transactions contemplated hereby do not constitute an “ownership change” within the meaning of Section 382 of the Code, thereby
preserving the Company’s ability to utilize such NOLs.
(u) Internal
Accounting and Disclosure Controls. The Company and each of its Subsidiaries maintains internal control over financial reporting (as
such term is defined in Rule 13a-15(f) under the Exchange Act) that is effective to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting
principles, including that (i) transactions are executed in accordance with management’s general or specific authorizations,
(ii) transactions are recorded as
necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset and liability accountability, (iii)
access to assets or incurrence of liabilities is permitted only in accordance with management’s general or specific authorization
and (iv) the recorded accountability for assets and liabilities is compared with the existing assets and liabilities at reasonable intervals
and appropriate action is taken with respect to any difference. The Company maintains disclosure controls and procedures (as such term
is defined in Rule 13a-15(e) under the Exchange Act) that are effective in ensuring that information required to be disclosed by the Company
in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods
specified in the rules and forms of the SEC, including, without limitation, controls and procedures designed to ensure that information
required to be disclosed by the Company in the reports that it files or submits under the Exchange Act, as applicable, is accumulated
and communicated to the Company’s management, including its principal executive officer or officers and its principal financial
officer or officers, as appropriate, to allow timely decisions regarding required disclosure. Neither the Company nor any of its Subsidiaries
has received any notice or correspondence from any accountant, Governmental Entity or other Person relating to any potential material
weakness or significant deficiency in any part of the internal controls over financial reporting of the Company or any of its Subsidiaries.
(v) Investment Company
Status. The Company is not, and upon consummation of the sale of the Securities will not be, an “investment
company,” an affiliate of an “investment company,” a company controlled by an “investment company” or
an “affiliated person” of, or “promoter” or “principal underwriter” for, an “investment
company” as such terms are defined in the Investment Company Act of 1940, as amended.
17
(w) Insurance.
The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks
and in such amounts as management of the Company believes to be prudent and customary in the businesses in which the Company and its Subsidiaries
are engaged. In accordance with the previous sentence, the Company currently maintains no insurance policies. Neither the Company nor
any such Subsidiary has been refused any insurance coverage sought or applied for, and neither the Company nor any such Subsidiary has
any reason to believe that it will be unable to renew its existing insurance coverage as and when such coverage expires or to obtain similar
coverage from similar insurers as may be necessary to continue its business at a cost that would not have a Material Adverse Effect.
(x) Manipulation of
Price. Neither the Company nor any of its Subsidiaries has, and, to the knowledge of the Company, no Person acting on their
behalf has, directly or indirectly, (i) taken any action designed to cause or to result in the stabilization or manipulation of the
price of any security of the Company or any of its Subsidiaries to facilitate the sale or resale of any of the Securities, (ii)
sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to
pay to any Person any compensation for soliciting another to purchase any other securities of the Company or any of its
Subsidiaries.
(y) Registration
Eligibility. The Company is eligible to register the resale of the Conversion Shares by the Buyers using Form S-1 promulgated under
the Securities Act.
(z) Shell
Company Status. The Company is not, and since January 9, 2026 upon the filing of the Company’s Current Report on Form 8K containing
Form 10 information in connection with the consummation of the Business Combination, has ceased to be, an issuer identified in, or subject
to, Rule 144(i).
(aa) Sanctions Matters.
Neither the Company nor any of its Subsidiaries or, to the knowledge of the Company, any director, officer or controlled affiliate of
the Company or any director or officer of any Subsidiary, is a Person that is, or is owned or controlled by a Person that is (i) the
subject of any sanctions administered or enforced by the U.S. Department of Treasury’s Office of Foreign Asset Control (“OFAC”),
the United Nations Security Council, the European Union, Her Majesty’s Treasury, or other relevant sanctions authorities, including,
without limitation, designation on OFAC’s Specially Designated Nationals and Blocked Persons List or OFAC’s Foreign Sanctions
Evaders List or other relevant sanctions authority (collectively, “Sanctions”), or (ii) located, organized or resident
in a country or territory that is the subject of Sanctions that broadly prohibit dealings with that country or territory (including,
without limitation, the Crimea, Zaporizhzhia and Kherson regions, the Donetsk People’s Republic and Luhansk People’s Republic
in Ukraine, Cuba, Iran, North Korea, Russia, Sudan and Syria (the “Sanctioned Countries”)). Neither the Company
nor any of its Subsidiaries nor any director, officer or controlled affiliate of the Company or any of its Subsidiaries, has ever had
funds blocked by a United States bank or financial institution, temporarily or otherwise, as a result of OFAC concerns.
18
(bb) Disclosure.
The Company confirms that neither it nor any other Person acting on its behalf has provided any of the Buyers or their agents or counsel
with any information that constitutes or could reasonably be expected to constitute material, non-public information concerning the Company
or any of its Subsidiaries, other than the existence of the transactions contemplated by this Agreement and the other Transaction Documents.
The Company understands and confirms that each of the Buyers will rely on the foregoing representations in effecting transactions in securities
of the Company. All disclosures provided to the Buyers regarding the Company and its Subsidiaries, their businesses and the transactions
contemplated hereby, including the schedules to this Agreement, furnished by or on behalf of the Company or any of its Subsidiaries, taken
as a whole, are true and correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary
in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. All of the
written information furnished by or on behalf of the Company or any of its Subsidiaries to each Buyer pursuant to or in connection with
this Agreement and the other Transaction Documents, taken as a whole, is true and correct in all material respects as of the date on which
such information was so provided and did not contain any untrue statement of a material fact or omit to state any material fact necessary
in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. No event or
circumstance has occurred or information exists with respect to the Company or any of its Subsidiaries or its or their business, properties,
liabilities, operations (including results thereof) or conditions (financial or otherwise), which, under applicable law, rule or regulation,
requires public disclosure at or before the date hereof or announcement by the Company but which has not been so publicly disclosed. All
financial projections and forecasts that have been prepared by or on behalf of the Company or any of its Subsidiaries and made available
to the Buyers have been prepared in good faith based upon reasonable assumptions and represented, at the time each such financial projection
or forecast was delivered to each Buyer, the Company's best estimate of future financial performance (it being recognized that such financial
projections or forecasts are inherently uncertain, subject to a verity of business, economic, and competitive risks, and are not to be
viewed as facts and that the actual results during the period or periods covered by any such financial projections or forecasts may differ
from the projected or forecasted results). The Company acknowledges and agrees that no Buyer makes or has made any representations or
warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 2.
(cc) No General
Solicitation. Neither the Company, nor any of its affiliates, nor any Person acting on its or their behalf, has engaged in any form
of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection with the offer
or sale of the Securities.
(dd) Private
Placement. Assuming the accuracy of the Buyers’ representations and warranties set forth in Section 2, no registration
under the Securities Act is required for the offer and sale of the Securities by the Company to the Buyers as contemplated hereby.
The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Principal Market, subject to
the compliance with the exchange cap limitation set forth in Section 1(d).
19
(ee) No Disqualification
Events. With respect to Securities to be offered and sold hereunder in reliance on Rule 506(b) under the Securities Act (“Regulation
D Securities”), none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other
officer of the Company participating in the offering contemplated hereby, any beneficial owner of 20% or more of the Company’s outstanding
voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities
Act) connected with the Company in any capacity at the time of sale (each, an “Issuer Covered Person” and, together,
“Issuer Covered Persons”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i)
to (viii) under the Securities Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule
506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification
Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the
Buyers a copy of any disclosures provided thereunder.
(ff) Other
Covered Persons. The Company is not aware of any Person that has been or will be paid (directly or indirectly) remuneration for solicitation
of Buyers or potential purchasers in connection with the sale of any Regulation D Securities.
(gg) No Disagreements
with Accountants and Lawyers. There are no material disagreements of any kind presently existing, or reasonably anticipated by the
Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company is
current with respect to any fees owed to its accountants and lawyers which could affect the Company’s ability to perform any of
its obligations under any of the Transaction Documents. In addition, on or prior to the date hereof, the Company had discussions with
its accountants about its financial statements previously filed with the SEC. Based on those discussions, the Company has no reason to
believe that it will need to restate any such financial statements or any part thereof.
4. COVENANTS.
(a) Form D and Blue
Sky. The Company shall file a Form D with respect to the Securities as required under Regulation D and to provide a copy thereof
to each Buyer promptly after such filing. The Company shall, on or before the Closing Date, take such action as the Company shall
reasonably determine is necessary in order to obtain an exemption for, or to, qualify the Securities for sale to the Buyers at the
Closing pursuant to this Agreement under applicable securities or “Blue Sky” laws of the states of the United States (or
to obtain an exemption from such qualification), and shall provide evidence of any such action so taken to the Buyers on or prior to
the Closing Date. Without limiting any other obligation of the Company under this Agreement, the Company shall timely make all
filings and reports relating to the offer and sale of the Securities required under all applicable securities laws (including,
without limitation, all applicable federal securities laws and all applicable “Blue Sky” laws), and the Company shall
comply with all applicable foreign, federal, state and local laws, statutes, rules, regulations and the like relating to the
offering and sale of the Securities to the Buyers.
20
(b) Reporting
Status. For the period beginning on the date hereof, and ending 6 months after the date on which all the Convertible Debentures are
no longer outstanding (the “Reporting Period”), the Company shall file on a timely basis all reports required to be
filed with the SEC pursuant to the Exchange Act, and the Company shall not terminate its status as an issuer required to file reports
under the Exchange Act even if the Exchange Act or the rules and regulations thereunder would no longer require or otherwise permit such
termination.
(c) Use
of Proceeds. Neither the Company nor any Subsidiary will, directly or indirectly, use the proceeds of the transactions contemplated
herein to repay any loans to any executives or employees of the Company or to make any payments in respect of any related party debt.
Neither the Company nor any of its Subsidiaries will, directly or indirectly, use the proceeds from the transactions contemplated herein,
or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person (a) for the purpose
of funding or facilitating any activities or business of or with any Person or in any country or territory that, at the time of such funding
or facilitation, is the subject of Sanctions or is a Sanctioned Country, or (b) in any other manner that will result in a violation of
Sanctions or Applicable Laws by any Person (including any Person participating in the transactions contemplated by this Agreement, whether
as underwriter, advisor, investor or otherwise). For the past five years, neither the Company nor any of its Subsidiaries has engaged
in, and is now not engaged in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing
or transaction is or was the subject of Sanctions or was a Sanctioned Country. The Company shall not, without the prior written consent
of the Buyer, loan, invest, transfer or “downstream” any cash proceeds, or assets or property acquired with cash proceeds
from the issuance and sale of the Convertible Debentures to any Subsidiary, unless the Buyer and the Subsidiary enter into a guarantee
in the form of the Global Guaranty.
(d) Listing.
To the extent applicable, the Company shall promptly secure the listing or designation for quotation (as the case may be) of all of the
Underlying Securities (as defined below) on the Principal Market, subject to official notice of issuance, and shall use reasonable efforts
to maintain such listing or designation for quotation (as the case may be) of all Underlying Securities from time to time issuable under
the terms of the Transaction Documents on such Principal Market for the Reporting Period. Neither the Company nor any of its Subsidiaries
shall take any action which could be reasonably expected to result in the delisting or suspension of the Common Shares on a Principal
Market during the Reporting Period. The Company shall pay all fees and expenses in connection with satisfying its obligations under this
Section 4(d). “Underlying Securities” means the (i) the Conversion Shares, and (ii) any common shares of the Company
issued or issuable with respect to the Conversion Shares or, including, without limitation, (1) as a result of any stock split, stock
dividend, recapitalization, exchange or similar event or otherwise and (2) shares of capital stock of the Company into which the shares
of Common Shares are converted or exchanged without regard to any limitations on conversion of the Convertible Debentures.
21
(e) Pledge of
Securities. Notwithstanding anything to the contrary contained in this Agreement, the Company acknowledges and agrees that,
subject to compliance with applicable federal and state securities laws, the Securities may be pledged by a Buyer in connection with
a bona fide margin agreement or other loan or financing arrangement that is secured by the Securities. The Company hereby agrees to
execute and deliver such documentation as a pledgee of the Securities may reasonably request in connection with a pledge of the
Securities to such pledgee by a Buyer.
(f) Disclosure of Transactions and Other Material Information.
(i) Disclosure
of Transactions. The Company shall, on or before the fourth Business Day after the date of this Agreement, file with the SEC a current
report on Form 8-K describing all the material terms of the transactions contemplated by the Transaction Documents in the form required
by the Exchange Act and attaching all the material Transaction Documents (including, required exhibits, the “Current Report”).
From and after the filing of the Current Report, the Company shall have publicly disclosed all material, non-public information (if any)
provided to any of the Buyers by the Company or any of its Subsidiaries or any of their respective officers, directors, employees or agents
in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the filing of the Current Report,
the Company acknowledges and agrees that any and all confidentiality or similar obligations with respect to the transactions contemplated
by the Transaction Documents under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their
respective officers, directors, affiliates, employees or agents, on the one hand, and any of the Buyers or any of their affiliates, on
the other hand, shall terminate.
(ii) Limitations on
Disclosure. The Company shall not, and the Company shall cause each of its Subsidiaries and each of its and their respective
officers, directors, employees and agents not to, provide any Buyer with any material, non-public information regarding the Company
or any of its Subsidiaries from and after the date hereof without first obtaining the express prior written consent of such Buyer
(which may be granted or withheld in such Buyer's sole discretion). In the event of a breach of any of the foregoing covenants or
any of the covenants or agreements contained in any other Transaction Document, by the Company, any of its Subsidiaries, or any of
its or their respective officers, directors, employees and agents (as determined in the reasonable good faith judgment of such
Buyer), in addition to any other remedy provided herein or in the Transaction Documents, such Buyer shall have the right to make a
public disclosure, in the form of a press release, public advertisement or otherwise, of such breach or such material, non-public
information, as applicable, without the prior approval by the Company, any of its Subsidiaries, or any of its or their respective
officers, directors, employees or agents. No Buyer shall have any liability to the Company, any of its Subsidiaries, or any of its
or their respective officers, directors, employees, affiliates, shareholders or agents, for any such disclosure. To the extent that
the Company delivers any material, non-public information to a Buyer without such Buyer’s consent, the Company hereby
covenants and agrees that such Buyer shall not have any duty of confidentiality with respect to, or a duty not to trade on the basis
of, such material, non-public information. Subject to the foregoing, neither the Company, its Subsidiaries nor any Buyer shall issue
any press releases or any other public statements with respect to the transactions contemplated hereby; provided, however, the
Company shall be entitled, without the prior approval of any Buyer, to make any press release or other public disclosure with
respect to such transactions (i) in substantial conformity with the 8-K Filing and contemporaneously therewith and (ii) as is
required by applicable law and regulations (provided that in the case of clause (i) each Buyer shall be consulted by the Company in
connection with any such press release or other public disclosure prior to its release). Without the prior written consent of the
applicable Buyer (which may be granted or withheld in such Buyer’s sole discretion), the Company shall not (and shall cause
each of its Subsidiaries and affiliates to not) disclose the name of such Buyer in any filing, announcement, release or otherwise.
Notwithstanding anything contained in this Agreement to the contrary and without implication that the contrary would otherwise be
true, the Company expressly acknowledges and agrees that no Buyer shall have (unless expressly agreed to by a particular Buyer after
the date hereof in a written definitive and binding agreement executed by the Company and such particular Buyer (it being understood
and agreed that no Buyer may bind any other Buyer with respect thereto)), any duty of confidentiality with respect to, or a duty not
to trade on the basis of, any material, non-public information regarding the Company or any of its Subsidiaries.
22
(iii) Other
Confidential Information. Disclosure Failures. In addition to other remedies set forth in this Section 4(g), and without limiting
anything set forth in any other Transaction Document, at any time after the Closing Date if the Company, any of its Subsidiaries, or any
of their respective officers, directors, employees or agents, provides any Buyer with material non-public information relating to the
Company or any of its Subsidiaries (each, the “Confidential Information”), the Company shall, on or prior to the applicable
Required Disclosure Date (as defined below), publicly disclose such Confidential Information on a Current Report on Form 8- K or otherwise
(each, a “Disclosure”). From and after such Disclosure, the Company shall have disclosed all Confidential Information
provided to such Buyer by the Company or any of its Subsidiaries or any of their respective officers, directors, employees or agents.
In addition, effective upon such Disclosure, the Company acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors,
affiliates, employees or agents, on the one hand, and any of the Buyers or any of their affiliates, on the other hand, shall terminate.
“Required Disclosure Date” means (x) if such Buyer authorized the delivery of such Confidential Information, either
(I) if the Company and such Buyer have mutually agreed upon a date (as evidenced by an e-mail or other writing) of Disclosure of such
Confidential Information, such agreed upon date or (II) otherwise, the seventh (7th) calendar day after the date such Buyer first received
any Confidential Information or (y) if such Buyer did not authorize the delivery of such Confidential Information, the first (1st) Business
Day after such Buyer’s receipt of such Confidential Information.
(g) Reservation of
Shares. So long as any of the Convertible Debentures remain outstanding the Company shall have reserved from its duly authorized
capital stock, and shall have instructed its transfer agent to irrevocably reserve, the maximum number of shares of Common Shares
issuable upon conversion of all Convertible Debentures (assuming for purposes hereof that (i) such Convertible Debentures are
convertible at the Floor Price (as defined therein) as of the date of determination and (ii) any such conversion shall not take into
account any limitations on the conversion of the Convertible Debentures set forth therein) (the “Required Reserve
Amount”); provided that at no time shall the number of shares of Common Shares reserved pursuant to this Section be
reduced other than proportionally in connection with any conversion and/or redemption, or reverse stock split. If at any time the
number of Common Shares authorized to be issued is not sufficient to meet the Required Reserve Amount, the Company will promptly
take all corporate action necessary to authorize and reserve a sufficient number of shares, including, without limitation, calling a
special meeting of stockholders to authorize additional shares to meet the Company's obligations pursuant to the Transaction
Documents, in the case of an insufficient number of authorized shares, recommending that stockholders vote in favor of an increase
in such authorized number of shares sufficient to meet the Required Reserve Amount. If at any time the number of Common Shares that
remain available for issuance under the Exchange Cap is less than 100% of the maximum number of shares issuable upon conversion of
all the Convertible Debentures then outstanding (assuming for purposes hereof that (x) the Convertible Debentures are convertible at
the Conversion Price (as defined in the Convertible Debenture) then in effect, and (y) any such conversion shall not take into
account any limitations on the conversion of the Convertible Debentures), the Company will use commercially reasonable efforts to
promptly call and hold a special meeting of stockholders for the purpose of seeking the approval of its stockholders as required by
the applicable rules of the Principal Market, for issuances of shares in excess of the Exchange Cap.
23
(h) Conduct
of Business. The business of the Company and its Subsidiaries shall not be conducted in violation of any law, ordinance or regulation
of any Governmental Entity, except where such violations would not reasonably be expected to result, either individually or in the aggregate,
in a Material Adverse Effect.
(i) Prohibition
on Short Sales and Hedging. The Buyer covenants and agrees that the Buyer, the Buyer’s officers or any persons or entities acting
on the Buyer’s behalf, or any entity managed or controlled by the Buyer, or which controls the Buyer, or is under common control
with the Buyer (collectively, the “Restricted Persons”) shall not, directly or indirectly, engage in or execute any
hedging activities, derivative transactions (including, without limitation, any forward sale contract, option, put, call, swap, or similar
arrangement), or “short sales” (as defined in Rule 200 of Regulation SHO under the Exchange Act) of the Common Shares or any
other securities of the Company, either for its own principal account or for the principal account of any other Restricted Person, during
the period beginning on and including the date hereof through and ending on the date that no Convertible Debentures remain outstanding
(the “Restricted Period”). This Section 4(i) does not prohibit any Restricted Person during the Restricted Period from
selling “long” (as defined in Rule 200 under Regulation SHO) Common Shares actually owned and possessed by such Restricted
Person at the time of such sale or that the Restricted Person is entitled to receive, but has not yet received from the Company of the
transfer agent, upon the completion of a pending conversion of the Convertible Debentures for which a valid Conversion Notice (as defined
in the Convertible Debentures) has been submitted to the Company.
(j) Trading
Information. Upon the Company’s request, the Buyer agrees to provide the Company with trading reports setting forth the number
and average sales prices of Conversion Shares sold by the Buyer during the prior trading week.
(k) Prohibited
Transactions. From the date hereof until all of the Convertible Debentures have been repaid or converted into Common Shares, the Company
agrees to not directly or indirectly enter into any contract, agreement or other item that would materially restrict or prohibit any of
the Company’s obligations to the Buyer(s) under the Transaction Documents, including, without limitation, any payments required
to be made by the Company to the Buyer(s) under the Convertible Debentures.
24
(l) Nasdaq
Listing of Additional Shares Notification. The Company shall file a Nasdaq Listing of Additional Shares notification form for the
listing of the Common Shares issuable upon conversion of the Convertible Debentures.
(m) From
the date hereof until all the Convertible Debentures have been repaid, without the prior written consent of the Buyer, the Company shall
not, and shall not permit any of its subsidiaries (whether or not a subsidiary on the date hereof) to, directly or indirectly (i) other
than Permitted Indebtedness, enter into, create, incur, assume, guarantee or suffer to exist any Indebtedness, (ii) other than Permitted
Liens, enter into, create, incur, assume or suffer to exist any Lien on or with respect to any of its property or assets now owned or
hereafter acquired or any interest therein or any income or profits therefrom, (iii) amend its charter documents, including, without limitation,
its certificate of incorporation and bylaws, in any manner that materially and adversely affects any rights of the holders of the Convertible
Debentures, (iv) make any payments in respect of any related party debt, (v) enter into, agree to enter into, or effect any Variable Rate
Transaction other than with the Buyer.
“Permitted Indebtedness”
shall mean: (i) indebtedness evidenced by the Convertible Debentures; (ii) indebtedness described on a Disclosure Schedule attached hereto;
(iii) indebtedness incurred solely for the purpose of financing the acquisition or lease of any equipment, including capital lease obligations
with no recourse other than to such equipment; (iv) indebtedness (A) the repayment of which has been subordinated to the payment of the
Convertible Debentures on terms and conditions acceptable to the Buyers, including with regard to interest payments and repayment of principal,
(B) which does not mature or otherwise require or permit redemption or repayment prior to or on the 91st day after the maturity date of
any Convertible Debentures then outstanding; and (C) which is not secured by any assets of the Company or its subsidiaries; (v) indebtedness
associated with acquiring new intellectual property assets and licenses, so long as the proceeds are going to the party(ies) from which
the Company is acquiring the assets, licenses, and other properties and (vi) any indebtedness (other than the indebtedness set out in
(i) – (v) above) incurred after the date hereof, provided that such indebtedness does not exceed $2,500,000 at any given time.
“Permitted
Liens” shall mean (1) any security interest granted to the Buyers to secure the obligations under the Convertible
Debentures, (2) any prior security interest granted to the Buyers, (3) existing Liens disclosed by the Company on a Disclosure
Schedule attached hereto; (4) inchoate Liens for taxes, assessments or governmental charges or levies not yet due, as to which the
grace period, if any, related thereto has not yet expired, or being contested in good faith and by appropriate proceedings for which
adequate reserves have been established in accordance with GAAP; (5) Liens of carriers, materialmen, warehousemen, mechanics and
landlords and other similar Liens which secure amounts which are not yet overdue by more than 60 days or which are being contested
in good faith by appropriate proceedings for which adequate reserves have been established in accordance with GAAP; (6) licenses,
sublicenses, leases or subleases granted to other persons not materially interfering with the conduct of the business of the
Company; (7) Liens securing capitalized lease obligations and purchase money indebtedness incurred solely for the purpose of
financing an acquisition or lease; (8) easements, rights-of-way, restrictions, encroachments, municipal zoning ordinances and other
similar charges or encumbrances, and minor title deficiencies, in each case not securing debt and not materially interfering with
the conduct of the business of the Company and not materially detracting from the value of the property subject thereto; (9) Liens
arising out of the existence of judgments or awards which judgments or awards do not constitute an Event of Default; (10) Liens
incurred in the ordinary course of business in connection with workers compensation claims, unemployment insurance, pension
liabilities and social security benefits and Liens securing the performance of bids, tenders, leases and contracts in the ordinary
course of business, statutory obligations, surety bonds, performance bonds and other obligations of a like nature (other than appeal
bonds) incurred in the ordinary course of business (exclusive of obligations in respect of the payment for borrowed money); (11)
Liens in favor of a banking institution arising by operation of law encumbering deposits (including the right of set-off) and
contractual set-off rights held by such banking institution and which are within the general parameters customary in the banking
industry and only burdening deposit accounts or other funds maintained with a creditor depository institution; (12) usual and
customary set-off rights in leases and other contracts; (13) escrows in connection with acquisitions and dispositions and (14)
royalties and other rights to revenue derived from the sale of the Company’s products that are granted in the ordinary course
of business.
25
“Variable Rate Transaction”
shall mean a transaction in which the Company (i) issues or sells any equity, warrants, or debt securities that are convertible into,
exchangeable or exercisable for, or include the right to receive additional Common Shares either (A) at a conversion price, exercise price,
exchange rate or other price that is based upon and/or varies with the trading prices of or quotations for the Common Shares at any time
after the initial issuance of such security, or (B) with a conversion, exercise or exchange price that is subject to being reset at some
future date after the initial issuance of such security or upon the occurrence of specified or contingent events directly or indirectly
related to the business of the Company or the market for the Common Shares (including, without limitation, any “full ratchet”
or “weighted average” anti-dilution provisions, but not including any standard anti-dilution protection for any reorganization,
recapitalization, non-cash dividend, stock split or other similar transaction), or (ii) enters into or effects any agreement, including
but not limited to an “equity line of credit,” “ATM agreement” or other continuous offering or similar offering
of Common Shares.
5. REGISTER; TRANSFER AGENT INSTRUCTIONS; LEGEND.
(a) Register. The
Company shall maintain at its principal executive offices or with the Transfer Agent (or at such other office or agency of the
Company as it may designate by notice to each holder of Securities), a register for the Convertible Debentures in which the Company
shall record the name and address of the Person in whose name the Convertible Debentures have been issued (including the name and
address of each transferee), the amount of Convertible Debentures held by such Person. The Company shall keep the register open and
available at all times during business hours for inspection of any Buyer or its legal representatives. The Company hereby
irrevocably agrees that it shall not require medallion guarantees in connection with any assignments or transfers of Common Shares
by the Buyer to any third party. The Company hereby authorizes its then-current transfer agent to rely on the foregoing and that the
Company hereby indemnifies and agrees to hold its then-current transfer agent harmless from any liability related to its complying
with the foregoing. Upon request by the Buyer, the Company further agrees to promptly provide its then-current transfer agent with
additional authorizations or indemnifications as may so request.
26
(b) Transfer
Restrictions. The Securities may only be disposed of in compliance with state and federal securities laws. In connection with any
transfer of Securities other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a
Buyer or in connection with a pledge as contemplated herein, the Company may require the transferor thereof to provide to the Company
an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall
be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities
under the Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement
and shall have the rights and obligations of a Buyer under this Agreement.
(c) Conversion
and Exercise Procedures. The form of Conversion Notice included in the Convertible Debentures set forth the totality of the procedures
required of the Buyers in order to convert the Convertible Debentures. Except as provided in Section 2(f) and Section 5(b), no additional
legal opinion, other information or instructions shall be required of the Buyers to convert their Convertible Debentures. The Company
shall honor conversions of the Convertible Debentures and shall deliver the Conversion Shares in accordance with the terms, conditions
and time periods set forth in the Convertible Debentures.
6. CONDITIONS TO THE COMPANY’S OBLIGATION TO SELL.
The obligation
of the Company hereunder to issue and sell the Convertible Debentures to each Buyer at each Closing is subject to the satisfaction, at
or before each Closing Date, of each of the following conditions, provided that these conditions are for the Company's sole benefit and
may be waived by the Company at any time in its sole discretion in accordance with the terms of Section 9(k):
(a) Such
Buyer shall have executed each of the Transaction Documents to which it is a party and delivered the same to the Company.
(b) Such
Buyer and each other Buyer shall have delivered to the Company the Purchase Price (less, in the case of any Buyer, the amounts withheld
pursuant to Section 4(d), if any) for the Convertible Debentures being purchased by such Buyer at the Closing by wire transfer of immediately
available funds in accordance with a letter, duly executed by an officer of the Company, setting forth the wire amounts of each Buyer
and the wire transfer instructions of the Company (the “Closing Statement”).
(c) The representations
and warranties of such Buyer shall be true and correct in all material respects (other than representations and warranties qualified
by materiality, which shall be true and correct in all respects) as of the date when made and as of each Closing Date as though
originally made at that time (except for representations and warranties that speak as of a specific date, which shall be true and
correct as of such specific date), and such Buyer shall have performed, satisfied and complied in all material respects with the
covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by such Buyer at or
prior to such Closing Date.
27
(d) No
statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by
any court or Governmental Entity of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by
the Transaction Documents.
(e) Solely
with respect to the Second Closing, the Registration Statement shall be effective in accordance with the provisions set forth in the Registration
Rights Agreement, including the effectiveness deadline set forth therein.
(f) With
respect to any Subsequent Closing, the Buyer shall have provided written consent to the amount and timing of such Subsequent Closing,
and each Subsequent Closing shall have closed within 12 months of the date of this Agreement.
7. CONDITIONS TO EACH BUYER'S OBLIGATION TO PURCHASE.
The obligation of each Buyer hereunder
to purchase its Convertible Debentures at each Closing is subject to the satisfaction, at or before each Closing Date, of each of the
following conditions, provided that these conditions are for each Buyer's sole benefit and may be waived by such Buyer at any time in
its sole discretion in accordance with the terms of Section 9(k):
(a) The
Company shall have duly executed and delivered to such Buyer each of the Transaction Documents to which it is a party and the Company
shall have duly executed and delivered to such Buyer a Convertible Debenture with a principal amount corresponding to the Subscription
Amount set forth opposite such Buyer’s name on the Schedule of Buyers attached as Schedule I for the Closing.
(b) Such
Buyer shall have received the opinion of counsel to the Company, dated as of the First Closing Date, in the form reasonably acceptable
to such Buyer.
(c) The
Company shall have delivered to each Buyer copies of its and each Subsidiaries copies of its charter, as well as any shareholder or operating
agreements by or among the shareholders or members of any of the Company’s Subsidiaries.
(d) The
Company shall have delivered to such Buyer a certificate evidencing the incorporation and good standing of the Company as of a date within
ten (10) days of the Closing Date.
(e) Each and every
representation and warranty of the Company shall be true and correct in all material respects (other than representations and
warranties qualified by materiality, which shall be true and correct in all respects) as of the date when made and as of each
Closing Date as though originally made at that time (except for representations and warranties that speak as of a specific date,
which shall be true and correct as of such specific date) and the Company shall have performed, satisfied and complied in all
respects with the covenants, agreements and conditions set forth in each Transaction Document required to be performed, satisfied or
complied with by the Company at or prior to each Closing Date.
28
(f) The
Common Shares (A) shall be designated for quotation or listed (as applicable) on the Principal Market and (B) shall not have been suspended,
as of each Closing Date, by the SEC or the Principal Market from trading on the Principal Market nor shall suspension by the SEC or the
Principal Market have been threatened, as of each Closing Date, either (I) in writing by the SEC or the Principal Market or (II) by receiving
a notification from the Principal Market of falling below the minimum maintenance requirements of the Principal Market that is not subject
to a cure period.
(g) The
Company shall have obtained all governmental, regulatory or third-party consents and approvals, if any, necessary for the sale of the
Securities, including without limitation, those required by the Principal Market, if any.
(h) No
statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by
any court or Governmental Entity of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by
the Transaction Documents.
(i) Since
the date of execution of this Agreement, no event or series of events shall have occurred that has resulted in or would reasonably be
expected to result in a Material Adverse Effect, or an Event of Default (as defined in the Convertible Debentures).
(j) Such Buyer shall have received the Closing Statement.
(k) (i)
From the date hereof to the applicable Closing Date, trading in the Common Shares shall not have been suspended by the SEC or the Principal
Market (except for any suspension of trading of limited duration agreed to by the Company, which suspension shall be terminated prior
to the Closing), and (ii) at any time from the date hereof to the applicable Closing Date, trading in securities generally as reported
by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades
are reported by such service, or on the Principal Market, nor shall a banking moratorium have been declared either by the United States
or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international
calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable
judgment of each Buyer, makes it impracticable or inadvisable to purchase the Securities at the Closing.
(l) The
board of directors of the Company has approved the transactions contemplated by the Transaction Documents; said approval has not been
amended, rescinded or materially modified and remains in full force and effect as of such Closing, and a true, correct and complete copy
of such resolutions duly adopted by the board of directors of the Company shall have been provided to the Buyers.
(m) The Company shall
have delivered to the Buyer a compliance certificate executed by an executive officer of the Company certifying that Company has
complied with all of the conditions precedent to the applicable Closing set forth herein and which may be relied upon by the Buyer
as evidence of satisfaction of such conditions without any obligation to independently verify.
29
(n) The
Company and its Subsidiaries shall have delivered to such Buyer such other documents, instruments or certificates relating to the transactions
contemplated by this Agreement as such Buyer or its counsel may reasonably request.
(o) Solely
with respect to the Second Closing, the Registration Statement shall be effective in accordance with the provisions set forth in the Registration
Rights Agreement, including the effectiveness deadline set forth therein.
(p) With
respect to any Subsequent Closing, the Buyer shall have provided written consent to the amount and timing of such Subsequent Closing,
and each Subsequent Closing shall have closed within 12 months of the date of this Agreement.
8. TERMINATION.
In the event that the
First Closing shall not have occurred with respect to a Buyer within five (5) days of the date hereof, then either such Buyer or the
Company shall have the right to terminate its obligations under this Agreement with respect to itself at any time on or after the
close of business on such date without liability of such terminating party to any other party; provided, however, (i) the right to
terminate this Agreement under this Section 8 shall not be available to such a party if the failure of the transactions contemplated
by this Agreement to have been consummated by such date is the result of such party's breach of this Agreement and (ii) the
abandonment of the sale and purchase of the Convertible Debentures shall be applicable only to such Buyer providing such written
notice, provided further that no such termination shall affect any obligation of the Company under this Agreement to reimburse such
Buyer for the expenses described herein. Nothing contained in this Section 8 shall be deemed to release any party from any liability
for any breach by such party of the terms and provisions of this Agreement or the other Transaction Documents or to impair the right
of any party to compel specific performance by any other party of its obligations under this Agreement or the other Transaction
Documents.
9. MISCELLANEOUS.
(a) Governing
Law. This Agreement and the rights and obligations of the parties hereunder shall, in all respects, be governed by, and construed
in accordance with, the laws (excluding the principles of conflict of laws) of the State of New York (including Section 5-1401 and Section
5-1402 of the General Obligations Law of the State of New York), including all matters of construction, validity and performance.
(b) Jurisdiction; Venue; Service.
(i) The
Company and each Buyer hereby irrevocably consent to the non- exclusive personal jurisdiction of the state courts of the State of New
York (the “Governing Jurisdiction”) and, if a basis for federal jurisdiction exists, the non-exclusive personal jurisdiction
of any United States District Court for the Governing Jurisdiction.
30
(ii) The
Company and each Buyer agree that venue shall be proper in any court of the Governing Jurisdiction selected by the Buyer or, if a basis
for federal jurisdiction exists, in any United States District Court in the Governing Jurisdiction. The Company and each Buyer waive any
right to object to the maintenance of any suit, claim, action, litigation or proceeding of any kind or description, whether in law or
equity, whether in contract or in tort or otherwise, in any of the state or federal courts of the Governing Jurisdiction on the basis
of improper venue or inconvenience of forum.
(iii) Any
suit, claim, action, litigation or proceeding of any kind or description, whether in law or equity, whether in contract or tort or otherwise,
brought either party against the other party arising out of or based upon this Agreement or any matter relating to this Agreement, or
any other Transaction Document, or any contemplated transaction, shall be brought in a court only in the Governing Jurisdiction. The Company
and each Buyer agree that any forum outside the Governing Jurisdiction is an inconvenient forum and that any suit, claim, action, litigation
or proceeding brought by one party against another party in any court outside the Governing Jurisdiction should be dismissed or transferred
to a court located in the Governing Jurisdiction. Furthermore, each party irrevocably and unconditionally agrees that it will not bring
or commence any suit, claim, action, litigation or proceeding of any kind or description, whether in law or equity, whether in contract
or in tort or otherwise, against the other party arising out of or based upon this Agreement or any matter relating to this Agreement,
or any other Transaction Document, or any contemplated transaction, in any forum other than the courts of the State of New York sitting
in New York County, and the United States District Court of the Southern District of New York, and any appellate court from any thereof,
and each of the parties hereto irrevocably and unconditionally submits to the jurisdiction of such courts and agrees that all claims in
respect of any such suit, claim, action, litigation or proceeding may be heard and determined in such New York State Court or, to the
fullest extent permitted by applicable law, in such federal court. Each party agrees that a final judgment in any such suit, claim, action,
litigation or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner
provided by law.
(iv) The
Company and the Buyer irrevocably consent to the service of process out of any of the aforementioned courts in any such suit, claim, action,
litigation or proceeding by the mailing of copies thereof by registered or certified mail postage prepaid, to it at the address provided
for notices in this Agreement, such service to become effective thirty (30) days after the date of mailing.
(v) Nothing
herein shall affect the right of the Buyer to serve process in any other manner permitted by law or to commence legal proceedings or to
otherwise proceed against the Company or any other Person in the Governing Jurisdiction or in any other jurisdiction.
31
(c) THE
PARTIES MUTUALLY WAIVE ALL RIGHT TO TRIAL BY JURY OF ALL CLAIMS OF ANY KIND ARISING OUT OF OR BASED UPON THIS AGREEMENT OR ANY MATTER
RELATING TO THIS AGREEMENT, OR ANY OTHER TRANSACTION DOCUMENT, OR ANY CONTEMPLATED TRANSACTION. THE PARTIES ACKNOWLEDGE THAT THIS IS A
WAIVER OF A LEGAL RIGHT AND THAT THE PARTIES EACH MAKE THIS WAIVER VOLUNTARILY AND KNOWINGLY AFTER CONSULTATION WITH COUNSEL OF THEIR
RESPECTIVE CHOICE. THE PARTIES AGREE THAT ALL SUCH CLAIMS SHALL BE TRIED BEFORE A JUDGE OF A COURT HAVING JURISDICTION, WITHOUT A JURY.
(d) Counterparts.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party. In the event that any signature
is delivered by an e-mail which contains a portable document format (.pdf) file of an executed signature page, such signature page shall
create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect
as if such signature page were an original thereof.
(e) Headings;
Gender. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of,
this Agreement. Unless the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine,
neuter, singular and plural forms thereof. The terms "including," "includes," "include" and words of like
import shall be construed broadly as if followed by the words "without limitation." The terms "herein," "hereunder,"
"hereof" and words of like import refer to this entire Agreement instead of just the provision in which they are found.
(f) Entire
Agreement, Amendments. This Agreement supersedes all other prior oral or written agreements between the Buyer, the Company, their
affiliates and persons acting on their behalf with respect to the matters discussed herein, and this Agreement and the instruments referenced
herein contain the entire understanding of the parties with respect to the matters covered herein and therein and, except as specifically
set forth herein or therein, neither the Company nor any Buyer makes any representation, warranty, covenant or undertaking with respect
to such matters. No provision of this Agreement may be amended other than by an instrument in writing signed by the party to be charged
with enforcement. As a material inducement for each Buyer to enter into this Agreement, the Company expressly acknowledges and agrees
that (x) no due diligence or other investigation or inquiry conducted by a Buyer, any of its advisors or any of its representatives shall
affect such Buyer’s right to rely on, or shall modify or qualify in any manner or be an exception to any of, the Company’s
representations and warranties contained in this Agreement or any other Transaction Document and (y) unless a provision of this Agreement
or any other Transaction Document is expressly preceded by the phrase “except as disclosed in the SEC Documents,” nothing
contained in any of the SEC Documents shall affect such Buyer’s right to rely on, or shall modify or qualify in any manner or be
an exception to any of, the Company’s representations and warranties contained in this Agreement or any other Transaction Document.
32
(g) Notices. Any
notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in
writing by letter and email and will be deemed to have been delivered: upon the later of (A) either (i) receipt, when delivered
personally or (ii) one (1) Business Day after deposit with an overnight courier service with next day delivery specified, in each
case, properly addressed to the party to receive the same and (B) receipt, when sent by electronic mail. The addresses and e-mail
addresses for such communications shall be:
If to the Company, to:
EVOLUTION
METALS & TECHNOLOGIES CORP.
4040 NE 2nd Ave, Ste 349
Miami, Florida 33137
Telephone: 561-225-3205
Attention:
David Wilcox
Frank Moon
Andrew Knaggs
Christopher Clower
E-Mail:
david.wilcox@evolution-metals.com
frank.moon@evolution-metals.com
andrew.knaggs@evolution-metals.com
christopher.clower@evolution-metals.com
With Copy to:
John Arrastia
4040 NE 2nd Ave, Ste 349
Miami, Florida 33137
Telephone: 561-225-3205
Attention: John Arrastia
E-Mail: john.arrastia@evolution-metals.com
If to a Buyer, to its address and e-mail
address set forth on the Schedule of Buyers, with copies to such Buyer's representatives as set forth on the Schedule of Buyers,
With copy to:
David Fine, Esq.
c/o Yorkville Advisors Global, LP
1012
Springfield Avenue
Mountainside, NJ 07092
Email: legal@yorkvilleadvisors.com
or to such other address, e-mail address
and/or to the attention of such other Person as the recipient party has specified by written notice given to each other party five
(5) days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of such notice,
consent, waiver or other communication, (B) electronically generated by the sender's e- mail service provider containing the time,
date, recipient e-mail address or (C) provided by an overnight courier service shall be rebuttable evidence of personal service,
receipt by facsimile or receipt from an overnight courier service in accordance with clause (i), (ii) or (iii) above,
respectively
33
(h) Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns,
including any purchasers of any of the Convertible Debentures (but excluding any purchasers of Underlying Securities, unless pursuant
to a written assignment by such Buyer). The Company shall not assign this Agreement or any rights or obligations hereunder without the
prior written consent of the Buyers. In connection with any transfer of any or all of its Securities, a Buyer may assign all, or a portion,
of its rights and obligations hereunder in connection with such Securities without the consent of the Company, in which event such assignee
shall be deemed to be a Buyer hereunder with respect to such transferred Securities.
(i) Indemnification.
(i) In
consideration of each Buyer's execution and delivery of the Transaction Documents and acquiring the Securities thereunder and in addition
to all of the Company's other obligations under the Transaction Documents, the Company shall defend, protect, indemnify and hold harmless
each Buyer and each holder of any Securities and all of their stockholders, partners, members, officers, directors, employees and direct
or indirect investors and any of the foregoing Persons' agents or other representatives (including, without limitation, those retained
in connection with the transactions contemplated by this Agreement) (collectively, the “Indemnitees”) from and against
any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses in connection
therewith (irrespective of whether any such Indemnitee is a party to the action for which indemnification hereunder is sought), and including
reasonable attorneys' fees and disbursements (the “Indemnified Liabilities”), incurred by any Indemnitee as a result
of, or arising out of, or relating to (i) any misrepresentation or breach of any representation or warranty made by the Company in any
of the Transaction Documents, (ii) any breach of any covenant, agreement or obligation of the Company or any Subsidiary contained in any
of the Transaction Documents or (iii) any cause of action, suit, proceeding or claim brought or made against such Indemnitee by a third
party (including for these purposes a derivative action brought on behalf of the Company or any Subsidiary) or which otherwise involves
such Indemnitee that arises out of or results from (A) the execution, delivery, performance or enforcement of any of the Transaction Documents,
(B) any transaction financed or to be financed in whole or in part, directly or indirectly, with the proceeds of the issuance of the Securities,
or (C) any disclosure properly made to such Buyer pursuant to Section 4(g), or (D) the status of such Buyer or holder of the Securities
either as an investor in the Company pursuant to the transactions contemplated by the Transaction Documents or as a party to this Agreement
(including, without limitation, as a party in interest or otherwise in any action or proceeding for injunctive or other equitable relief);
provided, however, that the company shall not be liable to any indemnitee to the extent such indemnified liabilities arise directly from
the gross negligence, fraud, or willful misconduct of such indemnitee, or from any breach by such indemnitee of its representations, warranties,
covenants, or agreements contained in this agreement. To the extent that the foregoing undertaking by the Company may be unenforceable
for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities
which is permissible under applicable law.
34
(ii) Promptly
after receipt by an Indemnitee under this Section 9(i) of notice of the commencement of any action or proceeding (including any governmental
action or proceeding) involving an Indemnified Liability, such Indemnitee shall, if a claim in respect thereof is to be made against the
Company under this Section 9(i), deliver to the Company a written notice of the commencement thereof, and the Company shall have the right
to participate in, and, to the extent the Company so desires, to assume control of the defense thereof with counsel mutually reasonably
satisfactory to the Company and the Indemnitee; provided, however, that an Indemnitee shall have the right to retain its own counsel with
the fees and expenses of such counsel to be paid by the Company if: (A) the Company has agreed in writing to pay such fees and expenses;
(B) the Company shall have failed promptly to assume the defense of such Indemnified Liability and to employ counsel reasonably satisfactory
to such Indemnitee in any such Indemnified Liability; or (C) the named parties to any such Indemnified Liability (including any impleaded
parties) include both such Indemnitee and the Company, and such Indemnitee shall have been advised by counsel that a conflict of interest
is likely to exist if the same counsel were to represent such Indemnitee and the Company (in which case, if such Indemnitee notifies the
Company in writing that it elects to employ separate counsel at the expense of the Company, then the Company shall not have the right
to assume the defense thereof and such counsel shall be at the expense of the Company), provided further, that in the case of clause (C)
above the Company shall not be responsible for the reasonable fees and expenses of more than one (1) separate legal counsel for the Indemnitees.
The Indemnitee shall reasonably cooperate with the Company in connection with any negotiation or defense of any such action or Indemnified
Liability by the Company and shall furnish to the Company all information reasonably available to the Indemnitee which relates to such
action or Indemnified Liability. The Company shall keep the Indemnitee reasonably apprised at all times as to the status of the defense
or any settlement negotiations with respect thereto. The Company shall not be liable for any settlement of any action, claim or proceeding
effected without its prior written consent, provided, however, that the Company shall not unreasonably withhold, delay or condition its
consent. The Company shall not, without the prior written consent of the Indemnitee, consent to entry of any judgment or enter into any
settlement or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such
Indemnitee of a release from all liability in respect to such Indemnified Liability or litigation, and such settlement shall not include
any admission as to fault on the part of the Indemnitee. Following indemnification as provided for hereunder, the Company shall be subrogated
to all rights of the Indemnitee with respect to all third parties, firms or corporations relating to the matter for which indemnification
has been made. The failure to deliver written notice to the Company within a reasonable time of the commencement of any such action shall
not relieve the Company of any liability to the Indemnitee under this Section 9(i), except to the extent that the Company is materially
and adversely prejudiced in its ability to defend such action.
(iii) The
indemnification required by this Section 9(i) shall be made by periodic payments of the amount thereof during the course of the investigation
or defense, within ten (10) days after bills supporting the Indemnified Liabilities are received by the Company.
(iv) The
indemnity agreement contained herein shall be in addition to (A) any cause of action or similar right of the Indemnitee against the Company
or others, and (B) any liabilities the Company may be subject to pursuant to the law.
35
(j) No
Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express their
mutual intent, and no rules of strict construction will be applied against any party.
(k) No
Waiver. Any waiver by a party of any breach of any provision of this Agreement shall not operate as or be construed to be a waiver
of any other breach of such provision or of any breach of any other provision of this Agreement. The failure of a party to insist upon
strict adherence to any term of this Agreement on one or more occasions shall not be considered a waiver or deprive that party of the
right thereafter to insist upon strict adherence to that term or any other term of this Agreement. No provision of this Agreement may
be waived or amended other than by a written agreement signed by the parties to this Agreement. No custom or practice of the parties at
variance with the terms hereof shall constitute a waiver by any party of its right to exercise any right, power or remedy available to
it hereunder or any other right, power or remedy or to demand strict compliance with the terms of this Agreement.
[REMAINDER PAGE INTENTIONALLY LEFT
BLANK]
36
IN WITNESS WHEREOF,
each Buyer and the Company have caused their respective signature page to this Securities Purchase Agreement to be duly executed as
of the date first written above.
COMPANY:
EVOLUTION METALS & TECHNOLOGIES CORP.
By:
/s/ David Wilcox
Name:
David Wilcox
Title:
Executive Chairman
37
IN WITNESS WHEREOF,
each Buyer and the Company have caused their respective signature page to this Securities Purchase Agreement to be duly executed as
of the date first written above.
BUYER:
YA II PN, LTD.
By:
Yorkville Advisors Global, LP
Its:
Investment Manager
By:
Yorkville Advisors Global II, LLC
Its:
General Partner
By:
/s/ Matt Beckmna
Name:
Matt Beckmna
Title:
Members
38
EX-10.2 — REGISTRATION RIGHTS AGREEMENT
EX-10.2
Filename: ea029007301ex10-2.htm · Sequence: 5
Exhibit 10.2
REGISTRATION RIGHTS AGREEMENT
THIS REGISTRATION RIGHTS
AGREEMENT (this “Agreement”), dated as of May 7, 2026, is made by and between YA II PN, LTD., a Cayman Islands
exempt limited company (the “Investor”), and EVOLUTION METALS & TECHNOLOGIES CORP., a company incorporated under the laws
of the State of Delaware (the “Company”). The Investor and the Company may be referred to herein individually as a
“Party” and collectively as the “Parties.”
WITNESSETH
WHEREAS:
A. In
connection with the Securities Purchase Agreement by and among the parties hereto of even date herewith (the “Securities
Purchase Agreement”), the Company has agreed, upon the terms and subject to the conditions of the Securities Purchase Agreement,
to issue and sell to the Investor up to $25,775,000 in aggregate principal amount of convertible debentures (the “Convertible
Debentures”), which shall be convertible into shares of the Company’s common stock, par value $0.0001 (the “Common
Shares”) (as converted, the “Conversion Shares”), plus up to an additional $74,225,000 of subsequent convertible
debentures (the “Subsequent Convertible Debentures”) in accordance with the Securities Purchase Agreement. Capitalized
terms not defined herein shall have the meaning ascribed to them in the Securities Purchase Agreement.
B. Pursuant
to the terms of, and in consideration for the Investor entering into, and to induce the Investor to execute and deliver the Securities
Purchase Agreement, the Company has agreed to provide certain registration rights under the Securities Act of 1933, as amended, and the
rules and regulations thereunder, or any similar successor statute (collectively, the “Securities Act”), and applicable
state securities laws and other rights as provided for herein.
AGREEMENT
NOW, THEREFORE, in
consideration of the premises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Company and the Investor hereby agree as follows:
1. DEFINITIONS.
Capitalized terms used herein
and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement. As used in this Agreement,
the following terms shall have the following meanings:
(a) “Applicable
Date” means the earlier to occur of (I) the first date on which the initial Registration Statement is declared effective by
the SEC (and each Prospectus contained therein is available for use on such date) or (II) the first date on which all of the Registrable
Securities are eligible to be resold by the Investor pursuant to Rule 144.
(b) “Business
Day” shall mean any day on which the Nasdaq is open for trading, other than any day on which commercial banks are authorized
or required to be closed in New York City.
(c) “Effective
Date” means the date that the applicable Registration Statement has been declared effective by the SEC.
(d) “Effectiveness
Deadline” means, (i) with respect to the initial Registration Statement required to be filed pursuant to Section 2(b), the earlier
of (A) the 60th calendar day following the filing date thereof and (B) the fifth Business Day after the date the Company is notified (orally
or in writing, whichever is earlier) by the SEC that such Registration Statement will not be reviewed or will not be subject to further
review and (ii) with respect to any additional Registration Statements that may be required to be filed by the Company pursuant to this
Agreement, the earlier of (A) the 60th calendar day following the date on which the Company files such additional Registration Statement
and (B) no later than the fifth Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the
SEC that such Registration Statement will not be reviewed or will not be subject to further review.
(e) “Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
(f) “Filing
Deadline” means, (i) with respect to the initial Registration Statement required to be filed pursuant to Section 2(b), the 30th
calendar day following the date hereof and (ii) with respect to any additional Registration Statements that may be required to be filed
by the Company pursuant to this Agreement, the date on which the Company was required to file such additional Registration Statement pursuant
to the terms of this Agreement.
(g) “Person”
means a corporation, a limited liability company, an association, a partnership, an organization, a business, an individual, a governmental
or political subdivision thereof or a governmental agency.
(h) “Prospectus”
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously
omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated under the Securities
Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable
Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus, including post-effective amendments,
and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.
(i) “Registrable
Securities” means all of (i) the Common Shares issuable upon conversion of the Convertible Debentures, (ii) solely after the
issuance of any Subsequent Converrtible Debentures, the Common Shares issuable upon conversion of such Subsequent Convertible Debentures,
and (iii) any Common Shares issued or issuable with respect to any shares described in subsections (i) and (ii) above by way of any stock
split, stock dividend or other distribution, recapitalization or similar event or otherwise (in each case without giving effect to any
limitations on exercise set forth in the Convertible Debentures).
2
(j) “Registration
Statement” means any registration statement of the Company filed pursuant to this Agreement, including the Prospectus, amendments
and supplements to such registration statement or Prospectus, including post-effective amendments, all exhibits thereto, and all material
incorporated by reference or deemed to be incorporated by reference in such registration statement.
(k) “Required
Registration Amount” means (i) with respect to the initial Registration Statement at least 5,400,000 Common Shares issued or
to be issued upon conversion of the Convertible Debentures, and (ii) with respect to subsequent Registration Statements such number of
Common Shares equal to the maximum number of Common Shares issuable upon conversion of all Convertible Debentures of Subsequent Convertible
Debentures then outstanding (assuming for purposes hereof that (x) such Convertible Debentures and Subsequent Convertible Debentures are
convertible at the Conversion Price (as defined therein) in effect as of the date of determination, and (y) any such conversion shall
not take into account any limitations on the conversion of the Convertible Debentures or the Subsequent Convertible Debentures set forth
therein), in each case subject to any cutback set forth in Section 2(e).
(l) “Rule 144” means Rule
144 under the Securities Act or any successor rule thereto.
(m) “Rule 415” means
Rule 415 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule
or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such Rule.
(n) “SEC”
means the Securities and Exchange Commission or any other federal agency administering the Securities Act and the Exchange Act at the
time.
(o) “Securities Act” shall have the meaning set forth in the Recitals above.
(p) “SEC
Guidance” means (i) any publicly-available written or oral guidance of the SEC staff, or any comments, requirements or requests
of the SEC staff and (ii) the Securities Act.
2. REGISTRATION.
(a) Registration
Period. The Company’s registration obligations set forth in this Section 2 including its obligations to file Registration Statements,
obtain effectiveness of Registration Statements, and maintain the continuous effectiveness of any Registration Statement that has been
declared effective shall begin on the date hereof and continue until all the Registrable Securities have been sold or may be sold without
any restrictions pursuant to Rule 144, as determined by the counsel to the Company pursuant to a written opinion letter to such effect,
addressed and reasonably acceptable to the Company’s transfer agent (the “Registration Period”).
(b) Mandatory
Registration. Subject to the terms and conditions of this Agreement, the Company shall (i) on or prior to the Filing Deadline,
prepare and file with the SEC an initial Registration Statement on Form S-3 (or, if the Company is not then eligible, on Form S- 1)
or any successor form thereto covering the resale by the Investor of Registrable Securities, and (ii) on or prior to the 30th
calendar day following receipt of each written notice by the Investor (a“Demand Notice”) delivered pursuant to
the terms hereof, prepare and file an additional Registration Statement covering the resale by the Investor of Registrable
Securities not covered by the initial Registration Statement. Each Registration Statement prepared pursuant hereto shall register
for resale at least the number of Common Shares equal to the Required Registration Amount as of date the Registration Statement is
initially filed with the SEC. Each Registration Statement shall contain “Selling Stockholders” and “Plan
of Distribution” sections. The Company shall use its commercially reasonable efforts to have each Registration Statement
declared effective by the SEC as soon as practicable, but in no event later than the Effectiveness Deadline. By 9:30 am, New York
time on the Business Day following the date of effectiveness, the Company shall file with the SEC in accordance with Rule 424 under
the Securities Act the final Prospectus to be used in connection with sales pursuant to such Registration Statement. Prior to the
filing of the Registration Statement with the SEC, the Company shall furnish a draft of the Registration Statement to the Investor
for their review and comment. The Investor shall furnish comments on the Registration Statement to the Company within 24 hours of
the receipt thereof from the Company. For the purposes hereof, the Investor shall be entitled to deliver a Demand Notice to the
Company at any time during the Registration Period if at such time (i) no Registration Statement is then in effect which the
Investor may use to resell Registrable Securities, or (ii) a Registration Statement is effective, but the holder has resold
substantially all of the Common Shares registered on such Registration Statement. In addition, the Investor may deliver a Demand
Notice to the Company at any time during the Registration Period during which (i) Subsequent Convertible Debentures have been
issued, (ii) the Company does not have a class of securities listed, or approved for listing, on a national securities exchange
registered pursuant to Section 6 of the Exchange Act, or (iii) Rule 144, as amended, would not allow the “tacking” of
the holding period of the Convertible Debenture or Subsequent Convertible Debentures onto the holding period of the Conversion
Shares issuable upon conversion thereof.
3
(c) Sufficient
Number of Shares Registered. If at any time all Registrable Securities are not covered by a Registration Statement filed pursuant
to Section 2(b) as a result of Section 2(e) or otherwise, the Company shall use commercially reasonable efforts to file with the SEC one
(1) or more additional Registration Statements so as to cover all of the Registrable Securities not covered by such initial Registration
Statement, in each case as soon as practicable (taking into account any position of the staff of the SEC with respect to the date on which
the Staff will permit such additional Registration Statement(s) to be filed with the SEC and the rules and regulations of the SEC). The
Company shall use commercially reasonable efforts to cause each such new Registration Statement to become effective as soon as reasonably
practicable following the filling thereof with the SEC.
(d) Amendments
and Supplements. During the Registration Period, subject to Allowable Grace Periods (as defined in Section 2(g) below), the
Company shall (i) promptly prepare and file with the SEC such amendments (including post-effective amendments) and supplements to a
Registration Statement and the Prospectus used in connection with a Registration Statement, which Prospectus is to be filed pursuant
to Rule 424 promulgated under the Securities Act, as may be necessary to keep such Registration Statement effective at all times
during the Registration Period, (ii) prepare and file with the SEC additional Registration Statements in order to register for
resale under the Securities Act all of the Registrable Securities in accordance with the terms of this Agreement; (iii) cause the
related Prospectus to be amended or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and
as so supplemented or amended to be filed pursuant to Rule 424; (iv) respond as promptly as reasonably possible to any comments
received from the SEC with respect to a Registration Statement or any amendment thereto and as promptly as reasonably possible
provide the Investor true and complete copies of all correspondence from and to the SEC relating to a Registration Statement
(provided that the Company may excise any information contained therein which would constitute material non-public information as to
any Investor which has not executed a confidentiality agreement with the Company); and (v) comply with the provisions of the
Securities Act with respect to the disposition of all Registrable Securities of the Company covered by such Registration Statement
until such time as all of such Registrable Securities shall have been disposed of in accordance with the intended methods of
disposition by the seller or sellers thereof as set forth in such Registration Statement. In the case of amendments and supplements
to a Registration Statement which are required to be filed pursuant to this Agreement (including pursuant to this Section 2(d)) by
reason of the Company’s filing a report on Form 10-K, Form 10-Q, or Form 8-K or any analogous report under the Securities
Exchange Act, the Company shall incorporate such report by reference into the Registration Statement, if applicable, or shall file
such amendments or supplements with the SEC on the same day on which the Exchange Act report is filed which created the requirement
for the Company to amend or supplement the Registration Statement.
(e) Reduction
of Registrable Securities Included in a Registration Statement. Notwithstanding anything contained herein, in the event that the SEC
requires the Company to reduce the number of Registrable Securities to be included in a Registration Statement in order to allow the Company
to rely on Rule 415 with respect to a Registration Statement, then the Company shall be obligated to include in such Registration Statement
(which may be a subsequent Registration Statement if the Company needs to withdraw a Registration Statement and refile a new Registration
Statement in order to rely on Rule 415) only such limited portion of the Registrable Securities as the SEC shall permit. Any Registrable
Securities that are excluded in accordance with the foregoing terms are hereinafter referred to as “Cut Back Securities.”
To the extent Cut Back Securities exist, promptly following such time as may be permitted by the SEC, the Company shall be required to
file a Registration Statement covering the resale of the Cut Back Securities (subject also to the terms of this Section) and shall use
commercially reasonable efforts to cause such Registration Statement to be declared effective as promptly as practicable thereafter, but
in no event later than the Effectiveness Deadline. Notwithstanding the foregoing to the contrary, the Company shall be obligated to use
diligent efforts to advocate with the SEC for the registration of all of the Registrable Securities in accordance with the SEC Guidance,
including without limitation, Compliance and Disclosure Interpretation 612.09. Unless otherwise directed in writing by a holder as to
its Registrable Securities, the number of Registrable Securities to be registered on such Registration Statement will be reduced as follows:
(i) first, the Company shall reduce or eliminate any securities to be included other than Registrable Securities; and (ii) second, the
Company shall reduce Registrable Securities on a pro rata basis based on the total number of Registrable Securities held by such holders
(or as otherwise expressly directed by the SEC).
4
(f) Piggy-Back
Registrations. If at any time there is not an effective Registration Statement covering all of the Registrable Securities and
the Company proposes to register the offer and sale of any shares of its Common Shares under the Securities Act (other than a
registration (i) pursuant to a Registration Statement on Form S-8 ((or other registration solely relating to an offering or sale to
employees or directors of the Company pursuant to any employee stock plan or other employee benefit arrangement), (ii) pursuant to a
Registration Statement on Form S-4 (or similar form that relates to a transaction subject to Rule 145 under the Securities Act or
any successor rule thereto), or (iii) in connection with any dividend or distribution reinvestment or similar plan), whether for its
own account or for the account of one or more stockholders of the Company and the form of Registration Statement to be used may be
used for any registration of Registrable Securities, the Company shall give prompt written notice (in any event no later than five
days prior to the filing of such Registration Statement) to the holders of Registrable Securities of its intention to effect such a
registration and, shall include in such registration all Registrable Securities with respect to which the Company has received
written requests for inclusion from the holders of Registrable Securities; provided, however, that, the Company shall
not be required to register any Registrable Securities pursuant to this Section 2(f) that have been sold or may be sold without any
restrictions pursuant to Rule 144, as determined by the counsel to the Company pursuant to a written opinion letter to such effect,
addressed and acceptable to the Company’s transfer agent.
(g) Allowable
Grace Period. Notwithstanding anything to the contrary contained herein, upon the advice of Company counsel in the form of a
written opinion, at any time after the effective date of a particular Registration Statement, the Company may, upon written notice
to the Investor, suspend the Investor’s use of any Prospectus (in which event the Investor shall discontinue sales of any
Registrable Securities pursuant to such Registration Statement contemplated by this Agreement, but shall settle any previously made
sales of Registrable Securities) if the Company (x) is pursuing an acquisition, merger, tender offer, reorganization, disposition or
other similar transaction and the Company determines in good faith that (A) the Company’s ability to pursue or consummate such
a transaction would be materially adversely affected by any required disclosure of such transaction in such Registration Statement
or other registration statement or (B) such transaction renders the Company unable to comply with SEC requirements, in each case
under circumstances that would make it impractical or inadvisable to cause any Registration Statement (or such filings) to be used
by the Investor or to promptly amend or supplement any Registration Statement contemplated by this Agreement on a post effective
basis, as applicable, or (y) has experienced some other material non-public event the disclosure of which at such time, in the good
faith judgment of the Company, would materially adversely affect the Company (each, an “Allowable Grace Period”);
provided, however, that in no event shall the Investor be suspended from selling Registrable Securities pursuant to any Registration
Statement for a period that exceeds twenty (20) consecutive calendar days or an aggregate of thirty (30) calendar days in any
365-day period. Upon disclosure of such information or the termination of the condition described above, the Company shall provide
prompt notice, but in any event within one Business Day of such disclosure or termination, to the Investor and shall promptly
terminate any suspension of sales it has put into effect and shall take such other reasonable actions to permit registered sales of
Registrable Securities as contemplated in this Agreement.
(h) No
Inclusion of Other Securities; Other Registration Statements. In no event shall the Company (i) include any securities other
than Registrable Securities on any Registration Statement filed hereunder without the Investor’s prior written consent or (ii)
prior to the Applicable Date, or at any time thereafter while any Registration Statement is not effective or the Prospectus
contained therein is not available for use, the Company shall not file a registration statement or an offering statement under the
Securities Act relating to securities that are not the Registrable Securities (other than a registration statement on Form S-8 or
such supplements or amendments to registration statements that are outstanding and have been declared effective by the SEC as of the
date hereof) (solely to the extent necessary to keep such registration statements effective and available and not for any other
reason).
5
3. RELATED OBLIGATIONS.
(a) The
Company shall, not less than three Business Days prior to the filing of each Registration Statement and not less than one Business Day
prior to the filing of any related amendments and supplements to all Registration Statements (except for annual reports on Form 10-K,
supplements and amendments to update the Registration Statement solely for information reflected in the Company’s annual reports
on Form 10-K, quarterly reports on Form 10-Q or current reports on Form 8-K), furnish to each Investor copies of all such documents proposed
to be filed, which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the reasonable
and prompt review of such Investor, The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements
thereto to which the Investor shall reasonably object in good faith; provided that, the Company is notified of such objection in
writing no later than two (2) Trading Days after the Investors have been so furnished copies of a Registration Statement.
(b) The
Company shall furnish to each Investor whose Registrable Securities are included in any Registration Statement, without charge, (i) an
electronic copy of such Registration Statement as declared effective by the SEC and any amendment(s) thereto, including financial statements
and schedules, all documents incorporated therein by reference, all exhibits and each preliminary prospectus, (ii) an electronic of the
final prospectus included in such Registration Statement and all amendments and supplements thereto (or such other number of copies as
such Investor may reasonably request) and (iii) such other documents, which are not publicly available through EDGAR, as such Investor
may reasonably request from time to time in order to facilitate the disposition of the Registrable Securities owned by such Investor.
(c) The
Company shall use commercially reasonable efforts to (i) register and qualify the Registrable Securities covered by a Registration Statement
under such other securities or “blue sky” laws of such jurisdictions in the United States as the Investor reasonably requests,(ii)
prepare and file in those jurisdictions, such amendments (including post-effective amendments) and supplements to such registrations
and qualifications as may be necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such other actions
as may be necessary to maintain such registrations and qualifications in effect at all times during the Registration Period, and (iv)
take all other actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions; provided,
however, that the Company shall not be required in connection therewith or as a condition thereto to (w) make any change to its certificate
of incorporation or by-laws, (x) qualify to do business in any jurisdiction where it would not otherwise be required to qualify but for
this Section 3(c), (y) subject itself to general taxation in any such jurisdiction, or (z) file a general consent to service of process
in any such jurisdiction. The Company shall promptly notify each Investor who holds Registrable Securities of the receipt by the Company
of any notification with respect to the suspension of the registration or qualification of any of the Registrable Securities for sale
under the securities or “blue sky” laws of any jurisdiction in the United States or its receipt of actual notice of the initiation
or threat of any proceeding for such purpose.
6
(d) At
any time prior to the end of the Registration Period, as promptly as practicable after becoming aware of such event or development, the
Company shall notify each Investor in writing of the happening of any event as a result of which the Prospectus included in a Registration
Statement, as then in effect, includes an untrue statement of a material fact or omission to state a material fact required to be stated
therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading (provided
that in no event shall such notice contain any material, nonpublic information), and promptly prepare a supplement or amendment to such
Registration Statement to correct such untrue statement or omission, and deliver ten (10) copies of such supplement or amendment to the
Investor. The Company shall also promptly notify each Investor in writing (i) when a Prospectus or any Prospectus supplement or post-effective
amendment has been filed, and when a Registration Statement or any post-effective amendment has become effective (notification of such
effectiveness shall be delivered to the Investor by facsimile on the same day of such effectiveness), (ii) of any request by the SEC for
amendments or supplements to a Registration Statement or related prospectus or related information, and (iii) of the Company’s reasonable
determination that a post-effective amendment to a Registration Statement would be appropriate. The Company shall respond as promptly
as reasonably practicable to any comments received from the SEC with respect to a Registration Statement or any amendment thereto.
(e) The
Company shall use commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness of a
Registration Statement, or the suspension of the qualification of any of the Registrable Securities for sale in any jurisdiction within
the United States of America and, if such an order or suspension is issued, to obtain the withdrawal of such order or suspension at the
earliest possible moment and to notify each Investor who holds Registrable Securities being sold of the issuance of such order and the
resolution thereof or its receipt of actual notice of the initiation or threat of any proceeding for such purpose.
(f) The
Company shall hold in confidence and not make any disclosure of information concerning the Investor provided to the Company unless
(i) disclosure of such information is necessary to comply with applicable law, including federal or state securities laws, (ii) the
disclosure of such information is necessary to avoid or correct a misstatement or omission in any Registration Statement, (iii) the
release of such information is ordered pursuant to a subpoena or other final, non-appealable order from a court or governmental body
of competent jurisdiction, or (iv) such information has been made generally available to the public other than by disclosure in
violation of this Agreement or any other agreement. The Company agrees that it shall, upon learning that disclosure of such
information concerning the Investor is sought in or by a court or governmental body of competent jurisdiction or through other
means, give prompt written notice to the Investor and allow the Investor, at the Investor’s expense, to undertake appropriate
action to prevent disclosure of, or to obtain a protective order for, such information.
(g) The
Company shall use commercially reasonable efforts to cause all the Registrable Securities to be listed on each securities exchange on
which the Common Shares is then listed. The Company shall pay all fees and expenses in connection with satisfying its obligation under
this Section 3(g).
(h) The
Company shall cooperate with the holders of the Registrable Securities to facilitate the timely preparation and delivery of
certificates representing the Registrable Securities to be sold pursuant to such Registration Statement or Rule 144 free of any
restrictive legends and representing such number of Common Shares and registered in such names as the holders of the Registrable
Securities may reasonably request a reasonable period of time prior to sales of Registrable Securities pursuant to such Registration
Statement or Rule; provided, that the Company may satisfy its obligations hereunder without issuing physical stock
certificates through the use of The Depository Trust Company's Direct Registration System.
7
(i) The
Company shall use commercially reasonable efforts to cause the Registrable Securities to be registered with or approved by such other
governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable Securities.
(j) The
Company shall otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the SEC in connection
with any registration hereunder.
(k) Within
one Business Day after a Registration Statement which covers Registrable Securities is declared effective by the SEC, the Company shall
deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities (with copies
to the Investor whose Registrable Securities are included in such Registration Statement) confirmation that such Registration Statement
has been declared effective by the SEC.
(l) The
Company shall take all other reasonable actions necessary to expedite and facilitate disposition by each Investor of Registrable Securities
pursuant to a Registration Statement.
4. OBLIGATIONS OF THE INVESTOR.
(a) The
Investor agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 2(g)
the Investor will immediately discontinue disposition of Registrable Securities pursuant to any Registration Statement covering such Registrable
Securities until the Investor’s receipt of the copies of the supplemented or amended prospectus contemplated by Section 2(g) or
receipt of notice that no supplement or amendment is required. Notwithstanding anything to the contrary, subject to compliance with the
securities laws, the Company shall cause its transfer agent to deliver unlegended certificates for Common Shares to a transferee of an
Investor in accordance with the terms of the Securities Purchase Agreement in connection with any sale of Registrable Securities with
respect to which an Investor has entered into a contract for sale prior to the Investor’s receipt of a notice from the Company of
the happening of any event of the kind described in Section 2(g) and for which the Investor has not yet settled.
(b) The
Investor covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to it
or an exemption therefrom in connection with sales of Registrable Securities pursuant to the Registration Statement.
5. EXPENSES OF REGISTRATION.
Each party shall bear its
own fees and expenses related to the transactions contemplated by this Agreements. For the avoidance of doubt, all expenses incurred
by the Company in complying with its obligations pursuant to this Agreement and in connection with the registration and disposition
of Registrable Securities shall be paid by the Company, including, without limitation, all registration, listing and qualifications
fees, printers expenses, and fees and expenses of the Company’s counsel and accountants (except legal fees of Investor’s
counsel associated with the review of the Registration Statement). The Investor shall pay any sales or brokerage commissions and
fees and expenses of counsel for, and other expenses of, the Investor incurred in connection with registration of Registrable
Securities.
8
6. INDEMNIFICATION.
With respect to Registrable Securities
which are included in a Registration Statement under this Agreement:
(a) To
the fullest extent permitted by law, the Company shall, and hereby does, indemnify, hold harmless and defend the Investor, the
directors, officers, partners, employees, agents, representatives of, and each Person, if any, who controls any Investor within the
meaning of the Securities Act or the Exchange Act (each, an “Indemnified Person”), against any losses, claims,
damages, liabilities, judgments, fines, penalties, charges, costs, reasonable attorneys’ fees, amounts paid in settlement or
expenses, joint or several (collectively, “Claims”) incurred in investigating, preparing or defending any action,
claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court or governmental,
administrative or other regulatory agency, body or the SEC, whether pending or threatened, whether or not an indemnified party is or
may be a party thereto (“Indemnified Damages”), to which any of them may become subject insofar as such Claims
(or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon: (i) any untrue
statement or alleged untrue statement of a material fact in a Registration Statement or any post-effective amendment thereto or in
any filing made in connection with the qualification of the offering under the securities or other “blue sky” laws of
any jurisdiction in which Registrable Securities are offered (“Blue Sky Filing”), or the omission or alleged
omission to state a material fact required to be stated therein or necessary to make the statements therein not misleading; (ii) any
untrue statement or alleged untrue statement of a material fact contained in any final prospectus (as amended or supplemented, if
the Company files any amendment thereof or supplement thereto with the SEC) or the omission or alleged omission to state therein any
material fact necessary to make the statements made therein, in light of the circumstances under which the statements therein were
made, not misleading; or (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any other
law, including, without limitation, any state securities law, or any rule or regulation there under relating to the offer or sale of
the Registrable Securities pursuant to a Registration Statement (the matters in the foregoing clauses (i) through (iii) being,
collectively, “Violations”). The Company shall reimburse the Investor and each such controlling person promptly
as such expenses are incurred and are due and payable, for any legal fees or disbursements or other reasonable expenses incurred by
them in connection with investigating or defending any such Claim. Notwithstanding anything to the contrary contained herein, the
indemnification agreement contained in this Section 6(a): (x) shall not apply to a Claim by an Indemnified Person arising out of or
based upon a Violation which occurs in reliance upon and in conformity with information furnished in writing to the Company by such
Indemnified Person expressly for use in connection with the preparation of the Registration Statement or any such amendment thereof
or supplement thereto; (y) shall not be available to the extent such Claim is based on a failure of the Investor to deliver or to
cause to be delivered the prospectus made available by the Company, if such prospectus was timely made available by the Company
pursuant to Section 3(b); and (z) shall not apply to amounts paid in settlement of any Claim if such settlement is effected without
the prior written consent of the Company, which consent shall not be unreasonably withheld. Such indemnity shall remain in full
force and effect regardless of any investigation made by or on behalf of the Indemnified Person.
(b) In
connection with a Registration Statement, the Investor agrees to indemnify, hold harmless and defend, to the same extent and in the same
manner as is set forth in Section 6(a), the Company, each of its directors, each of its officers, employees, representatives, or agents
and each Person, if any, who controls the Company within the meaning of the Securities Act or the Exchange Act (each an “Indemnified
Party”), against any Claim or Indemnified Damages to which any of them may become subject, under the Securities Act, the Exchange
Act or otherwise, insofar as such Claim or Indemnified Damages arise out of or is based upon any Violation, in each case to the extent,
and only to the extent, that such Violation occurs in reliance upon and in conformity with written information furnished to the Company
by such Investor expressly for use in connection with such Registration Statement; and, subject to Section 6(d), such Investor will reimburse
any legal or other expenses reasonably incurred by them in connection with investigating or defending any such Claim; provided, however,
that the indemnity agreement contained in this Section 6(b) and the agreement with respect to contribution contained in Section 7 shall
not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of such Investor,
which consent shall not be unreasonably withheld. Such indemnity shall remain in full force and effect regardless of any investigation
made by or on behalf of such Indemnified Party. Notwithstanding anything to the contrary contained herein, the indemnification agreement
contained in this Section 6(b) with respect to any prospectus shall not inure to the benefit of any Indemnified Party if the untrue statement
or omission of material fact contained in the prospectus was corrected and such new prospectus was delivered to each Investor prior to
such Investor’s use of the prospectus to which the Claim relates.
9
(c) Promptly
after receipt by an Indemnified Person or Indemnified Party under this Section 6 of notice of the commencement of any action or
proceeding (including any governmental action or proceeding) involving a Claim, such Indemnified Person or Indemnified Party shall,
if a Claim in respect thereof is to be made against any indemnifying party under this Section 6, deliver to the indemnifying party a
written notice of the commencement thereof, and the indemnifying party shall have the right to participate in, and, to the extent
the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control of the defense
thereof with counsel mutually satisfactory to the indemnifying party and the Indemnified Person or the Indemnified Party, as the
case may be; provided, however, that an Indemnified Person or Indemnified Party shall have the right to retain its own counsel with
the fees and expenses of not more than one (1) counsel for such Indemnified Person or Indemnified Party to be paid by the
indemnifying party, if, in the reasonable opinion of counsel retained by the indemnifying party, the representation by such counsel
of the Indemnified Person or Indemnified Party and the indemnifying party would be inappropriate due to actual or potential
differing interests between such Indemnified Person or Indemnified Party and any other party represented by such counsel in such
proceeding. The Indemnified Party or Indemnified Person shall cooperate fully with the indemnifying party in connection with any
negotiation or defense of any such action or claim by the indemnifying party and shall furnish to the indemnifying party all
information reasonably available to the Indemnified Party or Indemnified Person which relates to such action or claim. The
indemnifying party shall keep the Indemnified Party or Indemnified Person fully apprised at all times as to the status of the
defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for any settlement of any action,
claim or proceeding effected without its prior written consent; provided, however, that the indemnifying party shall not
unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior written consent of the
Indemnified Party or Indemnified Person, consent to entry of any judgment or enter into any settlement or other compromise which
does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party or Indemnified
Person of a release from all liability in respect to such claim or litigation. Following indemnification as provided for hereunder,
the indemnifying party shall be subrogated to all rights of the Indemnified Party or Indemnified Person with respect to all third
parties, firms or corporations relating to the matter for which indemnification has been made. The failure to deliver written notice
to the indemnifying party within a reasonable time of the commencement of any such action shall not relieve such indemnifying party
of any liability to the Indemnified Person or Indemnified Party under this Section 6, except to the extent that the indemnifying
party is prejudiced in its ability to defend such action.
(d) The
indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the investigation
or defense, as and when bills are received or Indemnified Damages are incurred.
(e) The indemnity
agreements contained herein shall be in addition to (i) any cause of action or similar right of the Indemnified Party or Indemnified
Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to pursuant to the law.
7. CONTRIBUTION.
To the extent any indemnification
by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum contribution with respect
to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted by law; provided, however, that:
(i) no seller of Registrable Securities guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities
Act) shall be entitled to contribution from any seller of Registrable Securities who was not guilty of fraudulent misrepresentation; and
(ii) contribution by any seller of Registrable Securities shall be limited in amount to the net amount of proceeds received by such seller
from the sale of such Registrable Securities.
10
8. REPORTS UNDER THE EXCHANGE ACT.
With a view to making available
to the Investor the benefits of Rule 144 promulgated under the Securities Act or any similar rule or regulation of the SEC that may at
any time permit the Investor to sell securities of the Company to the public without registration, and as a material inducement to the
Investor’s purchase of the Convertible Debentures, the Company represents, warrants, and covenants to the following:
(a) The
Company is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act and has filed all required reports under
Section 13 or 15(d) of the Exchange Act during the 12 months prior to the date hereof (or for such shorter period that the issuer
was required to file such reports), other than Form 8-K reports.
(b) During
the Registration Period, the Company shall file with the SEC in a timely manner all required reports under Section 13 or 15(d) of the
Exchange Act (it being understood that nothing herein shall limit the Company’s obligations under the Securities Purchase Agreement)
and such reports shall conform to the requirement of the Exchange Act and the SEC for filing thereunder.
(c) The
Company shall furnish to the Investor so long as such Investor owns Registrable Securities, promptly upon request, (i) a written statement
by the Company that it has complied with the reporting requirements of Rule 144, (ii) a copy of the most recent annual or quarterly report
of the Company and such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested
to permit the Investor to sell such securities pursuant to Rule 144 without registration.
9. AMENDMENT OF REGISTRATION RIGHTS.
Provisions of this Agreement
may be amended and the observance thereof may be waived (either generally or in a particular instance and either retroactively or prospectively),
only with the written consent of the Company and Investor. Any amendment or waiver effected in accordance with this Section 9 shall be
binding upon the Investor and the Company. No such amendment shall be effective to the extent that it applies to fewer than all of the
holders of the Registrable Securities. No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification
of any provision of any of this Agreement unless the same consideration also is offered to all of the parties to this Agreement.
11
10. MISCELLANEOUS.
(a) A
Person is deemed to be a holder of Registrable Securities whenever such Person owns or is deemed to own of record such Registrable Securities
or owns the right to receive the Registrable Securities. If the Company receives conflicting instructions, notices or elections from two
or more Persons with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election
received from the registered owner of such Registrable Securities.
(b) The Company shall not
file any other registration statements on Form S-3, Form S-1, or otherwise until the initial Registration Statement required hereunder
is declared effective by the SEC, provided that this Section 10(b) shall not prohibit the Company from filing amendments to registration
statements already filed. The Company shall not include any other securities on a Registration Statement unless otherwise agreed by the
Investor.
(c) Any
notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in
writing and will be deemed to have been delivered pursuant to the notice provisions of the Securities Purchase Agreement or to such
other address and/or electronic mail address and/or to the attention of such other person as the recipient party has specified by
written notice given to each other party five (5) days prior to the effectiveness of such change. Written confirmation of receipt
(A) given by the recipient of such notice, consent, waiver or other communication, (B) electronically generated by the
sender’s email service provider containing the time, date, and recipient email or (C) provided by a courier or overnight
courier service shall be rebuttable evidence of personal service, receipt by facsimile or receipt from a nationally recognized
overnight delivery service in accordance with this section.
(d) Failure
of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or remedy,
shall not operate as a waiver thereof.
(e) The
laws of the State of New York shall govern all issues concerning the relative rights of the Company and the Investors as its stockholders.
All other questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal
laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of
New York or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of New York.
Each party hereby irrevocably submits to the non-exclusive jurisdiction of the Supreme Court of the State of New York, sitting in New
York County, New York and federal courts for the Southern District of New York sitting New York, New York, for the adjudication of any
dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives,
and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is
improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action
or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that such
service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit
in any way any right to serve process in any manner permitted by law. If any provision of this Agreement shall be invalid or unenforceable
in any jurisdiction, such invalidity or unenforceability shall not affect the validity or enforceability of the remainder of this Agreement
in that jurisdiction or the validity or enforceability of any provision of this Agreement in any other jurisdiction. EACH PARTY HEREBY
IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN
CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.
12
(f) This
Agreement and the rights, duties and obligations of the Investor hereunder may only be assigned upon the transfer of a Convertible Debenture
or the Conversion Shares issued pursuant to a Convertible Debenture pursuant to the terms and restrictions on transfer set forth in the
Securities Purchase Agreement and the applicable Convertible Debenture. This Agreement and the provisions hereof shall be binding upon
and shall inure to the benefit of each of the parties and its successors and the permitted assigns of the parties. No assignment by any
party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate the Company unless and until
the Company shall have received (A) written notice of such assignment and (B) the written agreement of the assignee, in a form reasonably
satisfactory to the Company, to be bound by the terms and provisions of this Agreement (which may be accomplished by an addendum or certificate
of joinder to this Agreement).
(g) The
headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.
(h) This
Agreement may be executed in identical counterparts, both which shall be considered one and the same agreement and shall become effective
when counterparts have been signed by each party and delivered to the other party. Facsimile or other electronically scanned and delivered
signatures (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the
Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com), including by e-mail attachment, shall be deemed
to have been duly and validly delivered and be valid and effective for all purposes of this Agreement.
(i) Each
party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such
other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.
(j) The
language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules of
strict construction will be applied against any party.
(k) This
Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for the
benefit of, nor may any provision hereof be enforced by, any other Person.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
13
IN WITNESS WHEREOF, the
Investor and the Company have caused their signature page to this Registration Rights Agreement to be duly executed as of the date first
above written.
COMPANY:
EVOLUTION METALS & TECHNOLOGIES CORP.
By:
/s/ David Wilcox
Name:
David Wilcox
Title:
Executive Chairman
INVESTOR:
YA II PN, LTD.
By: Yorkville Advisors Global, LP
Its: Investment Manager
By:
Its:
Yorkville Advisors Global II, LLC
General Partner
By:
/s/ Matthew Beckman
Name:
Matthew Beckman
Title:
Manager
14
EX-10.3 — GUARANTY AND SECURITY AGREEMENT
EX-10.3
Filename: ea029007301ex10-3.htm · Sequence: 6
Exhibit 10.3
GLOBAL GUARANTY AGREEMENT
This Guaranty (as amended, amended and restated,
supplemented or otherwise modified from time to time, this “Guaranty”) is made as of May 7, 2026, by Evolution Metals
NewCo, Inc. a Delaware corporation (“EM NewCo”), Evolution Metals LLC, a Delaware limited liability company (“EM
LLC”), KCM Industry Co., Ltd. (“KCM”), KMMI Inc. (“KMMI”), NS World Co., Ltd. (“NS
World”) and Handa Lab Co., Ltd. (“Handa,” and collectively with EM NewCo, EM LLC, KCM, KMMI, NS World, and
any subsequent party that may join in this Guaranty, the “Guarantors”) in favor of YA II PN, LTD. (“YA II”
or the “Creditor”), with respect to all obligations of Evolution Metals & Technologies Corp., a Delaware corporation
(the “Debtor”) owed to the Creditor.
RECITALS
WHEREAS, the Creditor
and the Debtor have entered into a Securities Purchase Agreement (as amended, amended and restated, supplemented or otherwise modified
from time to time, the “Agreement”) on May 7, 2026 pursuant to which the Creditor shall provide loans to the Debtor,
to be evidenced by convertible debentures (the “Convertible Debentures”) to be issued by the Debtor to the Creditor,
pursuant to and upon the terms and conditions of the Agreement, in the aggregate amount of up to $100 million;
WHEREAS, it is a condition
precedent to the Creditor’s obligation to provide the loan to the Debtor that each Guarantor guarantees all of the Debtor’s
obligations under the Agreement, the Convertible Debentures issued thereunder, and all other instruments, agreements or other items executed
or delivered (collectively, the “Transaction Documents”) by the Debtor to the Creditor in connection with or related
to the Agreement. The Creditor is only willing to enter into the Agreement and provide loans to the Debtor if each Guarantor agrees to
execute and deliver to the Creditor this Guaranty; and
WHEREAS, the Guarantors
are, or will be at the time of issuance of the Convertible Debentures, wholly owned, or majority owned subsidiaries of the Debtor and
will benefit, directly or indirectly, from the Debtor entering into the Agreement, the issuance of the Convertible Debentures, and other
Transaction Documents and extensions of credit the Creditor will make to Debtor;
NOW, THEREFORE, for
good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, each Guarantor covenants and agrees as
follows:
1. Guaranty
of Payment and Performance. Each Guarantor, jointly and severally, hereby guarantees to the Creditor the full, prompt and unconditional
payment when due (whether at maturity, by acceleration or otherwise), and the performance, of all liabilities, agreements and other obligations
of the Debtor to the Creditor contained in the Convertible Debentures and the Transaction Documents (all the foregoing, collectively,
the “Obligations”). This Guaranty is an absolute, unconditional and continuing guaranty of the full and punctual payment
and performance of the Obligations and not of their collectability only and is in no way conditioned upon any requirement that the Creditor
first attempt to collect or require the performance of any of the Obligations from the Debtor or resort to any security or other means
of obtaining their payment.
Should the Debtor default in the payment or performance
of any of the Obligations, the obligations of the Guarantors hereunder shall become immediately due and payable to the Creditor, without
demand or notice of any nature, all of which are expressly waived by the Guarantors.
2. Limited
Guaranty. The liability of the Guarantor hereunder shall be limited to the amount of the Obligations due to the Creditor.
3. Waivers by
Guarantors; Creditor’s Freedom to Act. Each Guarantor hereby agrees that the Obligations will be paid and performed
strictly in accordance with their terms regardless of any law, regulation or order now or hereafter in effect in any jurisdiction
affecting any of such terms or the rights of the Creditor with respect thereto. Each Guarantor waives presentment, demand, protest,
notice of acceptance, notice of Obligations incurred and all other notices of any kind, all defenses that may be available by virtue
of any valuation, stay, moratorium law or other similar law now or hereafter in effect (other than payment in full of the
Obligations), any right to require the marshalling of assets of the Debtor, and all suretyship defenses generally. Without limiting
the generality of the foregoing, each Guarantor agrees to the provisions of any instrument evidencing, securing or otherwise
executed in connection with any Obligation and agrees that the obligations of such Guarantor hereunder shall not be released or
discharged, in whole or in part, or otherwise affected by (i) the failure of the Creditor to assert any claim or demand or to
enforce any right or remedy against the Debtor; (ii) any extensions or renewals of, or alteration of the terms of, any Obligation or
any portion thereof unless entered into by the Creditor; (iii) any rescissions, waivers, amendments or modifications of any of the
terms or provisions of any agreement evidencing, securing or otherwise executed in connection with any Obligation unless entered
into by the Creditor; (iv) the substitution or release of any entity primarily or secondarily liable for any Obligation; (v) the
adequacy of any rights the Creditor may have against any collateral or other means of obtaining payment or performance of the
Obligations; (vi) the impairment of any collateral securing the Obligations, including without limitation the failure to perfect or
preserve any rights the Creditor might have in such collateral or the substitution, exchange, surrender, release, loss or
destruction of any such collateral; (vii) failure to obtain or maintain a right of contribution for the benefit of such Guarantor;
(viii) errors or omissions in connection with the Creditor’s administration of the Obligations (except behavior constituting
bad faith, negligence, fraud, or willful misconduct); or (ix) any other act or omission that might in any manner or to any extent
vary the risk of any Guarantor or otherwise operate as a release or discharge of any Guarantor, all of which may be done without
notice to any Guarantor.
4. Unenforceability
of Obligations Against Debtor. If for any reason the Debtor is under no legal obligation to discharge or perform any of the Obligations,
or if any of the Obligations have become irrecoverable from the Debtor by operation of law or for any other reason, this Guaranty shall
nevertheless be binding on the Guarantors to the same extent as if the Guarantors at all times had been the principal obligors on all
such Obligations. In the event that acceleration of the time for payment of the Obligations is stayed upon the insolvency, bankruptcy
or reorganization of the Debtor, or for any other reason, all such amounts otherwise subject to acceleration under the terms of any agreement
evidencing, securing or otherwise executed in connection with any Obligation shall be immediately due and payable by the Guarantors.
2
5. Subrogation;
Subordination. Until the payment and performance in full of all Obligations, the Guarantors shall not exercise any rights
against the Debtor arising as a result of payment by the Guarantors hereunder, by way of subrogation or otherwise, and will not
prove any claim in competition with the Creditor in respect of any payment hereunder in bankruptcy or insolvency proceedings of any
nature; the Guarantors will not claim any set-off or counterclaim against the Debtor in respect of any liability of the Guarantors
to the Debtor; and the Guarantors waive any benefit of and any right to participate in any collateral that may be held by the
Creditor. The payment of any amounts due with respect to any indebtedness of the Debtor now or hereafter held by the Guarantor is
hereby subordinated to the prior payment in full of the Obligations. The Guarantor agrees that after the occurrence of any default
in the payment or performance of the Obligations, the Guarantors will not demand, sue for or otherwise attempt to collect any such
indebtedness of the Debtor to the Guarantors until the Obligations shall have been paid or performed in full. If, notwithstanding
the foregoing sentence, the Guarantors shall collect, enforce or receive any amounts in respect of such indebtedness, such amounts
shall be collected, enforced and received by the Guarantor as trustee for the Creditor and be paid over to the Creditor on account
of the Obligations without affecting in any manner the liability of the Guarantors under the other provisions of this Guaranty.
7. Termination;
Reinstatement. This Guaranty is irrevocable and shall continue until such time as the Obligations have been indefeasibly paid
or performed in full. This Guaranty shall be reinstated if at any time any payment made or value received with respect to an Obligation
is rescinded or must otherwise be returned by the Creditor upon the insolvency, bankruptcy or reorganization of the Debtor, or otherwise,
all as though such payment had not been made or value received.
8. Successors
and Assigns. This Guaranty shall be binding upon each Guarantor, its successors and assigns, and shall inure to the benefit of
and be enforceable by the Creditor and the Creditor’s shareholders, officers, directors, agents, successors and assigns.
9. Amendments
and Waivers. No amendment or waiver of any provision of this Guaranty nor consent to any departure by the Guarantor therefrom
shall be effective unless the same shall be in writing and signed by the Creditor. No failure on the part of the Creditor to exercise,
and no delay in exercising, any right hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any right
hereunder preclude any other or further exercise thereof or the exercise of any other right.
10. Notices.
All notices and other communications called for hereunder to the Creditor or the Debtor shall be made in writing as provided in the Agreement.
All notices and other communications called for hereunder to the Guarantors shall be made in writing as provided on Schedule I attached
hereto or as the Guarantors may otherwise notify the Creditor.
3
11. Governing Law;
Consent to Jurisdiction Waiver of Jury Trial. This Guaranty is intended to take effect as a sealed instrument and shall be
governed by, and construed in accordance with, the laws of the State of New York (excluding the laws applicable to conflicts or
choice of law). The Guarantor agrees that any suit for the enforcement of this Guaranty may be brought in the courts of the State of
New York, New York County and consents to the non-exclusive jurisdiction of such court and to service of process in any such
suit’s being made upon any Guarantor by mail at the address set forth at the head of this Guaranty. The Guarantor hereby
waives any objection that it may now or hereafter have to the venue of any such suit or any such court or that such suit was brought
in an inconvenient court. EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE
TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS GUARANTY OR THE TRANSACTIONS
CONTEMPLATED HEREIN, THE PERFORMANCE THEREOF OR THE FINANCINGS CONTEMPLATED HEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER
THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR
OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES
THAT IT AND THE OTHER PARTY HERETO HAVE BEEN INDUCED TO ENTER INTO THIS GUARANTY BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND
CERTIFICATIONS IN THIS PARAGRAPH.
12. Counterparts;
Effectiveness. This Guaranty may be executed in identical counterparts, both which shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party. Facsimile or other electronically
scanned and delivered signatures (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic
Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com),
including by e-mail attachment, shall be deemed to have been duly and validly delivered and be valid and effective for all purposes of
this Guaranty.
13. Maximum
Liability. Notwithstanding any provision in this Guaranty to the contrary, each Guarantor’s liability hereunder shall be
limited to an amount not to exceed the maximum amount which could be claimed by the Creditor from such Guarantor under this Guaranty without
rendering such claim voidable or avoidable under the Bankruptcy Code or under any applicable state Uniform Fraudulent Transfer Act, Uniform
Fraudulent Conveyance Act or similar statute or common law, in each case after taking into account, among other things, such Guarantor’s
right of contribution and indemnification. To effectuate the foregoing intention, the Debtor, Creditor, and Guarantors agree that the
Obligations of the Guarantors under this Guaranty at any time shall be limited to the maximum amount as will result in the Obligations
of the Guarantors under this Guaranty not constituting a fraudulent transfer or conveyance.
[Rest of page intentionally left blank. Signature
page follows.]
4
IN WITNESS WHEREOF, each Guarantor has caused
this Guaranty to be executed and delivered as a sealed instrument as of the date appearing on page one.
Evolution Metals NewCo, Inc.
By:
/s/
David Wilcox
Name:
David Wilcox
Title:
Executive Chairman
Evolution Metals LLC
By:
/s/
David Wilcox
Name:
David Wilcox
Title:
Manager
KCM Industry Co., Ltd.
By:
/s/
David Wilcox
Name:
David Wilcox
Title:
Manager
KMMI Inc.
By:
/s/
David Wilcox
Name:
David Wilcox
Title:
Manager
NS World Co., Ltd.
By:
/s/
David Wilcox
Name:
David Wilcox
Title:
Manager
Handa Lab Co., Ltd.
By:
/s/
David Wilcox
Name:
David Wilcox
Title:
Manager
5
EX-99.1 — PRESS RELEASE DATED MAY 11, 2026
EX-99.1
Filename: ea029007301ex99-1.htm · Sequence: 7
Exhibit 99.1
Evolution Metals & Technologies Corp. Secures $100 Million Investment
from Yorkville Advisors Global, LP
MIAMI, FL, May 11, 2026 (GLOBE NEWSWIRE) -- Evolution Metals &
Technologies Corp. (“EM&T”, Nasdaq: EMAT), a mid- and down-stream critical and strategic metals producer, has secured
an investment of up to $100 million from Yorkville Advisors Global, LP (“Yorkville”), a leading global asset manager.
EM&T intends to use the investment for the continued expansion
of its commercial operations, which include an intended increase in the annual tonnage of high-performance rare earth magnets produced.
David Wilcox, Executive Chairman of EM&T, stated:
“With the investment from Yorkville, Evolution continues to be
strategically positioned to advance the U.S. production of critical materials, including high-performance rare earth magnets, ex-China.
We have entered into an investment agreement that our Board and Management are highly confident will continue to drive existing and future
shareholder value. Our immediate plans are to expand our existing commercial rare earth magnet production and scale our operations through
the development of a fully integrated U.S. industrial campus.
“EM&T operates what we believe is the only known vertically
stacked critical materials supply chain spanning from end-of-life electronics and batteries, as well as high-grade concentrates, through
the manufacture of finished rare earth magnets, including high-performance rare earth magnets, and battery materials. We anticipate that
Phase I of EM&T’s planned U.S. industrial campus will establish the largest hydrometallurgical facility in the Western Hemisphere.
We feel strongly that Yorkville deeply understands EM&T’s business, development plans, and mission.”
The investment is structured as a flexible, multi-tranche convertible
facility of up to $100 million. The securities are being issued as debentures that are convertible into common stock, subject
to customary limitations, including compliance with applicable Nasdaq rules. The investment includes customary registration rights and
investor protections.
Clear Street LLC acted as sole advisor and placement agent to EM&T
on the transaction.
About Evolution Metals & Technologies Corp.
Evolution Metals & Technologies Corp. is a
U.S. based critical materials and advanced manufacturing company listed on Nasdaq. EMAT is focused on building a secure, non-China- dependent
supply chain for rare earth permanent magnets, battery materials, and related critical technologies, leveraging proven commercial-scale
operations, advanced processing technologies, and strategic partnerships.
Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking
statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of
1934, as amended, or the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not
limited to, statements regarding EMAT’s plans, objectives, expectations, projections, strategies, anticipated production capacity,
expansion plans, and financing activities. All statements, other than statements of historical facts, included herein and public statements
by our officers or representatives, that address activities, events or developments that our management expects or anticipates will or
may occur in the future, are forward-looking statements, including but not limited to such things as future business strategy, plans and
goals, competitive strengths and expansion and growth of our business. These forward-looking statements, along with terms such as “anticipate,”
“expect,” “intend,” “may,” “will,” “should,” and other comparable terms, involve
risks and uncertainties because they relate to events and depend on circumstances that will occur in the future, and include risks related
to changes in our operations; uncertainties concerning estimates; industry-related risks; the commercial success of, and risks related
to, our development activities; uncertainties and risks related to our reliance on contractors and consultants. Those statements include
statements regarding the intent, belief, or current expectations of EMAT and its management, as well as the assumptions on which such
statements are based. Although the Company has attempted to identify important factors that could cause actual results to differ materially
from those described in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated,
or intended. While these forward-looking statements were based on assumptions that the Company believes are reasonable when made, you
are cautioned that forward-looking statements are not guarantees of future performance and that actual results, performance, or achievements
may differ materially from those made in or suggested by the forward-looking statements contained in this press release. In addition,
even if our results, performance, or achievements are consistent with the forward-looking statements contained in this press release,
those results, performance, or achievements may not be indicative of results, performance, or achievements in later periods. Given these
risks and uncertainties, you are cautioned not to place undue reliance on these forward-looking statements. Any forward-looking statements
made in this press release speak only as of the date of those statements, and we undertake no obligation to update those statements or
to publicly announce the results of any revisions to any of those statements to reflect future events or developments unless required
by law. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed
or implied, including risks related to execution, financing, regulatory approvals, and market conditions. Additional information concerning
these and other factors that may impact EMAT’s expectations and projections can be found in filings it makes with the SEC, including
the Annual Report on Form 10-K of EMAT filed with the SEC on February 20, 2026, including those under “Risk Factors” therein,
and other documents filed or to be filed with the SEC by EMAT. SEC filings are available on the SEC’s website at www.sec.gov.
Investor Relations Contacts:
Judith McGarry
Evolution Metals & Technologies Corp.
investor.relations@evolution-metals.com
Arx Investor Relations
North American Equities Desk
EMAT@arxhq.com
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 12
v3.26.1
Cover
May 07, 2026
Cover [Abstract]
Document Type
8-K
Amendment Flag
false
Document Period End Date
May 07, 2026
Entity File Number
001-41183
Entity Registrant Name
Evolution Metals & Technologies Corp.
Entity Central Index Key
0001866226
Entity Tax Identification Number
87-1006702
Entity Incorporation, State or Country Code
DE
Entity Address, Address Line One
4040
NE 2nd Ave, Suite 349
Entity Address, City or Town
Miami
Entity Address, State or Province
FL
Entity Address, Postal Zip Code
33137
City Area Code
561
Local Phone Number
225-3205
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Title of 12(b) Security
Common Stock, $0.0001 par value per share
Trading Symbol
EMAT
Security Exchange Name
NASDAQ
Entity Emerging Growth Company
true
Elected Not To Use the Extended Transition Period
false
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 7A
-Section B
-Subsection 2
+ Details
Name:
dei_EntityExTransitionPeriod
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration